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Abstract
Mobile phone use has increased rapidly worldwide since the 1990’s. As mobile 
telephones are used close to the head, the exposure to the radiofrequency 
radiation emitted by mobile phones has been suggested as a possible risk factor 
for brain tumours. The effect of mobile phone use on risk of brain tumours, 
particularly gliomas and meningiomas as well as acoustic neuromas, was 
evaluated using both a case-control approach and a meta-analysis. In addition, 
one of the most important sources of error in a case-control study, selection bias 
due to differential participation, was assessed in a subset of the case-control 
data.
The risk of glioma and meningioma in relation to mobile phone use was 
investigated in population-based case-control studies conducted in five North 
European countries. All these countries used a common protocol and were 
included in a multinational study on mobile phone use and brain tumours, the 
INTERPHONE study, coordinated by the International Agency for Research on 
Cancer (IARC). Cases (1,521 gliomas and 1,209 meningiomas) were identified 
mostly from hospitals and controls (3,299) from national population registers 
or general practitioners’ patient lists. Detailed history of mobile phone use was 
obtained in personal interviews. Mobile phone use was assessed using several 
exposure indicators, such as regular use (phone use at least once a week for at 
least six months), duration of use as well as cumulative number of hours and calls.
To comprehensively evaluate the effect of mobile phone use on risk of brain 
tumours, the existing evidence from the epidemiological studies published on 
the issue was combined using meta-analysis. In the analysis, a pooled estimate 
was calculated for all brain tumours combined, and also separately for the 
three most common tumour types, glioma, meningioma and acoustic neuroma 
using inverse variance-weighted method. Pooled estimate was also obtained for 
different telephone types (NMT and GSM) and by the location of the tumour 
(same and opposite side of the head on which the phone was used).
Possible selection bias due to differential participation by exposure status in 
the Finnish arm of the INTERPHONE study was evaluated by comparing mobile 
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phone use between study participants and subjects who refused to participate in 
the study, but were willing to answer a short questionnaire covering only mobile 
phone use status and educational level. The data included 777 controls and 726 
cases with full interview, as well as 321 controls and 103 cases responding only 
to the short questionnaire. To assess the magnitude of selection bias, the risk 
for brain tumours was evaluated separately for the participants interviewed 
and for the combined group consisting of both these subjects and those who only 
responded to the short questionnaire.
In the case-control studies, mobile phone use was not conclusively related 
to increased risk of either glioma or meningioma. For both tumour types, the 
risk was decreased among regular mobile phone users compared to never and 
non-regular users (OR = 0.78, 95% CI: 0.68 – 0.91 for gliomas, OR = 0.76, 95% 
CI: 0.65 – 0.89 for meningiomas). According to the 12 studies included in the 
meta-analysis, the pooled estimate for all tumour types combined did not show 
an association between mobile phone use and brain tumours (OR = 0.98, 95% 
CI: 0.83 – 1.16). Nor was much evidence of increased risk found in the analyses by 
tumour type, telephone type or tumour location. In the Finnish INTERPHONE 
study, the study participants interviewed were more likely to be mobile phone 
users than the subjects who refused to give a full interview but responded to the 
short questionnaire. The risk for brain tumours associated with mobile phone 
use based on only interviewed participants was below unity, whereas the risk 
based on the combined group consisting of both full participants and subjects 
responding the short questionnaire was closer to unity.
The results of neither the case-control studies nor the meta-analysis 
provide consistent support for an association between mobile phone use and 
brain tumours. In the case-control studies, a decreased risk was found in relation 
to regular mobile phone use for both gliomas and meningiomas. As it is not 
plausible that mobile phone use reduces the risk for brain tumours, there is a 
possibility that such results are due to selection bias, which tends to distort the 
results in case-control studies towards the null. In the Finnish INTERPHONE 
study, an indication of selection bias was detected, as the risk for brain tumours 
related to mobile phone use was lower among study participants than in the 
group that also included the subjects who refused to grant a full interview but 
responded to the short questionnaire. Selection bias may also have distorted the 
results of the five-country case-control studies.
In conclusion, the present studies do not suggest mobile phone use as 
a cause of brain tumours. As there was decreased risks in the case-control 
studies, the possibility that the results are affected by bias, needs to be carefully 
considered in their interpretation.
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Tiivistelmä
Matkapuhelimen käyttö on lisääntynyt maailmanlaajuisesti 1990-luvulta 
alkaen. Koska matkapuhelinta käytetään lähellä päätä, puhelimen lähet-
tämälle radiotaajuiselle sähkömagneettiselle säteilylle altistumisen on ajateltu 
olevan yhteydessä aivokasvainten vaaraan. Matkapuhelimen käytön vaiku-
tusta aivokasvainten, erityisesti glioomien, meningeoomien ja akustikusneuri-
noomien, vaaraan arvioitiin sekä tapaus-verrokkiasetelmalla että meta-ana-
lyysin keinoin. Tämän lisäksi tapaus-verrokkitutkimuksen erästä keskeisintä 
virhelähdettä, valikoitumisharhaa, arvioitiin tutkimukseen osallistumisen 
suhteen tapaus-verrokkitutkimuksen osa-aineistossa.
Matkapuhelimen käyttöön liittyvää gliooman ja meningeooman 
vaaraa tutkittiin väestöpohjaisissa tapaus-verrokkitutkimuksissa, jotka 
tehtiin yhteensä viidessä Pohjois-Euroopan maassa. Kaikissa maissa 
käytettiin yhteistä tutkimusprotokollaa ja ne kuuluivat monikansalliseen 
matkapuhelimen käytön ja aivokasvainten yhteyttä selvittävään tutkimukseen, 
INTERPHONEen. INTERPHONE-tutkimusta koordinoi International Agency 
for Research on Cancer (IARC). Aivokasvaintapaukset (1521 glioomaa ja 1209 
meningeoomaa) identifioitiin pääosin sairaaloista ja verrokit (3299) kansallisista 
väestörekistereistä tai yleislääkäreiden potilasluetteloista. Tutkimushenkilöiden 
matkapuhelimen käytön historiaa selvitettiin henkilökohtaisin haastatteluin 
ja matkapuhelimen käyttöä arvioitiin useiden eri altistusindikaattoreiden 
perusteella. Tällaisia olivat esimerkiksi säännöllinen käyttö (puhelinta oli 
käytetty vähintään kerran viikossa vähintään 6 kuukauden ajan), käytön 
kokonaiskesto sekä kumulatiivinen tuntien ja puhelujen määrä.
Jotta voitiin arvioida matkapuhelimen käytön kokonaisvaikutusta 
aivokasvainten riskiin, käytettiin tutkimusmenetelmänä meta-analyysiä, 
jossa yhdistettiin tutkimustulokset kaikista tutkimusaihetta käsittelevistä 
epidemiologisista tutkimuksista. Matkapuhelimen käytön kokonaisvaikutusta 
kuvaava yhdistetty estimaatti laskettiin analyysissä kaikille aivokasvaimille 
yhteensä ja erikseen kolmelle yleisimmälle kasvaintyypille, joita ovat gliooma, 
meningeooma ja akustikusneurinooma. Yhdistetty estimaatti laskettiin myös 
puhelimen tyypin (NMT ja GSM) ja kasvaimen sijainnin mukaan (samalla 
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ja eri puolella päätä kuin puhelinta oli käytetty). Yhdistettyjen estimaattien 
laskemisessa käytettiin käänteisen varianssin painotuksen menetelmää.
Matkapuhelimen käytön yhteyttä tutkimukseen osallistumiseen ja 
siitä tutkimukseen aiheutuvaa mahdollista valikoitumisharhaa arvioitiin 
INTERPHONE-tutkimuksen suomalaisessa aineistossa vertaamalla keskenään 
tutkimushaastatteluun osallistuneita ja sellaisia henkilöitä, jotka kieltäytyivät 
osallistumasta tutkimukseen, mutta vastasivat matkapuhelimen käyttöä ja 
koulutusta käsittelevään lyhyeen kyselyyn. Tässä aineistossa oli yhteensä 
777 verrokkia ja 726 tapausta, jotka osallistuivat tutkimushaastatteluun 
sekä 321 verrokkia ja 103 tapausta, jotka vastasivat vain lyhyeen kyselyyn. 
Valikoitumisharhan suuruutta arvioitiin määrittämällä aivokasvainten vaaraa 
kuvaava estimaatti erikseen tutkimushaastatteluun osallistuneille henkilöille 
ja ryhmälle, johon kuuluivat sekä tutkimushaastatteluun osallistuneet että 
lyhyeen kyselyyn vastanneet henkilöt.
Tapaus-verrokkitutkimuksissa matkapuhelimen käyttöön ei näyttänyt 
liittyvän suurentunutta gliooman tai meningeooman vaaraa. Molempien 
kasvaintyyppien vaara oli pienempi säännöllisesti matkapuhelinta käyttävillä 
kuin niillä, jotka eivät olleet koskaan käyttäneet matkapuhelinta tai käyttivät 
sitä epäsäännöllisesti (OR = 0.78, 95% CI: 0.68 – 0.91 glioomille, OR = 0.76, 
95% CI: 0.65 – 0.89 meningeoomille). Myöskään meta-analyysiin sisällytettyjen 
12 tutkimuksen perusteella matkapuhelimen käytön kokonaisvaikutukselle 
laskettu yhdistetty estimaatti ei antanut viitteitä siitä, että matkapuhelimen 
käytöllä olisi yhteyttä aivokasvainten vaaraan (OR = 0.98, 95% CI: 0.83 – 1.16). 
Viitteitä suurentuneesta vaarasta ei juurikaan saatu kasvaimen tyypin, 
puhelimen tyypin tai kasvaimen sijainnin perusteella tehdyissä analyyseissä. 
Suomalaisessa INTERPHONE-tutkimuksessa matkapuhelimen käyttö oli 
yleisempää tutkimushaastatteluun osallistuneiden kuin siitä kieltäytyneiden, 
mutta lyhyeen kyselyyn vastanneiden henkilöiden joukossa. Matkapuhelimen 
käyttöön liittyvä aivokasvainten vaara oli pienempi tutkimushaastatteluun 
osallistuneilla henkilöillä. Yhdistetyllä ryhmällä, johon kuuluivat sekä 
tutkimushaastatteluun osallistuneet että vain lyhyeen kyselyyn vastanneet 
henkilöt, aivokasvainten vaara oli hieman edellistä suurempi, mutta ei 
kuitenkaan suurentunut.
Tapaus-verrokkitutkimusten tai meta-analyysin tulokset eivät tue 
olettamusta, että matkapuhelimen käytöllä olisi yhteyttä aivokasvainten vaaraan. 
Tapaus-verrokkitutkimuksissa havaittiin, että säännöllisillä matkapuhelimen 
käyttäjillä oli pienentynyt vaara sairastua glioomaan tai meningeoomaan. 
Koska ei ole uskottavaa, että matkapuhelimen käyttö pienentää aivokasvainten 
vaaraa, on mahdollista, että tällaiset tulokset johtuisivat valikoitumisharhasta. 
Tapaus-verrokkitutkimuksissa valikoitumisharha voi vääristää tuloksia siten, 
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että tutkimuksessa havaitaan pienempi vaara kuin mitä se on todellisuudessa. 
Viite valikoitumisharhan olemassa olosta saatiin suomalaisessa INTERPHONE-
tutkimuksessa, jossa matkapuhelimen käyttöön liittyvä aivokasvainten vaara 
oli pienempi tutkimushaastatteluun osallistuneiden joukossa kuin yhdistetyssä 
ryhmässä, johon kuuluivat näiden henkilöiden lisäksi myös vain lyhyeen 
kyselyyn vastanneet. On mahdollista, että valikoitumisharha on vääristänyt 
myös viidessä Pohjois-Euroopan maassa tehtyjen tapaus-verrokkitutkimusten 
tuloksia.
Edellä esitettyjen tutkimusten tulosten perusteella voidaan todeta, 
että matkapuhelimen käyttö ei näyttäisi aiheuttavan aivokasvaimia. Tapaus-
verrokkitutkimuksissa matkapuhelimen käyttöön liittyvän aivokasvainten 
vaaran havaittiin pienentyneen. Tuloksia on tulkittava kuitenkin erityisen 
varovaisesti, sillä on mahdollista, että ne johtuvat tutkimuksessa olevasta 
harhasta.
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Introduction
Mobile phone use has increased rapidly worldwide since the early 1990’s. In 
the North European countries, this technology was adopted especially early 
and mobile phones have been widely used since the mid-1990’s (Gibney 2005). 
Mobile phones emit a radiofrequency electromagnetic field, which is a part 
of non-ionizing radiation. Non-ionizing radiation has too low energy to break 
chemical bonds and thus it cannot directly cause DNA damage (mutations), 
which is required for cancer initiation (Valberg 1997). It is, however, unknown, 
whether radiofrequency radiation is capable of affecting cancer development at 
later stages, such as tumour progression or promotion.
While the role of radiofrequency radiation in carcinogenesis is unclear and 
no carcinogenic mechanism has been established, considerable public concern 
has arisen about the possible health effects of mobile phone use. Most of all, the 
concern is focused on brain tumours since mobile phones are used very close to 
the head and the energy of the radiofrequency radiation is mostly absorbed in 
the head and neck region.
To increase the knowledge of the possible effects of mobile phone use, a 
large multinational case-control study on brain tumours and mobile phone use, 
the INTERPHONE study, was initiated in 2000. The International Agency for 
Research on Cancer (IARC) coordinated the study and altogether 13 countries 
participated in it, Finland being one of them. Within the INTERPHONE 
study, five-country collaboration between Denmark, Finland, Sweden, Norway 
and Southeast England was also established shortly after the beginning of 
the study. The purpose of the five-country collaboration was to perform joint 
analyses, which was possible since all the study countries used the shared study 
protocol provided by the IARC (Cardis & Kilkenny 1999). A larger number of 
study subjects in shared datasets allows more comprehensive analyses and 
investigation of various aspects of mobile phone use, likewise more precise risk 
estimates.
The possible effect of mobile phone use on the risk of brain tumours has 
been investigated in several studies (Hardell et al. 1999; Dreyer et al. 1999; 
Muscat et al. 2000; Hardell et al. 2001; Inskip et al. 2001; Johansen et al. 2001; 
Auvinen et al. 2002; Hardell et al. 2002a; Hardell et al. 2002b; Muscat et al. 2002; 
Hardell et al. 2003; Lönn et al. 2004a; Christensen et al. 2004; Lönn et al. 2005; 
Christensen et al. 2005; Hardell et al. 2005a; Schoemaker et al. 2005; Hardell et 
al. 2006a; Hardell et al. 2006b; Hardell et al. 2006c; Schuz et al. 2006a; Schuz 
et al. 2006b; Hepworth et al. 2006; Takebayashi et al. 2006; Schlehofer et al. 
2007; Mild et al. 2007; Klaeboe et al. 2007; Hours et al. 2007; Takebayashi et al. 
2008; Hartikka et al. 2009; ). As the study results are somewhat inconsistent, 
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a meta-analysis provides a tool for a quantitative synthesis of individual studies 
and evaluation of the overall effect.
Shortly after the beginning of subject recruitment to the Finnish 
INTERPHONE study, study participation turned out to be relatively low, 
especially among controls. Due to the low participation rate, a concern arose 
whether the study participants represented the target population in terms of 
exposure. Selection bias may distort the results of a case-control study if study 
participation is related to the exposure of interest, which in this case was mobile 
phone use. Because selection bias was deemed possible, its magnitude needed 
to be investigated.
The studies in this dissertation were performed to investigate the possible 
relationship between mobile phone use and risk of brain tumours using both case-
control design and meta-analysis. In addition, the possibility and magnitude of 
selection bias due to differential participation by exposure status were evaluated 
in a subset of the case-control material where information for such evaluation 
was available.
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1. Review of the Literature
1.1. Radiofrequency radiation
1.1.1. Nature and sources of radiofrequency radiation
Electromagnetic radiation is all around us. Numerous devices in everyday life, such 
as radio, TV, mobile telephones and electric appliances produce electromagnetic 
radiation of different frequencies in their operation. Radiofrequency (RF) 
radiation is one type of electromagnetic radiation. In the frequency spectrum of 
electromagnetic radiation, RF is below optical radiation. There is some variation 
in the classification of frequency bands within the electromagnetic spectrum, 
but the RF area can be defined to cover the frequencies from 100 kHz to 300 
GHz (Ahlbom et al. 2004; Jokela 2006).
RF radiation cannot directly break chemical bonds and is therefore defined 
as non-ionising radiation. In terms of biological effects, this means that RF 
radiation cannot cause damage to DNA (mutations). In contact with the human 
body, RF radiation penetrates the tissues where the energy of RF radiation is 
absorbed and converted into heat. The heating, i.e. the thermal effect, is the only 
established mechanism for biological effects of RF radiation and it can cause 
tissue damage if the temperature rises too high (Lang & Jokela 2006b).
On the basis of the scientific evidence available, the International 
Commission on Non-Ionizing Radiation Protection (ICNIRP) has defined exposure 
limits, which protect people from the established harmful effects of RF radiation 
(ICNIRP 1998). The harmful effects are caused by excessive temperature rise in 
tissues due to absorption of RF radiation. In addition, the restrictions by ICNIRP 
contain safety margins to avoid any adverse effects, as the public exposure limit 
with regard to RF caused temperature rise has been set at one tenth or below 
of the value where harmful effects can occur. In general, it can be said that it is 
not likely that the exposure to RF sources used in the normal environment can 
cause temperature rise to the level where human tissues are in danger.
The sources of RF radiation to the general public include mobile telephones 
and their base stations, radio and TV transmitters and wireless networks. While 
radio and TV stations emit relatively high power levels (from tens to hundreds 
of kW) the exposure to the public remains low because the transmitters are 
located in high masts and the public has no access to the immediate vicinity of 
the mast (Jokela et al. 2006). This is because the level of RF radiation decreases 
substantially with the distance from the source. The exposure from mobile phone 
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base stations and wireless networks is also low because of the relatively low 
output power levels, which are 5 – 30 W for mobile phone base stations and 100 
mW – 1 W, for instance, for WLAN, which is commonly used wireless network 
technology in home and office environments (Jokela et al. 2006). In addition, 
mobile phone base stations are located in such a way that the public cannot be 
in touch with them and thus expose themselves to high levels, however many 
people are exposed to low levels as such technology is currently an integral part 
of our everyday lives.
In contrast to average citizens, the exposures of people working in the 
maintenance of radio and TV transmitters may be considerable, because the 
work is usually done while the transmitter is operating and the workers need to 
be located quite near the RF source. Subjects working with radars (with average 
power level of 1 kW), as well as dielectric and induction heaters (with power 
levels up to hundreds kW) are also exposed to RF radiation (Jokela et al. 2006). 
In addition, radio amateurs are exposed to RF due to use of ham radios. For the 
radiation protection of people exposed to RF radiation in their professions or 
leisure activities, the exposure limits established by ICNIRP and controlled by 
the authorities should be followed.
The current model of cancer biology states that DNA damage and further 
a series of mutations is required for cancer initiation. Due to the non-ionising 
nature of RF radiation, it is not likely that RF is able to act as a cancer initiator, 
even though some studies have reported RF-induced DNA damage in rat brain 
cells (Lai & Singh 1995; Lai & Singh 1996). It is also not clear whether RF 
radiation may affect later stages of carcinogenesis, such as tumour promotion 
or progression. An animal study reported that RF radiation may increase the 
number of tumours in mice susceptible to lymphoma (Repacholi et al. 1997), but 
these results could not be replicated elsewhere (Utteridge et al. 2002). In general, 
biological results in this field are contradictory and thus it is impossible to draw 
final conclusions about potential biological effects, especially as it is not known 
by which mechanism RF radiation may affect directly at the cell level.
1.1.2. Mobile phone as a source of radiofrequency radiation
Mobile phones, also called cellular phones, are now one of the most important 
sources of RF radiation in general population. While in the early 1990’s 
mobile phone use was quite rare, it seems that today the people not using a 
mobile phone are in the minority among Europeans. According to the Official 
Statistics of Finland, at the end of 2007 there were over six million mobile phone 
subscriber connections in Finland which equals 115 subscriber connections per 
100 inhabitants (Tilastokeskus 2008).
19
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To function, a mobile phone needs to communicate with a mobile phone 
base station using radio signals. Thus both the mobile phone and the base 
station emit RF radiation. The mobile phone network is divided into cells from 
which the mobile phone is in connection to the base station. The shape of the cell 
depends on the direction of the antenna at the base station and the surrounding 
geography, while the size of the cell depends on the number of mobile phone 
users in the area and the output power level of the base station. Since each 
cell can handle a limited number of concurrent phone calls, the number of base 
stations has been rapidly increasing to allow effective mobile phone use.
Two major mobile phone network types have been used in Europe, 
analogue (Nordic Mobile Telephone, NMT) and digital (Global System for Mobile 
Communications, GSM). NMT operates on 450 or 900 MHz frequencies whereas 
GSM uses frequencies of 900 and 1800 MHz. Currently, the digital phone network 
predominates since the analogue telephone system was closed down at the end of 
2000. In addition to NMT and GSM telephones, third generation mobile phones 
have recently been introduced, using a new system called Universal Mobile 
Telecommunication System (UMTS) or 3G, that operate in 1950 and 2150 MHz 
bands. However, in this dissertation only exposure from NMT and GSM phones 
is addressed, due to the timing of the present work.
An NMT 900 MHz phone emits continuously during speech at a constant 
power level of 1 W, whereas the GSM phones use pulsed signals and adaptive 
power control. The maximum power of pulse is 2 W for GSM 900 MHz and 
1 W for GSM 1800. The duration of pulses is 0.6 milliseconds and interval of 4.6 
milliseconds, which results in the phone emitting radiation only 1/8 of the time. 
Therefore, the maximum average output power level is 0.25 W and 0.125 W for 
the GSM phones. This maximum power level is used only in the weak field of the 
base station due to the adaptive power control of GSM phones. The quality of the 
connection to the base station and the way the phone is used affect the output 
power level of the mobile phone. When the distance to the base station increases, 
the phone emits at higher output power level. During a phone call, the phone 
emits RF radiation only while transmitting (during speech), and the base station 
constantly moderates the output power level of the mobile phone to achieve the 
lowest level necessary for efficient operation. The moderation of the power level 
can reduce the output power level of a GSM phone to below a hundredth of the 
maximum. When the phone is on standby, the phone sends pulses only at long 
intervals, typically 1/100 of the time (Jokela et al. 2006).
While the output power levels of mobile phones are relatively low, the 
exposure to RF radiation cannot necessarily be considered minor since the 
mobile phones are used close to the body. In electromagnetic radiation terms, 
such exposure is considered to occur in near-field. The exposure from a mobile 
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phone is confined to the immediate vicinity of the phone i.e. most of the RF 
energy emitted by a mobile phone affects the parts of the body that are either 
in contact or few centimetres away from the phone (Balzano 1999). Due to 
the frequency of mobile phone radiation, an applicable measure for exposure 
assessment regarding mobile phones is specific energy absorption rate (SAR), 
which is simplistically a measure for the heating caused by RF. SAR is defined as 
the energy absorption rate per tissue mass and it is expressed as W/kg. When RF 
radiation penetrates human tissue, loss of power due to interaction with tissue 
takes place. The amount of energy absorbed by the tissues depends on RF power 
level and frequency, distance from the antenna and position of the phone among 
many other factors (Balzano 1999).
Guidelines for limiting the public’s exposure to mobile phone radiation 
have been based on the SAR from the early 1980’s. The guidelines were set on the 
basis of the energy absorbed and for RF frequencies, the SAR is limited to such a 
level that the excess temperature rise remains below 1 °C. Such temperature rise 
equals a whole-body SAR of 4 W/kg and using 50 as a safety factor, the ICNIRP 
has set the whole-body SAR limit for the population at 0.08 W/kg. However, as 
mobile phone exposure is highly localised, the SAR of 2 W/kg set as the highest 
value for localised exposure is applied for mobile phone radiation (ICNIRP 
1998). The maximum averaged SAR for mobile phones with an output power 
level of 0.25 W has been reported to vary from 1.0 to 2.6 W/kg (van de Kamer 
& Lagendijk 2002). Thus, phones operate close to the guidelines. However, the 
maximum averaged SAR of 1.6 W/kg caused by 0.25 W power level has been 
reported to elevate brain temperature by 0.1 °C, which has no physiological 
significance (Van Leeuwen et al. 1999). It cannot, however, be ruled out that RF 
radiation could have some other interaction mechanisms in biological systems 
(Lang & Jokela 2006a).
The use of hands-free equipment substantially decreases the exposure 
caused by mobile phones (IEGMP 2000). Therefore, some authorities 
have recommended that people who are worried about the possible 
harmful effects of mobile phones should use hands-free equipment to 
minimize their exposure, even though using a mobile phone is considered 
safe (A common approach for the Nordic competent authorities 2004). 
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1.2. Brain tumours
1.2.1. Definition and incidence of brain tumours
In this dissertation, the term ”brain tumours” is used to cover tumours occurring 
in the central nervous system, such as gliomas, meningiomas and acoustic 
neuromas, even though the histological origin of the tumours is not always from 
brain cells, but from the meninges (meningiomas) or cranial nerves (acoustic 
neuromas). A similar approach has been common in other studies.
Historically, the classification of brain tumours has varied, but as the 
WHO classification (Kleihues & Cavenee 2000) has been widely accepted, it was 
also used as a basis of the classification in this dissertation. In this material, 
the gliomas comprise several subgroups including astrocytic, oligodendroglial, 
ependymal and chroroid plexus tumours, as well as mixed gliomas, glial tumours 
of uncertain origin and ganglioglioma. Meningiomas and acoustic neuromas 
cover more homogenous tumour types, as the meningiomas comprise tumours of 
meningothelial cells and acoustic neuromas comprise schwannomas (sometimes 
called also neurilemomas) of the acoustic nerve (or vestibulo-cochlear nerve i.e. 
the eighth cranial nerve).
Brain tumours constitute a relatively heterogeneous group of tumours that 
are among the ten most common cancer types in Finland. The number of new 
cases with a central nervous system tumour (also includes some other tumours 
than those of the brain, such as tumours of the spinal cord) is approximately 
950 per year (Suomen Syöpärekisteri 2009). The age-specific incidence of brain 
tumours usually increases until 60 – 70 years of age, and the incidence rates are 
relatively similar in developed countries. In the Nordic countries, however, the 
incidence is somewhat higher than in other countries, which may reflect true 
risk, diagnostic activity related to high level of health care, or completeness of 
tumour registration (Inskip et al. 1995). Generally, half of brain tumours are 
gliomas, a quarter are meningiomas, while the rest represent other tumour types 
such as acoustic neuromas and pituitary adenomas (Stewart & Kleihues 2003). 
Gliomas are more common among men (male:female incidence ratio 1.5), while 
meningiomas occur predominantly among women (male:female incidence ratio 
0.6) (Inskip et al. 1995). Among adult population in the Nordic countries, the 
incidence of gliomas in 1998 was around 8.5 among men and 5.8 among women 
per 100, 000 person-years (to the standard population of the Nordic countries 
in 1985) (Lönn et al. 2004b), while the incidence of meningiomas in 1997 was 
1.9 among men and 4.5 among women per 100, 000 person-years (to the world 
standard population) (Klaeboe et al. 2005). Both Nordic studies reported an 
increase in the incidence rates from the 1960’s to the 1990’s but suggest enhanced 
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diagnostic methods as the most probable explanation for the increase. Acoustic 
neuroma is a relatively rare tumour type accounting for 8% of all brain tumours 
and occurring equally frequently in both sexes (Kleihues & Cavenee 2000).
Most gliomas are malignant tumours, whereas most of the meningiomas 
and all acoustic neuromas are benign. However, a neoplastic process within the 
limited space of the skull inevitably causes harm by displacing brain tissue even 
if no invasion of the cerebral tissue is involved. Therefore, even benign tumours 
can be life-threatening. However, patients with malignant brain tumours have 
considerably lower survival rates than those with benign tumours. Whereas for 
all brain tumours in all age-groups the overall survival rate has been reported 
as 20% at five years, patients with glioblastoma have the poorest prognosis, as 
only 3% of cases are alive 3 years after diagnosis (Stewart & Kleihues 2003; 
Berger & Prados 2005). Other gliomas also have relatively poor prognosis, as 
the proportion of those alive 5 years after diagnosis varies from 44% to 65% 
depending on the subtype of the tumour (Preston-Martin & Mack 1996). In 
contrast to gliomas, meningiomas and acoustic neuromas can very often be cured 
completely  (Stewart & Kleihues 2003). 
1.2.2. Aetiology of brain tumours 
The aetiology of brain tumours is not well understood, as only few risk factors 
for brain tumours are known. High doses of ionizing radiation have consistently 
been shown to cause brain tumours. Among the survivors of the atomic bombing 
of Hiroshima and Nagasaki an increased risk has been detected for all tumours 
of the central nervous system, particularly for acoustic neuromas (Preston et 
al. 2002). Radiotherapy to the head for scalp ringworm during childhood has 
been reported to increase the risk of both gliomas and meningiomas (Ron et al. 
1988). Cranial radiotherapy in the treatment of acute lymphoblastic leukaemia 
in childhood has also been reported to cause secondary brain tumours (Neglia et 
al. 1991; Relling et al. 1999). Unlike high doses, the effect of low doses of ionising 
radiation, for instance from X-ray examinations, has been investigated but the 
findings do not support association to brain tumours (Ryan et al. 1992; Rodvall 
et al. 1998; Hardell et al. 2001; Blettner et al. 2007).
In addition to ionising radiation, few other risk factors for brain tumours 
are known. Increased risk for brain tumours is related to some relatively 
rare hereditary syndromes, such as neurofibromatosis, tuberous sclerosis and 
Li-Fraumeni syndrome. Neurofibromatosis type I is associated with gliomas, while 
neurofibromatosis type II mainly causes acoustic neuromas and meningiomas. 
Both tuberous sclerosis and Li-Fraumeni syndrome increase the risk of gliomas 
(astrocytomas, glioblastomas) (Stewart & Kleihues 2003).
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Social class may affect the risk of brain tumours. For all brain tumours 
and separately for gliomas, an increased risk has been reported in higher social 
classes, while meningiomas have been slightly more common in lower social 
classes (Preston-Martin et al. 2006). The association of all brain tumours with 
high socioeconomic status has been suggested to be explained by diagnostic 
bias caused by more active use of health care services pronounced in the higher 
social classes (Preston-Martin et al. 1993; Pukkala 1995). Recently, it has also 
been suggested that various tumour types have different social class patterns, 
probably reflecting a heterogeneous aetiology of the tumours (Inskip et al. 2003). 
It is possible that the more aggressive tumours are detected regardless of the 
patient’s social class, while the diagnostics of benign tumours may be more 
dependent on social class.
The effect of dietary intake (mainly N-nitroso compounds), head trauma, 
infections, occupational exposures and exposure to low frequency electromagnetic 
radiation on the risk of brain tumours has been investigated, but no consistent 
evidence of these factors as a cause of brain tumours has been reported (Preston-
Martin et al. 2006). A decreased glioma risk has been reported in several studies 
among subjects with allergic conditions (Brenner et al. 2002; Linos et al. 2007; 
Wigertz et al. 2007).
1.3. Radiofrequency radiation and health
1.3.1. Mobile phones and brain tumours
There are several publications on the possible effect of mobile phone use on 
brain tumour risk  (Hardell et al. 1999; Dreyer et al. 1999; Muscat et al. 2000; 
Hardell et al. 2001; Inskip et al. 2001; Johansen et al. 2001; Auvinen et al. 2002; 
Hardell et al. 2002a; Hardell et al. 2002b; Muscat et al. 2002; Hardell et al. 
2003; Lönn et al. 2004a; Christensen et al. 2004; Lönn et al. 2005; Christensen 
et al. 2005; Hardell et al. 2005a; Schoemaker et al. 2005; Hardell et al. 2006a; 
Hardell et al. 2006b; Hardell et al. 2006c; Schuz et al. 2006a; Schuz et al. 2006b; 
Hepworth et al. 2006; Takebayashi et al. 2006; Schlehofer et al. 2007; Mild et al. 
2007; Klaeboe et al. 2007; Hours et al. 2007; Takebayashi et al. 2008; Hartikka 
et al. 2009; Schoemaker & Swerdlow 2009). Of these, data from the Danish 
(Christensen et al. 2005), Swedish (Lönn et al. 2005) and Norwegian studies 
(Klaeboe et al. 2007), as well as a subset of the data in the UK study (Hepworth 
et al. 2006) are also included in the material of this dissertation (in the five 
country studies on the risk of gliomas and meningiomas).
Most epidemiological studies on mobile phone use and brain tumour risk 
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have been based on case-control design, while only two incident cohort studies 
(Johansen et al. 2001; Schuz et al. 2006b) have been published, the latter being 
an update of the first study. In addition, one case-case analysis (Hartikka et al. 
2009) and one cohort study addressing the brain cancer mortality of the mobile 
phone users (Dreyer et al. 1999) have been published. Almost all studies have 
used incident cases (except that by Hardell et al. 1999 using prevalent cases) 
and the most common types of tumours investigated are gliomas, meningiomas 
and acoustic neuromas. Most of the reports used either personal interview or 
postal questionnaire in the exposure assessment, while in four studies, the 
exposure assessment was based on telephone company records (Dreyer et al. 
1999; Johansen et al. 2001; Auvinen et al. 2002; Schuz et al. 2006b). In some of 
the studies the use of hands-free equipment has been taken into account, while 
in the others this was not reported.
Of the studies published on the issue, not all are based on unique datasets, 
since some original analyses have been pooled with each other or otherwise 
updated. Concerning the publications by Hardell, who has three different 
datasets but a greater number of publications, the original reports of each dataset 
are presented in the following four sections. The first dataset concerns a study 
performed in 1994 – 1996 (Hardell et al. 1999), the second in 1997 – 2000 (Hardell 
et al. 2002a) and the third in 2000 – 2003 (Hardell et al. 2005a; Hardell et al. 
2006c). After publishing these original study reports, several other reports based 
on the same datasets were also published by the same study group (Hardell et 
al. 2001; Hardell et al. 2002b; Hardell et al. 2003; Hardell et al. 2006a; Hardell 
et al. 2006b; Mild et al. 2007). They are not presented since they could not be 
regarded as original publications. Similarly, the Swedish (Lönn et al. 2004a) and 
Danish (Christensen et al. 2004) acoustic neuroma studies will not be discussed, 
as they are also included in a more comprehensive study on acoustic neuromas 
presented in Section 1.3.1.3 (Schoemaker et al. 2005).
1.3.1.1. Case-control studies of gliomas
The risk for gliomas in relation to mobile phone use has been investigated in 13 
case-control studies. Of these, one was conducted in Japan (Takebayashi et al. 
2008), two in the U.S.A. (Muscat et al. 2000; Inskip et al. 2001) while the others 
are European (Hardell et al. 1999; Auvinen et al. 2002; Hardell et al. 2002a; 
Christensen et al. 2005; Lönn et al. 2005; Hepworth et al. 2006; Hardell et al. 
2006c; Schuz et al. 2006a; Klaeboe et al. 2007; Hours et al. 2007).
The studies conducted in the U.S.A. are hospital-based and the European 
studies are population-based. In hospital-based studies, the controls are usually 
patients from the same hospitals as the cases, but treated for other medical 
conditions, whereas in population-based design, the controls are usually enrolled 
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through population registries. The Japanese study is between these two designs, 
as the cases were recruited from hospitals and the controls were selected from 
general population. Together the studies of mobile phone use and risk of gliomas 
include more than 4,600 glioma cases and 9,300 controls. In half of the studies, 
the highest exposure category used for mobile phone use was > 10 years (Hardell 
et al. 2002a; Lönn et al. 2005; Christensen et al. 2005; Hepworth et al. 2006; Schuz 
et al. 2006a; Hardell et al. 2006c; Takebayashi et al. 2008), while in the others 
the maximal exposure periods were shorter (from > 2 years to > 6 years).
In some studies, there were indications of an association between mobile 
phone use and risk of glioma, while the majority of results showed no association 
(Table 1). Increased risks were reported for ever use of mobile phone in a Finnish 
study (OR = 1.5, 95% CI: 1.0 – 2.4) (Auvinen et al. 2002) and for regular ipsilateral 
use (phone use on the same side where the tumour occurred, OR = 1.24, 95% 
CI: 1.02 – 1.52) in an English study (Hepworth et al. 2006). Both the Finnish and 
English studies also reported several results showing no association between 
mobile phone use and risk of glioma. In addition, the company records used as 
a basis of the exposure assessment in the Finnish study are a possible source 
of error, as the actual user of the mobile phone is not known and did not allow 
identification of users with subscriptions owned by employers. Further, in the 
laterality analysis of the English study, a reduced risk was also detected in 
relation to contralateral use (phone use on the opposite side to that where the 
tumour occurred) that together with the positive finding for ipsilateral use is 
consistent with recall bias. It is possible that the patient’s recall of the side of 
phone use is affected by the fact that the patient is aware of the location of the 
tumour.
In contrast to the results of most studies, the study group of Hardell 
detected several increased risks in relation to mobile phone use in the study 
published in 2006, where the risk of gliomas was investigated in various 
different analyses. The risk of malignant tumours was increased in relation 
to > 1-year of use of both analogue (OR = 2.60, 95% CI: 1.50 – 4.30) and digital 
phones (OR = 1.90, 95% CI: 1.30 – 2.70) and the risks were also reported to be 
increased with increasing years of use (Hardell et al. 2006c). In addition, the 
risk of ipsilateral tumours was increased in relation to use of both analogue 
(OR = 3.10, 95% CI: 1.60 – 6.20) and digital phones (OR = 2.60, 95% CI: 1.60 – 4.10). 
The authors conclude that the study provided evidence of an increased risk of 
malignant tumours. The study has, however, been criticized for methodological 
and analytical limitations (SSI Report 2006).
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1.3.1.2. Case-control studies of meningiomas
Risk of meningioma in relation to mobile phone use has been investigated in 11 
studies (Table 1). Most of these were conducted in Europe (Hardell et al. 1999; 
Auvinen et al. 2002; Hardell et al. 2002a; Christensen et al. 2005; Lönn et al. 
2005; Hardell et al. 2005a; Schuz et al. 2006a; Klaeboe et al. 2007; Hours et al. 
2007), while one was performed in the U.S.A. (Inskip et al. 2001) and one in 
Japan (Takebayashi et al. 2008). The studies include together more than 2,500 
meningioma cases and 7,400 controls.
In six of the studies (Hardell et al. 2002a; Christensen et al. 2005; Lönn et 
al. 2005; Hardell et al. 2005a; Schuz et al. 2006a; Takebayashi et al. 2008), the 
longest duration of mobile phone use was > 10 years, while in the other studies 
categories from > 2 to > 6 years were used. Of the studies, only the study group 
of Hardell has consistently reported increased risks for meningiomas in relation 
to mobile phone use. Increased risk was reported for > 10 years use of analogue 
phones (OR = 2.10, 95% CI: 1.10 – 4.30) and for contralateral tumours in relation 
to ever use of mobile phone (OR = 2.60, 95% CI: 1.10 – 6.00), while many other 
results of the study did not indicate an association between mobile phone use 
and meningioma  (Hardell et al. 2005a). Both positive findings were based on 
rather a small number of exposed cases (20 and 14 respectively) and controls 
(40 and 28 respectively) in the analysis. Due to some methodological issues in 
the Hardell study it has been suggested that the results should be interpreted 
with caution (SSI Report 2006).
1.3.1.3. Case-control studies of acoustic neuromas
Acoustic neuromas have been investigated in ten case-control studies, of which 
one is Japanese (Takebayashi et al. 2006), two were performed in the U.S.A. 
(Inskip et al. 2001; Muscat et al. 2002) and the rest in Europe (Hardell et al. 
1999; Hardell et al. 2002a; Schoemaker et al. 2005; Hardell et al. 2005a; Klaeboe 
et al. 2007; Schlehofer et al. 2007; Hours et al. 2007). The studies included a 
total of more than 1,400 cases and 8,500 controls. The largest of these studies, 
with 678 cases, is a collaborative analysis of five countries in Northern Europe 
(Schoemaker et al. 2005). The highest exposure category including subjects with 
the longest duration of mobile phone use was > 10 years in the four studies 
(Hardell et al. 2002a; Schoemaker et al. 2005; Hardell et al. 2005a; Schlehofer et 
al. 2007), while in the rest of the studies, the longest exposure durations were 
from > 3 to > 8 years.
The studies have not provided consistent evidence for the risk of acoustic 
neuroma in relation to mobile phone use, even though mobile phone use was 
investigated in several different ways (Table 1). In the five-country joint analysis 
(Schoemaker et al. 2005), increased OR (1.8, 95% CI: 1.1, 3.1) for 10 or more 
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years of ipsilateral use was found, while the rest of the results did not support 
any association. The authors suggest that the result may be affected by bias, 
either due to hearing loss typical for acoustic neuromas leading to the change 
of the phone side, or to recall bias. Again, the studies by Hardell reported an 
increase of acoustic neuromas among mobile phone users (Hardell et al. 2002a; 
Hardell et al. 2005a). An increased risk has been reported for analogue phone use 
(OR = 3.50, 95% CI: 1.80 – 6.80) (Hardell et al. 2002a) and subsequently to that 
for > 1-year of use of both analogue (OR = 4.20, 95% CI: 1.80 – 10.00) and digital 
phones (OR = 2.00, 95% CI: 1.05 – 3.80) (Hardell et al. 2005a). For 5 – 10 years 
of use the risks were again increased in relation to both types of phones, as the 
ORs were 5.10 (1.90, 14.00) and 2.70 (1.30, 5.70) for analogue and digital phones 
respectively (Hardell et al. 2005a). Also, the risk of ipsilateral acoustic neuromas 
was increased in relation to the use of both phone types. However, concerns with 
respect to the methodology and reporting have been expressed regarding both 
the 2002 study  (AGNIR 2003) and the 2005 study (SSI Report 2006).
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Table 1. Results of the case-control studies of mobile phones and brain tumours.
Study, year OR, gliomas
(95% CI)
OR, meningiomas
(95% CI)
OR, acoustic 
neuromas
(95% CI)
OR, ≥ 10 years 
of use 
(95% CI)
Hardell, 1999 0.98 (0.63, 1.50) a 1.05 (0.49, 2.27) 0.78 (0.14, 4.20) 1.20 (0.56, 2.59) b
Muscat, 2000 0.80 (0.50, 1.20)  –  –  – 
Inskip, 2001c 0.80 (0.60, 1.20) 0.80 (0.40, 1.30) 1.00 (0.50, 1.90)  – 
Hardell 2002a 1.10 (0.90, 1.50) a, d 0.80 (0.60, 1.03) d 1.20 (0.70, 2.20) d 1.80 (1.10, 2.90) b
Auvinen, 2002 1.50 (1.00, 1.24) 1.10 (0.50, 2.40)  –  – 
Muscat, 2002c  –  – 1.70 (0.50, 5.10) e  – 
Christensen, 2005 0.71 (0.50, 1.01) 0.83 (0.54, 1.28)  – 0.48 (0.19, 1.26) f
Lönn, 2005 0.80 (0.60, 1.00) 0.70 (0.50, 0.90)  – 0.90 (0.50, 1.60) g
Schoemaker, 2005  –  – 0.90 (0.70, 1.10) 1.10 (0.70, 1.80)
Hardell 2005  – 1.30 (0.90, 1.90) d 2.00 (1.05, 3,80) d 2.00 (0.90, 4.50) d, h
Hepworth, 2006 0.94 (0.78, 1.13)  –  – 1.14 (0.74, 1.73)
Hardell 2006c 1.90 (1.30, 2.70) a  –  – 3.60 (1.70, 7.50) a, d
Schüz, 2006a 0.98 (0.74, 1.29) 0.84 (0.62, 1.13)  – 2.20 (0.94, 5.11) g
Takebayashi, 2007  –  – 0.73 (0.43, 1.23)  – 
Schlehofer, 2007  –  – 0.67 (0.38, 1.19)  – 
Klaeboe, 2007 0.60 (0.40, 0.90) 0.80 (0.50, 1.10) 0.50 (0.20, 1.00)  – 
Hours 2007 1.15 (0.65, 2.05) 0.74 (0.43, 1.28) 0.92 (0.53, 1.59)  – 
Takebayashi, 2008 1.22 (0.63, 2.37) 0.70 0.42, 1.16)  – 0.58 (0.09, 3.86) g
 
a) For all malignant tumours (based on the text, these represent tumours that are included in the glioma group in the
    material of this thesis)
b) For all tumours combined, use of analogue phones
c) The estimates reported in the study were relative risks (RR).
d) Use of digital phones 
e) For 3 – 6 years of use, as the study did not report any risks for overall use.
f)  For high-grade glioma
g) For glioma
h) For all benign tumours combined
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1.3.1.4. Other studies of mobile phone use and brain tumours
Concerning mobile phone use and brain tumours, two cohort studies have been 
published to date, the first in 2001 covering years 1982 – 1995 (Johansen et al. 
2001) and an update of this study in 2006 with extension of follow-up until 
2002 (Schuz et al. 2006b). The studies were conducted in Denmark and included 
420, 095 subjects with mobile phone subscriptions. The mean follow-up time 
since the start of the first mobile phone subscription was 8.5 years. The three 
most common types of brain tumours in the study population were investigated, 
among several other types of cancer. The number of cases with glioma, 
meningioma and acoustic neuroma observed during the study period in the 
study population was 257, 68 and 31 respectively.
The authors of the cohort studies conclude that no evidence of increased 
brain tumour risk caused by mobile phones was detected in the study. Risk was 
not associated with all tumours combined (SIR = 0.97) or any single tumour type, 
as the SIRs for gliomas, meningiomas and nerve sheath tumours comprising 
most acoustic neuromas were 1.01 (0.89, 1.14), 0.86 (0.67, 1.09) and 0.73 (0.50, 
1.03) respectively. The risk was not elevated among long-term mobile phone 
users as the SIR for > 10 years of use was 0.66 (0.44, 0.95), based on 56, 648 
users. The authors consider such a result surprising, as it is not biologically 
plausible that using a mobile phone would decrease the risk of developing a 
brain tumour. They conclude that the result can be due to chance, as the result 
was based on only 28 cases, but also consider the possibility that there is an 
unknown negative confounding factor affecting the results.
The mortality of mobile phone customers has been investigated in two 
studies (Rothman et al. 1996; Dreyer et al. 1999) that both used the telephone 
operators’ databases as the exposure source. The first study focused only on the 
overall mortality that was found to be slightly lower for mobile phone customers 
than for general population. The latter study also addressed the mortality from 
brain cancer, which was not increased for mobile phone customers compared to 
the rest of population. Overall cancer mortality was likewise not elevated among 
mobile phone customers. The data of the study, however, were quite limited as 
the follow-up period was only one year and the study included only a few cases 
of brain cancer deaths, while the cohort included 285, 561 subjects.
Mobile phone use and location of glioma have been investigated in one 
case-case analysis that included 99 glioma patients (Hartikka et al. 2009). In 
the study, the glioma risk among mobile phone users was evaluated by focusing 
on the most heavily exposed part of the brain by defining the midpoint of the 
tumour and the location of the exposure. The risk for glioma among mobile phone 
users was not statistically significantly increased;  except for contralateral use 
the OR was 4.93 (1.13, 21.46). The authors consider the small sample size to be 
30
STUK-A246
the main limitation of the study and conclude that a larger study is needed.
The risk of pituitary tumours in relation to mobile phone use was 
investigated in a recent case-control study (Schoemaker & Swerdlow 2009). 
The data included 291 cases and 630 controls. The study showed no association 
between exposure and disease, while mobile phone use was analysed in several 
different ways. The pituitary adenomas were also included in the Japanese 
study presented earlier, but no increased risks were detected (Takebayashi et 
al. 2008).
In addition, two meta-analyses, in which the overall effect of mobile phone 
use on brain tumour risk is evaluated by pooling the original studies, have been 
published (Kan et al. 2008; Hardell et al. 2008). These meta-analyses will be 
dealt with in more detail in the discussion.
1.3.2. Effect of mobile phone use on other cancer types
The effect of mobile phone use on other cancer types has been investigated in 
some studies. The outcomes of the studies have been salivary gland cancers 
(Auvinen et al. 2002; Hardell et al. 2004; Lönn et al. 2006; Sadetzki et al. 2008), 
lymphoma (Hardell et al. 2005b; Linet et al. 2006), testicular cancer (Hardell 
et al. 2007a), uveal melanoma (Stang et al. 2001; Stang et al. 2009) and facial 
nerve tumours (Warren et al. 2003).
In one study, an indication of an association between salivary gland cancer 
and mobile phone use was detected (Sadetzki et al. 2008), while the other three 
studies on the issue reported no association (Auvinen et al. 2002; Hardell et al. 
2004; Lönn et al. 2006). Regarding lymphoma, some evidence of an increased 
risk has been reported, but based on very small number of cases (Hardell et al. 
2005b; Linet et al. 2006). The risk for testicular cancer (Hardell et al. 2007a) or 
facial nerve tumours (Warren et al. 2003) was not increased in relation to mobile 
phone use. The risk of uveal melanoma has been investigated by a German study 
group in two studies, of which the first reported an increased risk (Stang et al. 
2001) but the second did not detect such an association (Stang et al. 2009).
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2. Aims of the Study
The general aim of the study was to evaluate the effect of mobile phone use on 
the risk of brain tumours.
Specific aims of this study were:
1. to assess the possible risk for glioma and meningioma in relation to mobile 
phone use
2. to summarize the evidence of the published results of the studies on mobile 
phone use and brain tumours
3. to appraise the impact of selection bias due to non-participation in the 
Finnish case-control study on mobile phone use and brain tumours
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3. Materials and Methods
3.1. Recruitment of subjects to case-control studies
The risk of glioma and meningioma in relation to mobile phone use was 
investigated in population-based case-control studies conducted in five North 
European countries, Denmark, Finland, Sweden, Norway and the United 
Kingdom, between the years 2000 and 2004. The exact study periods differed 
slightly between countries, but in Finland the study period was from November 
2000 to September 2002. As the case-control studies were a part of extensive 
international research collaboration, the INTERPHONE Study coordinated by 
WHO, a common research protocol provided by IARC was followed in each country 
(Cardis & Kilkenny 1999). In the five North European countries, an additional 
questionnaire focusing on the female reproductive and hormonal factors, birth 
characteristics, head injuries as well as details of allergic conditions was also 
used in data collection. The INTERPHONE study concentrated on the most 
common brain tumours, such as glioma, meningioma and acoustic neuroma.
The case-control studies of glioma and meningioma were carried out 
in Denmark (nationwide), Finland (excluding Northern Lapland and Åland, 
representing 98% of the national population), Norway (the southern and central 
parts, representing 90% of the entire population), Sweden (Umeå, Stockholm, 
Gothenburg and Lund regions, 65% of the population) and the United Kingdom 
(Thames region of Southeast England, 23% of the population). The local ethics 
committees approved the study protocols in each country.
Eligibility criteria for cases included age 20 – 69 years at diagnosis in the 
Nordic countries and 18 – 59 years in Southeast England, residence in the study 
area and either diagnosis of glioma (International Classification of Diseases 
for Oncology, Third Edition, codes 9380 – 9384, 9390 – 9394, 9400, 9401, 9410, 
9411, 9420 – 9424, 9430, 9440 – 9444, 9450 – 9451, 9505) or meningioma (codes 
9530 – 9539). Incident cases during the study period 2000 – 2004 were identified 
through neurosurgery, oncology and neurology departments in the study areas. 
In Finland, the cases were recruited from the five university hospital areas 
(Helsinki, Turku, Tampere, Kuopio and Oulu). To evaluate and enhance the 
completeness of coverage, the cases were also checked against the national or 
regional cancer registries.
In the Nordic countries, national population registers were used for control 
selection, whereas in the UK in the absence of such a register, the controls were 
randomly selected from general practitioners’ patient lists, which may represent 
the general population slightly more weakly than the national population 
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registers. The controls were frequency-matched to the cases by sex, five-year 
age group and region of residence in all countries. Eligible study subjects were 
approached either personally at the clinics (cases) or by post (controls). The study 
was not introduced as focusing on mobile phone use except in Sweden, but most 
subjects were likely aware of this due to media coverage of the issue. All study 
subjects received both an invitation letter and written information about the 
study before being invited to participate. If the subjects contacted by post did 
not respond, a reminder was sent or the subject was approached by telephone. 
Informed consent was obtained from all study participants.
3.2. Data collection
3.2.1. Exposure assessment in case-control studies (Studies I and II)
Exposure assessment in the case-control studies on glioma and meningioma was 
based on a personal interview conducted by trained interviewers and typically 
performed either at hospital or in some countries at the subject’s home. The 
interview was computer-assisted in all other countries but Finland, where a 
paper questionnaire with identical wording was used at the time of the interview. 
Proxy interviews were used for 12% of glioma cases, 1.6% of meningioma cases 
and 0.06% of controls.
The interview covered use of hand-held mobile phones, medical history, 
education and family history of brain tumours. Regarding mobile phone use, 
information on each mobile phone that the subject had regularly used was collected 
separately. Regular use of mobile phones was defined as making or receiving calls 
at least once a week for at least six months. For those who had been using a mobile 
phone regularly, a detailed history of mobile phone use was obtained, including 
start and end dates, frequency and laterality of use, type of phone, use of hands-free 
devices, and other factors, such as type of telephone network. Show cards, either 
on the computer or paper, were used to facilitate recall of the phone models used. 
Information on the phone models, calendar period of use, operator and network 
code of the phone number were used to classify phones as analogue or digital. 
 
3.2.2. Retrieval of studies for meta-analysis (Study III)
A meta-analysis was performed to estimate the overall magnitude 
of the risk for gliomas, meningiomas and acoustic neuromas in relation 
to mobile phone use. The epidemiological evidence on mobile phone 
use and brain tumours was searched from the PubMed database 
(www.ncbi.nlm.nih.gov) using the following search terms either in abstract or title: 
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1) mobile/cellular phone/telephone and 2) brain tumour/cancer/neoplasm or 
glioma or meningioma or neuroma/schwannoma. In addition to the PubMed 
search, the reference lists of the articles retrieved were browsed.
A total of 19 articles (Hardell et al. 1999; Dreyer et al. 1999; Muscat et al. 
2000; Hardell et al. 2001; Inskip et al. 2001; Johansen et al. 2001; Hardell et al. 
2002a; Auvinen et al. 2002; Hardell et al. 2002b; Muscat et al. 2002; Hardell et al. 
2003; Warren et al. 2003; Christensen et al. 2004; Lönn et al. 2004a; Christensen 
et al. 2005; Hardell et al. 2005a; Schoemaker et al. 2005; Lönn et al. 2005; Hardell 
et al. 2006c) were identified from the PubMed database by 1 December 2005. The 
inclusion criteria required the articles: 1) to be original publications, 2) to use 
individual exposure data, 3) to be based on case-control or cohort format, 4) to report 
quantitative measures of association (point estimates expressed either as odds 
ratios, ORs or as standardised incidence ratios, SIRs) and 5) to report information 
needed for the estimation of confidence intervals (standard error or confidence 
interval of effect measure, or number of subjects by exposure and outcome 
status). As meta-analysis requires that the studies to be pooled have similar 
aims and end-points, one study was excluded because the end-point was brain 
tumour mortality rather than incidence (Dreyer et al. 1999) and another since it 
addressed only facial nerve tumours (Warren et al. 2003). No unpublished reports 
were identified. No studies were excluded due to language other than English or 
due to dissimilar procedures, as both inclusion criteria and exposure assessment 
methods were similar enough to allow pooling. Grading by quality was not 
regarded as necessary since the approaches in the studies were relatively uniform.
Of the 17 studies identified fulfilling the criteria, five studies (Hardell 
et al. 2001; Hardell et al. 2002b; Hardell et al. 2003; Christensen et al. 2004; 
Lönn et al. 2004a) were excluded from the analysis, because they used study 
subjects overlapping with the other studies that were already included in the 
material, leaving finally twelve studies (Hardell et al. 1999; Muscat et al. 2000; 
Inskip et al. 2001; Johansen et al. 2001; Auvinen et al. 2002; Hardell et al. 2002a; 
Muscat et al. 2002; Christensen et al. 2005; Lönn et al. 2005; Schoemaker et al. 
2005; Hardell et al. 2005a; Hardell et al. 2006c) in the analysis (Table 2). All 
studies used incident brain tumour cases. One of the studies was a cohort study 
(Johansen et al. 2001), while all others used a case-control design. Half of the 
studies (Hardell et al. 1999; Hardell et al. 2002a; Lönn et al. 2005; Schoemaker 
et al. 2005; Hardell et al. 2005a; Hardell et al. 2006c) reported excluding the 
exposure within one year or less from the index date (diagnosis of cases and 
corresponding date among controls) in the analysis, while no such restriction of 
exposure was reported in the other half of the studies. The participation rates 
were 73% – 92% among cases and 51% – 91% among controls.
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3.2.3. Data collection from refusing study subjects (Study IV)
As the response proportion in the case-control study of brain tumours was 
not entirely satisfactory in Finland, especially among controls, an additional 
short questionnaire focusing solely on mobile phone use status and educational 
attainment was prepared during the first year of the study period. The overall 
participation rate in the Finnish part of the INTERPHONE study was 46% 
among primary controls and 84% among cases. The most common reasons for 
refusal were lack of time, inconvenience and illness in the family.
To evaluate the possible bias due to differential participation in the case-
control study of brain tumours in Finland, the short questionnaire was used 
during the first five months of the study (from April 2001) to collect information 
from those subjects who refused to grant the full personal interview, both for 
cases approached personally at the clinics and controls approached by telephone. 
The short questionnaire contained only two questions, one regarding mobile 
phone use (regular use or not and start date) and the other elicited the highest 
educational level attained.
3.3. Statistical methods
3.3.1. Statistical methods in the case-control studies (Studies I and II)
As frequency matching was used throughout the INTERPHONE study, the entire 
control group recruited for all brain tumours in the matched strata of either the 
glioma or the meningioma cases, were used in the analyses to increase statistical 
power. Several features of reported mobile phone use in relation to glioma and 
meningioma were analysed using both continuous and categorical exposure 
variables. The cut-points for the categorical exposure variables were defined 
according to the distribution among controls, so that the never and non-regular 
users formed the reference category, while the other cut-points were defined by 
the 50th and 75th percentiles of the exposure distribution among regular mobile 
phone users. In the analyses of cumulative number of calls and cumulative 
hours of mobile phone use, the exposure was corrected for the reported use of 
hands-free devices. The exposure was reduced by 100% if the subject reported 
use of hands-free devices all the time, by 75% if most of the time, 50% if half of 
the time and 25% if sometimes but less than half of the time.
For the calculation of exposure indices, a reference date was determined 
for each subject. The reference date was the date of diagnosis for cases, whereas 
for controls the reference date was set according to the interview date taking 
into account the fact that the controls were interviewed on average later than 
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the cases. Since the prevalence of mobile phone use was likely to increase rapidly 
over time and it was essential to avoid the effect of the possible interview lag 
among controls, the reference date for controls was defined using the following 
formula: refdatecontrol = intdatecontrol – [(mean intdatecases – mean diagdatecases) – (mean 
intdatecases – mean intdatecontrols)]. The reference date calculations were performed 
separately for each country. To allow for a minimum latency of one year, all 
mobile phone use within one year prior to the reference date was excluded 
from the analysis, except when calculating the years since first use, which was 
evaluated up to the reference date.
The odds ratios (OR) for glioma and meningioma in relation to mobile 
phone use were estimated by conditional logistic regression, with strata by sex, 
five-year age group, region and country. The glioma and meningioma datasets 
were analysed separately. Based on the literature on the aetiology of glioma and 
meningioma, highest educational level attained, family history of glioma (in the 
glioma analysis) or meningioma (in the meningioma analysis), radiotherapy to 
the head and neck region (at least ten years before the reference date), and past 
diagnosis of neurofibromatosis or tuberous sclerosis of the subject were regarded 
as potential confounders. All the analyses were conducted both with and without 
considering the effects of the potential confounding factors.
The risk of glioma and meningioma was evaluated separately by type of 
phone (analogue and digital) and by tumour location (laterality). The laterality of 
the tumour was assessed in relation to the reported predominant side of mobile 
phone use (more than 50% of the time on the same side), using both a method 
based on cases only (Inskip et al. 2001) and another method also including the 
controls with more statistical power (Lönn et al. 2005). The original laterality 
method by Lönn was slightly modified as the reference group was set to comprise 
only never and non-regular users, without those using the phone on the other 
side, who were regarded as non-exposed by Lönn in the unmodified form of this 
method. As this modification was also done for the glioma analysis subsequent 
to the publication of the original report (Study I) where the original version of 
the method was used, the results reported here are somewhat different from 
the previously published results regarding glioma. All analyses were conducted 
using STATA statistical software, version 9 (Statacorp 2005).
3.3.2. Methods used in the meta-analysis (Study III)
The studies selected for the meta-analysis were reviewed independently by two 
authors (Lahkola & Tokola), and all relevant data (ORs, RRs and SIRs with 
95% CIs) were retrieved and entered into evidence tables.
In the absence of heterogeneity between studies, the meta-analysis was 
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carried out using the inverse variance-weighted method for combining the 
ORs (Sutton et al. 2000). This approach is equivalent to fixed effects analysis, 
assuming that the effect is constant across studies and all differences between 
studies are attributable to random variation (Sutton et al. 2000). When there 
was heterogeneity between studies, we used random effects analysis, which 
allows the true risks to vary between studies and assumes a random distribution 
of these estimates around a common central value.
The weights were calculated based on the width (subtraction of the 
upper and lower limit) of the confidence interval, due to problems with the 
rounding of the original confidence intervals (CI) in some of the studies. Also, 
to improve accuracy, the overall OR for brain tumours was recalculated for 
one study (Hardell et al. 2002a), because the original CIs in the article were 
reported with only one decimal. For four studies (Lönn et al. 2005; Schoemaker 
et al. 2005; Hardell et al. 2005a; Hardell et al. 2006c), two exposure categories, 
5 – 9 years (or 5 – 10 years) and > 10 years into > 5 years, were pooled to achieve 
uniform exposure classification. Further, for those studies reporting the 
estimates for different tumour categories only separately (Johansen et al. 2001; 
Christensen et al. 2005) estimates were pooled to calculate of the overall OR 
(meta-analysis of all tumours combined). When the estimates were not reported 
for all mobile phones combined (but only separately for analogue and digital 
phones), the OR for digital phones was used for calculations of the total OR. 
This was done because digital phone use was more common in most studies 
and also, it was very likely that the same individuals had been using both 
analogue and digital telephones and were thus included in both categories in the 
original reports (Hardell et al. 2002a; Hardell et al. 2005a; Hardell et al. 2006c).
The meta-analysis concentrated on the subjects most likely to demonstrate 
an effect (if such exists), i.e. the mobile phone users with the longest period of use. 
In most studies, the highest exposure category was defined as five or more years of 
use, but in four studies, the longest period was shorter than this (4 years, 3 – 6 years, 
2 years and the cohort study with a mean follow-up time of 3.1 years). A pooled 
OR was calculated for all brain tumours combined and also separately for three 
tumour types: gliomas (9 studies), meningiomas (8 studies) and acoustic neuromas 
(6 studies). A pooled estimate was also calculated separately by telephone types 
(analogue and digital, 7 studies) and for ipsi/contralateral use (reported phone 
use on the same/opposite side of the head where the tumour occurred, 7/5 studies).
Possible heterogeneity between the studies included in the meta-analysis 
was assessed using the Q statistic to determine whether the results of various 
studies were consistent enough to be combined. The sensitivity, i.e. the influence 
of single studies, was evaluated by repeating the calculations of pooled estimates 
while excluding each study at a time.
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3.3.3. Assessment of selection bias in Finnish case-control study (Study IV)
The possible selection bias due to differential participation in the Finnish 
case-control study was investigated in relation to both mobile phone use and 
education. In order to assess the effect of the selection bias, we used the data 
collected through the personal interviews with the study participants and also 
that obtained from the short questionnaire addressed to those subjects who 
refused to grant the full personal interview. Cases and controls were investigated 
separately and the analyses were based on a total of 829 cases (337 women 
and 492 men) and 1,098 controls (532 women and 566 men). Of the cases, 726 
subjects were full participants with personal interview and 103 incomplete 
participants with only the short survey, whereas among controls the respective 
corresponding numbers were 777 and 321.
Both mobile phone use status (regular vs. never/ non-regular user) and 
educational level of the full study participants was compared to those of the 
subjects with the short questionnaire only (incomplete participants). In addition 
to this, the effect of sex, education, five-year age group and mobile phone use on 
study participation was evaluated by logistic regression. Education was classified 
into three categories in the analyses;  low (elementary or comprehensive school), 
intermediate (upper secondary school, vocational school or college) and high 
(polytechnic, university). The effect of selection bias was assessed by comparing 
the OR for brain tumours based on the full study participants with the OR based 
on the information of both the full study participants and the subjects with only 
the short questionnaire (incomplete participants). The effect measure used was 
the Mantel-Haenszel estimate of odds ratio (OR) obtained from analysis stratified 
by sex, five-year age group, region (university hospital area) and education.
In addition to the full study participants and incomplete participants, 
there were a total of 65 cases and 519 controls who refused to participate in 
both the full interview and the short questionnaire. To evaluate mobile phone 
use among these subjects, we searched a public telephone number database 
for the possible mobile phone numbers of two sub-groups of controls: randomly 
selected 50 study participants and 50 total refusers. The number search from 
the database was performed based on the name and home address of the subject 
and those for whom a matching entry (in terms of both criteria) was found were 
classified as mobile phone users.
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4. Results
4.1. Risk of glioma and meningioma in relation 
to mobile phone use (Studies I and II)
A total of 2,530 eligible glioma cases, 1,629 meningioma cases and 6,581 controls 
were identified in the studies. Of the glioma cases, 60% (1,521 subjects, range 
37 – 81% between countries) and of meningioma cases, 74% (1,209 subjects, 
range 55 – 90%) participated to the study. The corresponding figure for controls 
was 50% (3,301 subjects, range 42 – 69%) (Table 3). The main reasons for 
non-participation were refusal (8% of glioma cases, 9% of meningioma cases 
and 33% of controls), illness or death (18% of glioma cases, 3% of meningioma 
cases and 0.5% of controls) and failure to contact the subject (7% of glioma 
cases, 8% of meningioma cases and 15% of controls). Since both datasets (glioma 
and meningioma) contained strata either without cases or controls, the number 
of subjects included in the analyses was somewhat smaller than the number 
of participating subjects (the number of excluded subjects was 170 for glioma 
and 349 for meningioma analysis). Demographic characteristics of the study 
subjects are shown in Table 4.
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Gliomas (n = 1521) Meningiomas (n = 1209) Controls (n = 3301)
n % n % n %
Sex
Male 893 58.7 301 24.9 1530 46.4
Female 628 41.3 908 75.1 1771 53.7
Age at interview
18 – 29 134 8.8 22 1.8 219 6.6
30 – 39 252 16.6 119 9.8 467 14.2
40 – 49 329 21.6 279 23.1 742 22.5
50 – 59 480 31.6 485 40.1 1116 33.8
60 – 69 326 21.4 304 25.1 757 22.9
Highest 
educational level
Comprehensive 
school 429 28.2 399 33.0 933 28.3
Secondary/ 
vocational school 367 24.1 285 23.6 789 23.9
Upper secondary 
school 336 22.1 236 19.5 832 25.2
University 380 25.0 284 23.5 740 22.4
Not known 9 0.6 5 0.4 7 0.2
Mobile phone use
Regular use, yes/no 867/629 58/42 573/631 48/52 1853/1281 59/41 
Years since first 
use, mean/ max 3.7/ 16.5  – 2.8/ 14.9  – 3.5/ 15.4  – 
Cumulative hours of 
use, mean/ max a) 596/ 31817  – 408/ 35960  – 375/ 35475  – 
Subjects using 
hands-free devices
194 12.8 85 7.0 331 10.0
Table 4. Demographic characteristics of the study subjects of the case-control study on 
brain tumours and mobile phone use (Studies I and II).
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Adjustment for family history and socio-economic status in the analyses 
did not affect the results, nor did the exclusion of subjects with neurofibromatosis, 
tuberous sclerosis or a previous history of radiotherapy to the head and neck 
region. Therefore, all results are from analyses taking into account only the 
stratification variables (sex, five-year age group, region and country).
Regular use of mobile phone was reported by 58% (867) of glioma cases, 
48% (573) of meningioma cases and 59% (1,853) of controls. The OR for glioma 
in relation to regular mobile phone use was 0.78 (0.68, 0.91) and for meningioma 
it was 0.76 (0.65, 0.89) (Table 5). Years since first mobile phone use resulted 
in almost identical estimates for glioma and meningioma, as the ORs for the 
different tumour types were 0.99 (0.97, 1.01) and 0.99 (0.96, 1.01) per year 
respectively.
Cumulative number of calls was not associated either with the risk 
of glioma (OR = 1.00 per 10,000 calls, 95% CI: 0.97, 1.04) or meningioma 
(OR = 1.00 per 10,000 calls, 95% CI: 0.96, 1.05). In the glioma analysis, the 
OR for cumulative hours of mobile phone use based on analyses of continuous 
variable was 1.006 per 100 hours (1.002, 1.010) but there was no trend of risk 
with cumulative hours of use when the data were examined in categories (Table 
5). A similar phenomenon was seen in the meningioma analysis, where the OR 
for continuous variable was 1.005 per 100 hours (1.001, 1.010).
Since the analyses of continuous and categorical variables for cumulative 
hours of use gave inconsistent results for both glioma and meningioma, the data 
were further explored and it emerged that the distribution of the continuous 
variable in both datasets was skewed. The continuous variable of cumulative 
hours of use included some very high and most likely erroneous values, which, in 
turn, was reflected in subjects with implausibly high reported mean daily hours 
of use over long periods, leading to an untrue relationship between exposure 
and disease. When the subjects with more than 2 hours daily use through entire 
exposure history were excluded (in the glioma analysis: 49 controls and 49 cases, 
2.1% of observations, in the meningioma analysis: 44 controls and 27 cases, 1.7% 
of observations), no relation was detected either for gliomas or meningiomas.
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The analyses based on different telephone types did not show an association 
between mobile phone use and gliomas or meningiomas (Table 5). Neither did 
the laterality analysis based on the method of Lönn (Lönn et al. 2005) yield 
evidence that mobile phone use on the same side of the head as the tumour were 
associated with each other. The estimates were mostly below 1.0 and the results 
were fairly similar for both tumour types (Table 6). Mobile phone use on the 
opposite side of the head from the tumour site yielded even smaller estimates 
of risk, for both gliomas and meningiomas (Table 6). The updated analyses 
of glioma showed less association than the original results presented in the 
publication, where the ORs for year since first ipsilateral use were 1.08 (0.88, 
1.31), 1.10 (0.89, 1.35) and 1.39 (1.01, 1.92) in categories of 1.5 – 4, 5 – 9 and >10 
years respectively (Study I).
When the location of gliomas was investigated using the case-only method 
(Inskip et al. 2001) the relative risk (RR) for ipsilateral mobile phone use of 
1.24 (Fisher’s exact test: p<0.001, two-sided) was obtained on the basis of 674 
(394 exposed, 278 unexposed) glioma cases. For meningiomas, the RR obtained 
in the similar analysis was 1.09 (p = 0.10) on the basis of 212 exposed and 184 
unexposed meningioma cases.
47
STUK-A246
Ta
b
le
 6
. 
O
d
d
s 
ra
ti
o
s 
fo
r 
g
lio
m
a 
an
d
 m
en
in
g
io
m
a 
in
 r
el
at
io
n
 t
o
 l
at
er
al
it
y 
o
f 
tu
m
o
u
rs
 a
n
d
 r
ep
o
rt
ed
 s
id
e 
o
f 
m
o
b
ile
 p
h
o
n
e 
u
se
 
(S
tu
di
es
 I 
an
d 
II)
.
G
lio
m
as
 a )
Co
nt
ro
ls
 a)
O
R 
(9
5%
 C
I)
M
en
in
gi
om
as
 a)
Co
nt
ro
ls
 a)
O
R 
(9
5%
 C
I)
Ip
si
la
te
ra
l p
ho
ne
 u
se
 b )
Fr
eq
ue
nc
y 
of
 u
se
N
ev
er
/ n
on
-re
gu
la
r u
se
 c
)
53
2
12
81
1.
0
48
6
12
49
1.
0
Re
gu
la
r
47
1
10
02
0.
93
 (0
.7
8,
 1
.1
1)
 
25
0
91
8
0.
81
 (0
.6
6,
 0
.9
9)
Ye
ar
s 
si
nc
e 
fir
st
 u
se
1.
5-
4 
d)
20
5
48
5
0.
86
 (0
.7
0,
 1
.0
9)
12
8
44
2
0.
77
 (0
.6
0,
 0
.9
9)
5-
9
18
9
40
0
0.
92
 (0
.7
3,
 1
.1
6)
89
36
3
0.
78
 (0
.5
6,
 1
.0
4)
≥1
0
77
11
7
1.
14
 (0
.8
2,
 1
.6
0)
33
11
3
1.
05
 (0
.6
7,
 1
.6
5)
Cu
m
ul
at
iv
e 
ho
ur
s 
of
 u
se
 e)
< 
m
ed
ia
n
20
2
49
2
0.
88
 (0
.7
1,
 1
.0
9)
12
7
46
9
0.
75
 (0
.5
9,
 0
.9
7)
m
ed
ia
n-
3r
d  q
ua
rti
le
11
3
25
1
0.
86
 (0
.6
5,
 1
.1
3)
59
20
8
0.
82
 (0
.5
7,
 1
.1
5)
>3
rd
 qu
ar
til
e
13
6
24
7
1.
02
 (0
.7
8,
 1
.3
3)
58
22
5
0.
89
 (0
.6
2,
 1
.2
7)
a)
 T
he
 n
um
be
rs
 d
o 
no
t e
xa
ct
ly
 m
at
ch
 th
e 
to
ta
l n
um
be
rs
 o
f g
lio
m
a 
an
d 
m
en
in
gi
om
a 
ca
se
s 
(1
52
1 
an
d 
12
09
) a
nd
 c
on
tro
ls
 (3
30
1)
 s
in
ce
 th
er
e 
w
er
e 
st
ra
ta
 w
ith
ou
t 
   
 c
as
es
 a
nd
 s
tra
ta
 w
ith
ou
t c
on
tro
ls
 in
 th
e 
da
ta
 (t
he
 n
um
be
r o
f e
xc
lu
de
d 
su
bj
ec
ts
 w
as
 1
70
 fo
r g
lio
m
a 
an
d 
34
9 
fo
r m
en
in
gi
om
a 
an
al
ys
is
). 
Th
e 
nu
m
be
r o
f c
on
tro
ls
   
 is
 d
iff
er
en
t i
n 
gl
io
m
a 
an
d 
m
en
in
gi
om
a 
an
al
ys
es
 fo
r t
hi
s 
sa
m
e 
re
as
on
). 
Al
so
, t
hi
s 
an
al
ys
is
 in
cl
ud
es
 o
nl
y 
su
bj
ec
ts
 w
ith
 b
ot
h 
si
de
 o
f t
um
ou
r a
nd
 u
se
 k
no
w
n.
 
b)
 Ip
si
la
te
ra
l p
ho
ne
 u
se
 =
 m
ob
ile
 p
ho
ne
 u
se
 o
n 
th
e 
sa
m
e 
si
de
 o
f t
he
 h
ea
d 
as
 th
e 
tu
m
ou
r, 
co
nt
ra
la
te
ra
l p
ho
ne
 u
se
 =
 m
ob
ile
 p
ho
ne
 u
se
 o
n 
th
e 
op
po
si
te
 s
id
e 
of
 th
e
   
 h
ea
d 
as
 th
e 
tu
m
ou
r.
c)
 R
ef
er
en
ce
 c
at
eg
or
y 
us
ed
 in
 a
ll 
an
al
ys
es
. T
he
 n
um
be
r o
f c
as
es
 in
 th
e 
re
fe
re
nc
e 
gr
ou
p 
in
 th
e 
gl
io
m
a 
an
al
ys
is
 is
 d
iff
er
en
t t
o 
th
e 
m
ai
n 
an
al
ys
is
 (6
29
) s
in
ce
 th
er
e 
   
 w
er
e 
97
 c
as
es
 fo
r w
ho
m
 th
e 
si
de
 o
f t
he
 tu
m
ou
r w
as
 n
ot
 d
ef
in
ed
 (8
0 
w
ith
 a
 c
en
tra
l t
um
ou
r a
nd
 1
7 
w
ith
 a
 m
is
si
ng
 v
al
ue
). 
In
 th
e 
m
en
in
gi
om
a 
an
al
ys
is
 th
e 
   
 n
um
be
rs
 d
iff
er
 w
ith
 th
e 
m
ai
n 
an
al
ys
is
 (6
31
) f
or
 th
e 
sa
m
e 
re
as
on
 (1
15
 c
en
tra
l t
um
ou
rs
 a
nd
 3
0 
m
is
si
ng
 v
al
ue
s)
.
d)
 L
ow
er
 li
m
it 
1.
5 
ye
ar
s 
si
nc
e 
ph
on
e 
us
e 
w
as
 d
ef
in
ed
 a
s 
re
gu
la
r w
he
n 
ph
on
e 
w
as
 u
se
d 
fo
r a
t l
ea
st
 s
ix
 m
on
th
s 
du
rin
g 
a 
pe
rio
d 
at
 le
as
t o
ne
 y
ea
r p
rio
r t
o 
re
fe
re
nc
e 
da
te
.
e)
 E
st
im
at
es
 a
dj
us
te
d 
fo
r u
se
 o
f h
an
ds
-fr
ee
 d
ev
ic
es
. F
or
 ip
si
la
te
ra
l p
ho
ne
 u
se
 d
at
a 
ar
e 
di
vi
de
d,
 a
cc
or
di
ng
 to
 th
e 
di
st
rib
ut
io
n 
in
 c
on
tro
ls
, i
nt
o 
<1
36
, 1
36
-5
67
 a
nd
 >
56
7 
in
 
   
 th
e 
gl
io
m
a 
an
al
ys
is
, a
nd
 <
13
6,
 1
36
-5
73
 a
nd
 >
57
3 
in
 th
e 
m
en
in
gi
om
a 
an
al
ys
is
. F
or
 c
on
tra
la
te
ra
l p
ho
ne
 u
se
, d
at
a 
ar
e 
di
vi
de
d 
in
to
 <
13
2,
 1
32
-5
53
 a
nd
 >
55
3 
in
 th
e 
gl
io
m
a
   
 a
na
ly
si
s,
 a
nd
 <
13
3,
 1
33
-5
66
 a
nd
 >
56
6 
in
 th
e 
m
en
in
gi
om
a 
an
al
ys
is
.
48
STUK-A246
G
lio
m
as
 a)
Co
nt
ro
ls
 a)
O
R 
(9
5%
 C
I)
M
en
in
gi
om
as
 a)
Co
nt
ro
ls
 a)
O
R 
(9
5%
 C
I)
Co
nt
ra
la
te
ra
l p
ho
ne
 u
se
 b)
Fr
eq
ue
nc
y 
of
 u
se
N
ev
er
/ n
on
-re
gu
la
r u
se
 c)
53
2
12
81
1.
0
48
6
12
49
1.
0
Re
gu
la
r
35
4
98
6
0.
73
 (0
.6
1,
 0
.8
8)
22
4
90
5
0.
67
 (0
.5
4,
 0
.8
3)
Ye
ar
s 
si
nc
e 
fir
st
 u
se
1.
5-
4 
b)
15
0
47
4
0.
68
 (0
.5
4,
 0
.8
6)
10
5
42
4
0.
62
 (0
.4
7,
 0
.8
0)
5-
9
13
7
39
1
0.
71
 (0
.5
5,
 0
.9
1)
95
36
4
0.
78
 (0
.5
8,
 1
.0
5)
≥1
0
67
12
1
0.
97
 (0
.6
8,
 1
.3
8)
24
11
7
0.
62
 (0
.3
8,
 1
.0
3)
Cu
m
ul
at
iv
e 
ho
ur
s 
of
 u
se
 e)
< 
m
ed
ia
n
14
0
48
5
0.
63
 (0
.5
0,
 0
.8
0)
11
1
45
6
0.
62
 (0
.4
8,
 0
.8
0)
m
ed
ia
n-
3r
d 
qu
ar
til
e
97
24
9
0.
77
 (0
.5
8,
 1
.0
3)
50
22
0
0.
65
 (0
.4
5,
 0
.9
4)
>3
rd
 q
ua
rti
le
10
6
24
0
0.
86
 (0
.6
4,
 1
.1
5)
58
21
6
0.
81
 (0
.5
6,
 1
.1
7)
Ta
b
le
 6
. C
on
tin
ue
d.
a)
 T
he
 n
um
be
rs
 d
o 
no
t e
xa
ct
ly
 m
at
ch
 th
e 
to
ta
l n
um
be
rs
 o
f g
lio
m
a 
an
d 
m
en
in
gi
om
a 
ca
se
s 
(1
52
1 
an
d 
12
09
) a
nd
 c
on
tro
ls
 (3
30
1)
 s
in
ce
 th
er
e 
w
er
e 
st
ra
ta
 w
ith
ou
t 
   
 c
as
es
 a
nd
 s
tra
ta
 w
ith
ou
t c
on
tro
ls
 in
 th
e 
da
ta
 (t
he
 n
um
be
r o
f e
xc
lu
de
d 
su
bj
ec
ts
 w
as
 1
70
 fo
r g
lio
m
a 
an
d 
34
9 
fo
r m
en
in
gi
om
a 
an
al
ys
is
). 
Th
e 
nu
m
be
r o
f c
on
tro
ls
   
 is
 d
iff
er
en
t i
n 
gl
io
m
a 
an
d 
m
en
in
gi
om
a 
an
al
ys
es
 fo
r t
hi
s 
sa
m
e 
re
as
on
). 
Al
so
, t
hi
s 
an
al
ys
is
 in
cl
ud
es
 o
nl
y 
su
bj
ec
ts
 w
ith
 b
ot
h 
si
de
 o
f t
um
ou
r a
nd
 u
se
 k
no
w
n.
 
b)
 Ip
si
la
te
ra
l p
ho
ne
 u
se
 =
 m
ob
ile
 p
ho
ne
 u
se
 o
n 
th
e 
sa
m
e 
si
de
 o
f t
he
 h
ea
d 
as
 th
e 
tu
m
ou
r, 
co
nt
ra
la
te
ra
l p
ho
ne
 u
se
 =
 m
ob
ile
 p
ho
ne
 u
se
 o
n 
th
e 
op
po
si
te
 s
id
e 
of
 th
e
   
 h
ea
d 
as
 th
e 
tu
m
ou
r.
c)
 R
ef
er
en
ce
 c
at
eg
or
y 
us
ed
 in
 a
ll 
an
al
ys
es
. T
he
 n
um
be
r o
f c
as
es
 in
 th
e 
re
fe
re
nc
e 
gr
ou
p 
in
 th
e 
gl
io
m
a 
an
al
ys
is
 is
 d
iff
er
en
t t
o 
th
e 
m
ai
n 
an
al
ys
is
 (6
29
) s
in
ce
 th
er
e 
   
 w
er
e 
97
 c
as
es
 fo
r w
ho
m
 th
e 
si
de
 o
f t
he
 tu
m
ou
r w
as
 n
ot
 d
ef
in
ed
 (8
0 
w
ith
 a
 c
en
tra
l t
um
ou
r a
nd
 1
7 
w
ith
 a
 m
is
si
ng
 v
al
ue
). 
In
 th
e 
m
en
in
gi
om
a 
an
al
ys
is
 th
e 
   
 n
um
be
rs
 d
iff
er
 w
ith
 th
e 
m
ai
n 
an
al
ys
is
 (6
31
) f
or
 th
e 
sa
m
e 
re
as
on
 (1
15
 c
en
tra
l t
um
ou
rs
 a
nd
 3
0 
m
is
si
ng
 v
al
ue
s)
.
d)
 L
ow
er
 li
m
it 
1.
5 
ye
ar
s 
si
nc
e 
ph
on
e 
us
e 
w
as
 d
ef
in
ed
 a
s 
re
gu
la
r w
he
n 
ph
on
e 
w
as
 u
se
d 
fo
r a
t l
ea
st
 s
ix
 m
on
th
s 
du
rin
g 
a 
pe
rio
d 
at
 le
as
t o
ne
 y
ea
r p
rio
r t
o 
re
fe
re
nc
e 
da
te
.
e)
 E
st
im
at
es
 a
dj
us
te
d 
fo
r u
se
 o
f h
an
ds
-fr
ee
 d
ev
ic
es
. F
or
 ip
si
la
te
ra
l p
ho
ne
 u
se
 d
at
a 
ar
e 
di
vi
de
d,
 a
cc
or
di
ng
 to
 th
e 
di
st
rib
ut
io
n 
in
 c
on
tro
ls
, i
nt
o 
<1
36
, 1
36
-5
67
 a
nd
 >
56
7 
in
 
   
 th
e 
gl
io
m
a 
an
al
ys
is
, a
nd
 <
13
6,
 1
36
-5
73
 a
nd
 >
57
3 
in
 th
e 
m
en
in
gi
om
a 
an
al
ys
is
. F
or
 c
on
tra
la
te
ra
l p
ho
ne
 u
se
, d
at
a 
ar
e 
di
vi
de
d 
in
to
 <
13
2,
 1
32
-5
53
 a
nd
 >
55
3 
in
 th
e 
gl
io
m
a
   
 a
na
ly
si
s,
 a
nd
 <
13
3,
 1
33
-5
66
 a
nd
 >
56
6 
in
 th
e 
m
en
in
gi
om
a 
an
al
ys
is
.
49
STUK-A246
 
 
4.2. Meta-analysis of brain tumours and 
mobile phone use (Study III)
The main result of the meta-analysis, the pooled estimate for all tumour types 
combined, based on the twelve studies on brain tumours and mobile phone use, 
did not show an association between exposure and disease (OR = 0.98, 95% 
CI: 0.83 – 1.16, Figure 1). As there was evidence for heterogeneity between the 
pooled studies, a random effects model was used for the calculation of the main 
result. According to the sensitivity analysis, the OR was not found to be strongly 
influenced by any single study (Table 7).
Hardell 2006
Hardell 2005a
Schoemaker 2005
Christensen 2005
Lönn 2005
Muscat 2002
Hardell 2002
Auvinen 2002
Johansen 2001
Inskip 2001
Muscat 2000
Hardell 1999
Pooled OR
0,0 0,5 1,0 1,5 2,0 2,5 3,0 3,5 4,0 4,5 5,0 5,5
 
 
 
Figure 1. Results of the studies (ORs with 95% CIs) included in the meta-analysis and the 
pooled OR (0.98, 95% CI 0.83 – 1.16) for the risk of brain tumours in relation to mobile 
phone use (on log scale).
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Study excluded from the 
analysis
OR a) 95% CI p for 
heterogeneity a)
Hardell 1999 0.99 0.83 – 1.19 0.429
Muscat 2000 1.00 0.83 – 1.19 0.448
Inskip 2001 0.99 0.82 – 1.18 0.419
Johansen 2001 0.99 0.81 – 1.21 0.511
Auvinen 2002 0.95 0.80 – 1.13 0.476
Hardell 2002a 0.99 0.82 – 1.19 0.428
Muscat 2002 0.97 0.84 – 1.15 0.440
Lönn 2005 1.02 0.85 – 1.21 0.442
Christensen 2005 1.02 0.86 – 1.21 0.473
Schoemaker 2005 0.99 0.81 – 1.20 0.516
Hardell 2005 0.94 0.79 – 1.11 0.442
Hardell 2006c 0.93 0.79 – 1.09 0.418
a) After exclusion of the study indicated on each particular row
Table 7. The Sensitivity analysis (effect of single studies) of the pooled OR (0.98, 95% 
CI 0.83 – 1.16, p for heterogeneity 0.454, for all brain tumours) (Study III).
The pooled estimates calculated for different histological types of tumours 
were similar both to each other and to the main result. The pooled estimate 
for gliomas and meningiomas were slightly below one, whereas for acoustic 
neuromas the OR was slightly above one. Moreover, no major differences in 
the results were detected in the analysis by telephone type (analogue/ digital), 
while the estimate for analogue phones was slightly higher than that for digital 
phones. For ipsilateral tumours (i.e. those occurring on the same side as that 
on which the mobile phone was used) the OR was above one, with borderline 
non-significance, whereas the OR for contralateral tumors was very close to one. 
(Table 8).
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4.3. Selection bias in the Finnish case-control study on 
mobile phone use and brain tumours (Study IV)
Among the controls in the Finnish study of brain tumours, regular use of mobile 
phone was more common among full study participants (83%, 95% CI:  81, 86) 
than among the incomplete participants with only the short survey (73%, 95% 
CI: 68, 76).  Among cases too, the full study participants reported mobile phone 
use more frequently than the incomplete participants (76%, 95% CI: 73, 80, 
versus 64%, 95% CI: 55, 74) (Table 9).
Control full participants were more highly educated than those controls 
only completing the short questionnaire. The prevalence of high, intermediate 
and low level of education among full study participants was 16%, 54% and 29%, 
whereas for the incomplete participants the corresponding figures were 9, 44 and 
48% respectively (p<0.001). For cases too, the educational level seemed to be in 
relation to full participation, as the proportion of subjects with high educational 
level was greater among the full study participants than incomplete participants 
(22% and 6% respectively) (Table 9).
 
Table 9. Mobile phone use and educational level by study participation in the Finnish 
case-control study on brain tumours (Study IV).
Cases (n = 829)  
n (%)
Controls (n = 1098) 
n (%)
Study participants 
(n = 726)
Incomplete 
participants 
(n = 103)
Study participants 
(n = 777)
Incomplete 
participants 
(n = 321)
Regular mobile phone use
Yes 554 (76%) 65 (64%) 646 (83%) 230 (72%)
No 172 (24%) 36 (36%) 131 (17%) 87 (27%)
Highest educational level
Low 257 (35%) 51 (50%) 228 (29%) 150 (47%)
Intermediate 313 (43%) 46 (46%) 422 (54%) 138 (43%)
High 156 (21%) 6 (6%) 127 (16%) 28 (9%)
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In the multivariate logistic regression, there was an association between 
mobile phone use and full study participation both among cases and controls 
even after controlling for age, sex and education. The crude and adjusted ORs 
for full participation were 1.9 (1.4, 2.5) and 1.9 (1.4, 2.8) for controls respectively, 
whereas for cases the figures were 1.8 (1.1, 2.8) and 1.5 (0.9, 1.4) respectively. 
The odds ratio for regular mobile phone use based on the full study participants, 
was 0.55 (0.39, 0.77), whereas the OR based on the incomplete participants was 
0.62 (0.26, 1.51). The OR based on both full study participants and incomplete 
participants was 0.73 (0.56, 0.96).
Of the 50 randomly selected controls who participated fully in the study, 
64% had a listed mobile phone number, whereas among those 50 controls who 
refused to participate both in the study and in the short questionnaire, only for 
42% was a mobile phone number found (p = 0.03). This finding indicates that 
mobile phone use may have played a role in study participation.
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5. Discussion
5.1. General discussion of the results
In light of the findings of the work presented in this dissertation, mobile 
phone use is not likely to have a major impact on the risk of brain tumours. In 
the five-country case-control studies on mobile phone use, the risk for either 
gliomas or meningiomas was not generally elevated despite the numerous 
analyses investigating several different measures of mobile phone use. The only 
indication of a possible positive association between mobile phone use and brain 
tumours was detected in the case-case analysis of laterality, where the risk 
for ipsilateral gliomas was slightly increased, based on a substantially smaller 
number of cases than in the main analysis. The reported side of the head where 
the cases had mainly used the phone may be affected by the fact that they 
were aware of the side of their tumour (recall bias). Therefore, this result needs 
careful interpretation due to the possibility of bias in the reporting of the side 
of phone use, and also because of the smaller number of subjects included in the 
analysis than in the data in total. However, the finding is also consistent with a 
local effect of the RF radiation emitted by a mobile phone.
The analyses of cumulative hours of mobile phone use yielded inconsistent 
results for both gliomas and meningiomas. In the analyses based on a continuous 
exposure indicator, a slightly increased risk for gliomas and meningiomas was 
detected, while no such association was found when the data were examined 
in categories. The analyses of continuous variables in both datasets were, 
however, driven by a small number of influential extreme values. Some of them 
may be erroneous, as they included implausibly high daily hours of use, up to 
17 hours per day. When the subjects with the highest daily phone use 
(> 2 hours throughout the entire usage history) were excluded, no association 
was detected for either gliomas or meningiomas. In the validation studies, where 
the self-reported data collected within the INTERPHONE study was compared 
to the data provided by the telephone operators, duration of calls was not the 
most adequate indicator of mobile phone use, since the consistency between the 
two sources of information is low (Samkange-Zeeb et al. 2004;  Berg et al. 2005; 
Vrijheid et al. 2008).
As cumulative hours of use in the present data were initially computed 
from two separate measures of exposure, the number and duration of calls 
per day taking into account the duration of entire exposure history, it may be 
imprecise and therefore it should probably not be regarded as the principal tool 
for exposure assessment regarding mobile phone use. During the planning phase 
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of the analyses and fully unaware of such imprecision of the estimate, cumulative 
hours of use was, however, considered an important measure reflecting the 
lifetime cumulative exposure to RF radiation emitted by mobile phones.
In the meta-analysis, where the results of 12 epidemiological studies 
focusing on the possible brain tumour risk of mobile phones were combined, 
little association between the exposure and disease was detected within five 
years from the start of use. There was no association for all brain tumours 
combined, or for tumours of different histological origin analysed in separate 
groups. A weak non-significant association was detected in relation to use of 
analogue telephones. An increased risk for ipsilateral tumours with borderline 
significance was detected but the result needs to be interpreted with caution, 
as the original studies included in the meta-analysis may have been subject to 
recall bias in the reporting of the side of phone use among brain tumour cases.
The overall findings of this dissertation concur with the majority of 
original studies performed by other study groups, also the studies within the 
INTERPHONE collaboration (presented in the Section 1.3.1). The publication 
of the INTERPHONE study results based on the whole 13-country analysis 
have now been expected for several years, but it seems that they will finally be 
published in the near future. The 13-country results are of great value, as the 
data includes the most cases published in any study so far.
Subsequent to the meta-analysis of this dissertation, another two meta-
analyses also including the most recent original studies on mobile phone use and 
brain tumours were published (Kan et al. 2008; Hardell et al. 2008). The results 
of the first work regarding the overall effect of mobile phone use were fairly 
similar to those detected in the meta-analysis of this dissertation, while some 
evidence of increased risk for brain tumours was detected in relation to long-
term (≥ 10 years) use (OR = 1.25, 95% CI 1.01 – 1.54) based on five studies. The 
authors, however, concluded that this result should be confirmed by additional 
data from future studies. For some reason, the meta-analysis did not include all 
studies available at the time when the work was accomplished.
The authors of the latter meta-analysis again reported similar results 
regarding the overall effect but suggest that there is a consistent pattern of an 
association between mobile phone use and ipsilateral glioma (OR = 2.0, 95% 
CI 1.2 – 3.4) and acoustic neuroma (OR = 2.4, 95% CI 1.1 – 5.3) using ≥ 10 years 
latency period (Hardell et al. 2008). Those results, however were based on only 
those studies that reported estimates for more than 10 years of mobile phone use, 
leaving in the analysis a total of 6 studies for glioma and 4 studies for acoustic 
neuroma. In the main analysis for overall effect of mobile phone use, there were 
altogether 10 glioma studies (OR = 0.9, 95% CI 0.8 – 1.1) and 9 acoustic neuroma 
studies (OR = 0.9, 95% CI 0.7 – 1.1). The risk of meningioma was not elevated in 
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any analysis. Prior to the Swedish meta-analysis, the same authors published 
a review with a narrow meta-analysis where they also reported elevated risks 
for gliomas and acoustic neuromas (Hardell et al. 2007b). Interestingly, most 
of the studies included in that report are the same as those included in the 
meta-analysis in the material of this dissertation that did not find such an 
association.
For criticism, one needs to emphasize that not all studies included in 
the two Swedish meta-analyses are based on individual datasets, as both the 
individual studies published separately and the five-country joint analyses 
within the INTERPHONE collaboration are included in the material. As the 
data from both Sweden and Denmark are also included in the five-country case-
control studies on glioma and acoustic neuroma, there is overlap in material 
between the studies included in the Swedish meta-analyses. Finally, the majority 
of the evidence supporting an association between mobile phone use and brain 
tumours is from the author’s own scientific work that has already been questioned 
in the scientific field due to methodological limitations. Hardell’s study group 
seems to find positive associations in almost all studies but it has not, however, 
been possible to find such sources of error in their reports that would explain 
the positive results. In the latter Swedish meta-analysis, the authors, however, 
report that if they excluded their own two studies from the analysis the ORs for 
≥ 10 years of ipsilateral use would be 1.5 (1.1, 1.9) and 2.1 (0.7, 6.1) for glioma 
and acoustic neuroma, respectively.
In addition to the previous two meta-analyses, one review reporting 
combined risk estimates for mobile phone use and brain tumours has also 
recently been published (Kundi 2009). The authors suggest that there is evidence 
of an increased risk (OR for gliomas = 1.5, 95% CI 1.2 – 1.8) but point out that 
there was no evidence-based exposure metric available and the duration of 
mobile phone use was still too low in the published studies. They also suggest 
that several biases may have distorted the results of the original studies.
In contrast to the studies presented above, several reviews and committee 
reports on the health effects of mobile phone use have previously concluded that 
there is no convincing evidence that mobile phone use can cause brain tumours 
(Valberg 1997; IEGMP 2000; AGNIR 2003; Ahlbom et al. 2004; Feychting et 
al. 2005; SCENIHR 2007; SSI Report 2007; Kan et al. 2008; SSI Report 2008; 
SCENIHR 2009). The most recent summaries suggest that mobile phone use of 
less than 10 years does not increase the risk for brain tumours but on long-term 
use the data are still sparse and conclusions tentative (SSI Report 2008; SCENIHR 
2009). Therefore, a common recommendation of the committee reports is to 
carry on further research particularly on long-term exposures and to use cohort 
design to avoid the sources of error commonly present in case-control studies.
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5.2. Strengths and weaknesses of the present studies
There are several strengths in the studies presented in this dissertation. The 
case-control studies on brain tumours included a larger number of cases, both for 
gliomas and meningiomas, compared to studies published earlier on the issue. 
The number of subjects allowed detailed analyses of various aspects of mobile 
phone use and increased precision of risk estimates. On the other hand, the 
weaknesses of the case-control studies were the low participation rate among 
controls and the fact that the exposure assessment was based on self-reports 
of past exposure. The number of long-term users in these studies was still low 
compared to the total number of subjects included. If mobile phone use had an 
effect on brain tumour development, it might have needed longer duration of 
exposure than what it was possible to achieve in these studies. The effect of 
confounding seemed unlikely in the studies, since controlling for the known 
factors, particular hereditary syndromes and previous exposure to ionising 
radiation, did not alter the results in any analysis. In addition, adjustment 
for possible interview lag among controls was likely to minimise the role of 
confounding in relation to the timing of exposure before the interview.
Meta-analysis serves as a powerful tool to estimate the overall effect of 
particular exposure and disease. Also, despite some inconsistencies regarding 
classification of exposures, the studies included in the meta-analysis were 
similar enough, allowing the comprehensive pooling and effective assessment 
of the overall magnitude of the possible effect of mobile phone use on the risk 
for brain tumours. Nevertheless, combining published results in a meta-analysis 
does not allow equally flexible exploration of material as use of primary data. For 
instance, cross-classification of laterality and amount of use was not possible. As 
the majority of the original studies did not show an association between mobile 
phone use and risk of brain tumours, the presence of publication bias in the 
meta-analysis is unlikely. Usually publication bias is introduced when studies 
with positive results are both submitted and accepted for publication more easily 
than those with results indicating no effect (Gail & Benichou 2000). On the other 
hand, the longest exposure history achieved in the meta-analysis, due to the 
limitations of the studies included, was five years, which is a relatively short 
period for tumour induction. Therefore, as the meta-analysis failed to investigate 
long-term exposures, further research is needed before firm conclusions can be 
drawn.
Differences in study participation by exposure status may induce selection 
bias. For instance, if unexposed controls are under-represented among the study 
subjects, it will lead to the underestimation of the overall effect. The study 
on selection bias showed that the controls who were not mobile phone users 
were less likely to participate in the Finnish part of the INTERPHONE study. 
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However, a similar phenomenon was also detected among cases. Based on these 
observations, the presence of selection bias in the Finnish study was possible, 
which was seen when the risk for brain tumours in relation to mobile phone 
use was evaluated. The OR for brain tumours based on study participants 
was below unity and showed an apparent protective effect. However, when the 
incomplete participants were included in the analysis, the protective effect was 
substantially reduced. Although there was evidence that mobile phone use had 
played a role in study participation, it resulted in only a slight distortion of the 
outcome measure away from the null. Thus, the effect of selection bias was not 
deemed considerable in the Finnish study.
Even though the results regarding selection bias concerned only the 
Finnish part of the INTERPHONE study, it is likely that the five country studies 
of glioma and meningioma may also have been affected by selection bias. The risk 
estimates almost throughout the glioma and meningioma studies were below 
unity and thus showed a protective effect similar to that detected in the Finnish 
selection bias study. Decreased risks have also been reported elsewhere, both 
for glioma and meningioma (Table 1). The Swedish INTERPHONE study group 
has also reported an indication of the presence of selection bias in the Swedish 
study (Lönn et al. 2005), where the controls were more likely to participate if 
they were mobile phone users possibly leading to the decreased risk estimates 
detected in the study.
The recent results from the INTERPHONE study based on most 
participating study centres also suggest that study participation is related to 
mobile phone use, even the study was not introduced in all countries as a “mobile 
phone study” but as a “study focusing on brain tumour aetiology”. The effect of 
such selection is reported to result in a downward bias of around 10% in odds 
ratios for regular mobile phone use (Vrijheid et al. 2009). Prior to that study, a 
simulation of the impact of possible selection bias within the INTERPHONE 
study was also performed (Vrijheid et al. 2006b). When unexposed study subjects 
were assumed to be under-represented in the study population, the simulations 
resulted in reduced risk estimates for mobile phone use and risk of brain tumours. 
Selection bias had, however, less impact on the estimates than random error. In 
light of these findings regarding selection bias, it is more likely that the low risk 
estimates in glioma and meningioma studies are caused by selection bias than 
that mobile phone use actually protects against brain tumours.
In addition to selection bias, several other sources of errors may also have 
affected the results regarding the case-control studies. As mobile phone use is 
nowadays an unremarkable part of everyday activities, the accurate recall of 
past usage patterns may be problematic. Also, the amount of use has tended to 
increase, which may result in reporting exposures reflecting more closely current 
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than past behaviour. Reports of past mobile phone use are subject to random 
error, as recall, even in the short term, has been shown to be inaccurate (Parslow 
et al. 2003; Samkange-Zeeb et al. 2004; Berg et al. 2005). In a recent  study 
on INTERPHONE material (Vrijheid et al. 2006b), the recall errors possibly 
affecting the results were investigated by simulations, which were partly based 
on the data received from the previous validation studies performed among 
group of volunteer subjects in eight INTERPHONE countries (Vrijheid et al. 
2006a). In the validation studies, the self-reported mobile phone use figures were 
compared with the data received from telephone operators, and it was found 
that over-reporting of the duration of calls by 50 – 100% was common among 
the study subjects. In a Finnish study based on a small sample of volunteers, 
an average overestimation by 46% of the duration of calls was also detected 
(Tokola et al. 2008).
According to the simulations of the INTERPHONE data (Vrijheid et 
al. 2006b), non-differential random recall error (affecting cases and controls 
similarly) in exposure measurement is likely to bias the risk estimates towards 
the null. In a scenario with differential random error in exposure measurement, 
the random recall error was supposed to affect cases more than controls resulting 
in bias towards the null, even though the magnitude of error was large and it 
varied among cases. The authors concluded that the magnitude of systematic 
errors was considerably smaller than the random errors. Non-differential 
systematic error increased the risk estimates when the exposure (duration of 
calls or number of calls) was underestimated, while overestimation of exposure 
(duration of calls) led to decreased risks. In case of differential systematic recall 
error, the cases were subject to either underestimation (due to their state of health 
affecting the recall) or overestimation (case subjects attributing their disease 
to the exposure) of exposure, while controls were not prone to systematic recall 
error. The simulations showed that either underestimation or overestimation 
of exposure (duration of calls or number of calls) among cases had a relatively 
minor effect on the estimates, however if there was any effect, it was towards the 
null. The simulation was, however, based on a simplistic scenario, with only one 
type of error occurring at a time, while in reality a variety of errors are likely 
to occur concurrently.
In conclusion, random errors in the recall of mobile phone use can lead to 
substantial underestimation of brain tumour risk, when the true risk estimate is 
above unity. Also, the effect of random error exceeded the effect of systematic error 
in the INTERPHONE study, and differences in recall between cases and controls 
did not have a substantial additional effect on the results. Therefore, in addition 
to the aforementioned selection bias, random errors may be one explanation 
for the decreased risk estimates detected in the dose-response analyses in the 
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case-control studies on glioma and meningioma. In the future, several sources of 
random errors probably present in the studies of this dissertation can be avoided 
by a prospective study, where exposure data is collected from both the study 
subjects and telephone records. To obtain valid information on brain tumour 
risk, such a study should, however, have possibly a long, perhaps as much as 
20-year follow-up. At the time of writing, a large prospective cohort study called 
COSMOS has been launched in Europe. In all, it is important to improve risk 
estimation for RF exposure from mobile phones primarily for brain tumours but 
also other potential health effects. The public health significance of the issue 
is vast, as wireless technology is present in people’s everyday lives throughout 
the world. The rapidly changing technology, however, presents a challenge 
for epidemiological studies, which always lag behind the latest technological 
developments.
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6. Conclusions
In this dissertation, the association between mobile phone use and the risk of 
brain tumours was investigated.
1. The possible risk for glioma and meningioma in relation to mobile phone 
use was investigated using data from case-control studies performed in 
five North European countries. These studies (I and II) did not provide 
consistent evidence for an increased risk of either glioma or meningioma 
in relation to mobile phone use. Some indication of an association was 
detected in the analyses of cumulative number of calls using a continuous 
exposure indicator. The studies may, however, be affected by errors and 
biases. However, the studies contained a larger number of subjects than 
previously published studies on the issue. As large-scale mobile phone use 
was adopted early in the five North European countries, the estimation of 
the effects of long-term exposure was also possible in the studies.
2. The published results of the studies on mobile phone use and brain tumours 
were summarized by means of a meta-analysis (Study III), where a pooled 
estimate of the risk was obtained. The results of the meta-analysis showed 
that mobile phone use was not clearly associated with a substantially 
increased risk of brain tumours according to the twelve studies published 
between 1999 and 2006. The main limitations were a relatively short 
latency and failure to combine different exposure measures.
3. The magnitude of selection bias due to non-participation was assessed in 
the Finnish case-control study on mobile phone use and brain tumours. 
According to the study (IV), an indication of selection bias in the Finnish 
data was detected, as mobile phone users were slighly more willing to 
participate in the study. The effect of selection bias on the results was not, 
however, regarded as substantial.
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Public concern has been expressed about the possible adverse health
effects of mobile telephones, mainly related to intracranial tumors.
We conducted a population-based case–control study to investigate
the relationship between mobile phone use and risk of glioma among
1,521 glioma patients and 3,301 controls. We found no evidence of
increased risk of glioma related to regular mobile phone use (odds
ratio, OR5 0.78, 95% conﬁdence interval, CI: 0.68, 0.91). No signif-
icant association was found across categories with duration of use,
years since ﬁrst use, cumulative number of calls or cumulative hours
of use. When the linear trend was examined, the OR for cumulative
hours of mobile phone use was 1.006 (1.002, 1.010) per 100 hr, but
no such relationship was found for the years of use or the number of
calls. We found no increased risks when analogue and digital phones
were analyzed separately. For more than 10 years of mobile phone
use reported on the side of the head where the tumor was located,
an increased OR of borderline statistical signiﬁcance (OR 5 1.39,
95% CI 1.01, 1.92, p trend 0.04) was found, whereas similar use on
the opposite side of the head resulted in an OR of 0.98 (95% CI 0.71,
1.37). Although our results overall do not indicate an increased risk
of glioma in relation to mobile phone use, the possible risk in the
most heavily exposed part of the brain with long-term use needs to
be explored further before ﬁrm conclusions can be drawn.
' 2007 Wiley-Liss, Inc.
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Mobile phone use has increased rapidly worldwide since the early
1990s. Mobile phones emit radiofrequency electromagnetic ﬁelds that
are non-ionizing radiation, i.e. have too low energy to break chemical
bonds. Hence, such ﬁelds cannot cause DNA damage (mutations),
which is required for cancer initiation.1 However, radiofrequency ﬁelds
might be involved in cancer development at later stages, including tu-
mor progression or promotion. Despite the fact that no carcinogenic
mechanism for radiofrequency radiation has been established,2 there is
public concern about the possible health effects of mobile phone use.
This is mainly related to intracranial tumors, as mobile phones are
used close to the head and the radiofrequency ﬁeld is absorbed mostly
in the head and neck region. The studies published on the issue have
covered a relatively small number of study subjects with long-term ex-
posure, and so far the epidemiological evidence does not suggest any
clear increase of intracranial tumors related to mobile phone use,
although some positive ﬁndings have been reported.3–19
We conducted a collaborative population-based case–control
study on the association of mobile phone use with intracranial
tumors in 5 Northern European countries, using a shared protocol
of the INTERPHONE study coordinated by the International
Agency for Research on Cancer.20 We report here the results con-
cerning glioma, based on the combined data from Denmark, Fin-
land, Norway, Sweden and Southeast England, where mobile
phones have been widely used for at least a decade.21
Materials and methods
Study design and population
This population-based case–control study on mobile phone use
and risk of gliomas was conducted in Denmark (nationwide),
Finland (98% of the population, excluding Northern Lapland and
A˚land), Norway (the Southern and Middle parts), Sweden (geo-
graphical areas covered by the regional Cancer Registries in
Umea˚, Stockholm, Gothenburg and Lund regions) and the United
Kingdom (Thames region of Southeast England). Of these, the
Swedish, Danish and British studies have been reported previ-
ously.11,12,15 We recently reported also a collaborative analysis of
acoustic neuromas based on these studies.13
Eligible cases were subjects resident in the study areas and
diagnosed with glioma (International Classiﬁcation of Diseases
for Oncology, Third Edition, codes 9380–9384, 9390–9394, 9400,
9401, 9410, 9411, 9420–9424, 9430, 9440–9444, 9450–9451, 9505)
between September 2000 and February 2004 (the study periods
were different between countries) at ages 20–69 years in the Nor-
dic countries and 18–59 years in Southeast England. The material
reported here is based on a wider age range than that in the
INTERPHONE Study20 to increase the number of study subjects
and to cover the young age groups with intensive mobile phone
use. Incident cases were identiﬁed through neurosurgery, oncol-
ogy and neurology departments in the study areas. Cases were
also checked against the national or regional cancer registries to
evaluate and enhance completeness of coverage.
In the Nordic countries, controls were selected from national
population registers with frequency-matching on age, sex and
region of residence of cases. In the UK, where no such population
register exists, the controls were randomly selected from general
practitioners’ lists, frequency-matched on the above-mentioned
factors. Cases were approached either by mail, or personally at
the clinics with written information about the study, and were
requested to participate in the study, whereas all controls were
approached by mail. If there was no reply from those who
were approached by mail, another letter was sent or the subject
was approached by telephone. All study subjects received both an
invitation letter and written information about the study before
asking for participation. The study protocols in each country were
approved by the local ethics committees. Informed consent was
obtained from all study subjects.
Data collection
Trained interviewers conducted the personal interviews. Typically,
the interviews were performed at hospital or at the subject’s home;
with 11% of interview of cases and 6% for controls conducted over
the telephone (mainly in Norway). The interview was computer-
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assisted in all countries, except Finland where a paper questionnaire
with identical wording was used. In the interview, information was
obtained on the use of handheld mobile phones, medical history, high-
est level of education attained and family history of brain tumors. The
DECT phones or other cordless phones were not enquired about
because they were not regarded as potential material exposure sour-
ces, since the average power that they transmit is only 0.01 W vs
0.25/0.125 W with GSM 900/1800 phones. Regular use of mobile
phones (at least once a week for at least 6 months) was assessed. For
regular users, the interview covered a detailed history of mobile phone
use, including start and end dates of use, types of phones used and the
frequency of use, laterality, use of hands-free equipment, and other
circumstances of use such as type of telephone network. Show cards
either on paper or on the computer were used in all countries to aid
participants’ recall of the models of phones they had regularly used.
Information on the model of phones, calendar period of use, operator
and network code of the phone number was used to classify phones as
analogue and digital.
Statistical analysis
Three intracranial tumor types (glioma, meningioma and acous-
tic neuroma) were included in the INTERPHONE study. Since
frequency-matching was used throughout the study, we have used
the entire control group for all intracranial tumors in the frequency
matching strata of the glioma cases, in order to maximize power.
Based on the information obtained in the interview, several charac-
teristics related to mobile phone use were investigated, including ever
and regular mobile phone use, the cumulative number of calls, the cu-
mulative hours of mobile phone use, lifetime years of use and years
since ﬁrst use. Continuous exposure variables were classiﬁed into cat-
egories with the cut-points based on the distribution among controls;
the never and non-regular users formed the reference category with
the median and third quartile of the exposure variable among regular
mobile phone users used as the other cut-points. In addition, the high-
est exposure group was investigated in some analyses, with the cut-
point deﬁned as the highest 10% of controls with regular mobile
phone use. The cumulative number of calls and the cumulative hours
of mobile phone use were adjusted for the reported use of hands-free
devices, using methods described previously.9,10
All exposure within 1 year before the reference date was
ignored, except when calculating the years since ﬁrst use of mo-
bile phones (Table III). For cases, the reference date was the date
of diagnosis, i.e. refdatecase 5 diagdatecase. For controls, the refer-
ence date was set based on the interview date of the control, with
adjustment for the mean interval between the diagnostic and inter-
view date of cases and the difference between the mean interview
date of cases and controls, i.e. refdatecontrol 5 intdatecontrol 2
(mean intdatecases 2 mean diagdatecases) 2 (mean intdatecases 2
mean intdatecontrols). This correction was made to adjust for the
fact that the controls were interviewed on average later than the
cases, and because the prevalence of mobile phone use increased
rapidly with calendar period.
The odds ratios (OR) for glioma risk in relation to mobile phone
use were obtained by using conditional logistic regression, with
strata deﬁned by country, region, sex and ﬁve-year age group at
the reference date. Educational level, family history of glioma,
previous radiation therapy to the head and neck region (received
more than 10 years before the reference date), neuroﬁbromatosis
or tuberous sclerosis of the subject were regarded as potential con-
founders. All the analyses were conducted both with and without
taking into account the effects of potential confounding factors
(by adjustment for education and family history of glioma, and
additionally, excluding subjects with a history of radiotherapy to
the head and neck or with hereditary conditions affecting the risk
of glioma). The results were not materially affected by taking into
account those potential confounding factors, in all instances the
effect was less than 2%, and therefore the stratiﬁed estimates with-
out adjustment for potential confounders (other than those used
for matching) are reported. The statistical signiﬁcance of trend in
risk of glioma in relation to exposure was obtained by using a lin-
ear term, which was assigned values corresponding to the ordered
exposure categories (e.g. 4 exposure classes numbered 1–4). This
was done both for the entire study population with subjects not
using mobile phones regularly as baseline and also separately with
exclusion of the nonexposed subjects.
ORs were obtained by type of phone (analogue and digital) and
also separately for glioblastomas (ICD-O-3 codes 9440, 9441, and
9442), representing the largest subgroup of gliomas. The ORs for reg-
ular mobile phone use were also calculated separately for men and
women and by 5-year age group at the reference date. Laterality anal-
yses, where the location of the tumor was assessed in relation to the
reported predominant side of mobile phone use, were also conducted
based on 2 previously described methods.5,10 The reliability of the lat-
ter method10 was also investigated by simulations, repeating the ran-
dom allocation of index hemisphere (corresponding to tumor lateral-
ity) to controls 500 times independently. Further, analyses were con-
ducted both based on the whole dataset and individually by country.
Heterogeneity in the results between countries, 5-year age groups and
sexes were assessed with a log likelihood ratio test by comparing
nested models with one including both main effects and an interaction
between the factor, for instance the country, and the exposure and the
other including only the main effects. The statistical software STATA
(version 9) was used for all the analyses.22
Results
A total of 2,530 potential cases and 6,581 potential controls
were invited to participate in the study. Of the eligible cases, 60%
(1,521 subjects) participated (range 37–81% between countries,
Table I). The corresponding ﬁgure for controls was 50% (3,301
TABLE I – COUNTRY SPECIFIC DETAILS OF THE CASES AND CONTROLS
Denmark Finland Norway Sweden UK-Southeast England Total
Cases
Included 247 266 284 363 361 1,521
Participation rate 71% 81% 77% 74% 37% 60%
Number with histopathology 247 262 274 339 344 1,466
Interview lag, median and
interquartile range (days)
68 (39–115) 15 (3–31) 452 (192–732) 87 (55–146) 142 (39–244) 92 (39–244)
Interview type
Hospital 120 264 56 210 12 662
Home 117 0 64 92 329 602
Other/missing 10 2 164 61 20 257
Telephone 0 3 145 18 0 166
Controls
Included 819 870 353 629 630 3,301
Participation rate 52% 42% 69% 66% 43% 50%
Number of telephone interviews 0 7 159 40 2 208
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subjects, range 42–69%). The main reasons for nonparticipation
were refusal (8% of cases and 33% of controls), illness or death
(18% of cases and 0.5% of controls) and inability to contact the
subject (7% of cases and 15% of controls). Proxy interviews were
used for 12% of cases and <1% of controls. The quality of the in-
formation received in the interview was evaluated by the inter-
viewers and 67% of cases and 78% of controls were judged by the
interviewer to recall their mobile phone use ‘‘well’’ or ‘‘very
well.’’ Demographic characteristics of the study subjects are
shown in Table II.
Ever use of a mobile phone was reported by 92% (1,389) of
cases and 94% (2,945) of controls. The OR for glioma in relation
to ever use of a mobile phone was 0.63 (95% conﬁdence interval,
CI, 0.48, 0.82). Of the cases, 58% (867) reported using a mobile
phone regularly while the ﬁgure for regular use by controls was
59% (1,853). For regular mobile phone use, the OR was 0.78
(0.68, 0.91) (Table III). The country-speciﬁc results for regular
use were 0.70 (0.51, 0.96) for Denmark, 0.80 (0.56, 1.13) for
Finland, 0.62 (0.42, 0.91) for Norway, 0.82 (0.61, 1.09) for Sweden
and 0.95 (0.70, 1.29) for Southeast England. There was no signiﬁ-
cant heterogeneity between countries in results for regular use
(p 5 0.47) or any other indicator of mobile phone use (results not
shown).
TABLE II – DEMOGRAPHIC CHARACTERISTICS OF THE STUDY POPULATION
Cases
(n5 1,521)
Controls
(n5 3,301)
N % N %
Sex
Male 893 58.7 1,530 46.4
Female 628 41.3 1,771 53.7
Age at reference date (years)
18–29 145 9.5 245 7.4
30–39 265 17.4 486 14.7
40–49 323 21.2 761 23.1
50–59 484 31.8 1,097 33.2
60–69 304 20.0 712 21.6
Highest educational level
Compulsory school 429 28.2 933 28.3
Secondary/vocational school 367 24.1 789 23.9
Upper secondary school 336 22.1 832 25.2
University 380 25.0 740 22.4
Not known 9 0.6 7 0.2
Country
Denmark 247 16.2 819 24.8
Finland 266 17.5 870 26.4
Norway 284 18.7 353 10.7
Sweden 363 23.9 629 19.1
Southeast England 361 23.7 630 19.1
TABLE III – ODDS RATIOS OF GLIOMA (INCLUDING GLIOBLASTOMA) AND GLIOBLASTOMA SEPARATELY RELATED TO MOBILE PHONE USE, WITH
NUMBER OF CASES AND CONTROLS INCLUDED IN THE ANALYSES
All glioma
(n5 1,521)
OR
(95% CI)
Glioblastoma
(n5 710)
OR
(95% CI)
Controls
(n 5 3,301)
Frequency of use1
Never/nonregular use 629 1.0 330 1.0 1,281
Regular use 867 0.78 (0.68, 0.91) 368 0.77 (0.64, 0.93) 1,853
Years since ﬁrst use1
Never/nonregular use 629 1.0 330 1.0 1,281
1.5–42 384 0.77 (0.65, 0.92) 165 0.82 (0.65, 1.04) 895
5–9 342 0.75 (0.62, 0.90) 141 0.69 (0.54, 0.88) 739
10 143 0.95 (0.74, 1.23) 64 0.86 (0.62, 1.21) 220
p for trend5 0.28 p for trend5 0.08
p trend, for users only5 0.29 p trend, for users only 5 0.93
Lifetime years of use1
Never/nonregular use 629 1.0 330 1.0 1,281
0.5–4 504 0.75 (0.64, 0.88) 210 0.77 (0.62, 0.96) 1,176
5–9 259 0.78 (0.64, 0.95) 111 0.73 (0.56, 0.96) 529
10 88 0.94 (0.69, 1.28) 38 0.77 (0.51, 1.17) 134
p for trend5 0.67 p for trend5 0.14
p trend, for users only5 0.27 p trend, for users only 5 0.81
Cumulative number of calls1,3
Never/nonregular use 626 1.0 327 1.0 1,278
<2,172 352 0.73 (0.62, 0.87) 153 0.71 (0.56, 0.89) 897
2,172–7,792 205 0.74 (0.60, 0.91) 87 0.79 (0.59, 1.05) 444
>7,792 265 0.91 (0.74, 1.12) 104 0.83 (0.63, 1.11) 455
p for trend5 0.93 p for trend5 0.49
p trend, for users only5 0.05 p trend, for users only 5 0.24
Cumulative hours of use 1,3
Never/nonregular use 626 1.0 327 1.0 1,278
<125 368 0.75 (0.64, 0.89) 166 0.75 (0.60, 0.95) 895
125–503 193 0.69 (0.55, 0.85) 79 0.66 (0.49, 0.89) 446
>503 262 0.90 (0.73, 1.10) 100 0.85 (0.63, 1.13) 455
p for trend5 0.98 p for trend5 0.50
p trend, for users only5 0.09 p trend, for users only 5 0.30
Cumulative number of calls by time since ﬁrst use1
Never/nonregular use 629 1.0 330 1.0 1,281
<10 years 724 0.76 (0.65, 0.88) 304 0.75 (0.62, 0.92) 1,633
10 years (1,512 calls) 49 0.68 (0.47, 0.99) 25 0.67 (0.41, 1.08) 111
10 years (>1,512 calls) 83 1.12 (0.81, 1.55) 31 0.89 (0.57, 1.41) 106
Cumulative hours of use by time since ﬁrst use1
Never/nonregular use 629 1.0 330 1.0 1,281
<10 years 724 0.76 (0.65, 0.88) 304 0.75 (0.61, 0.92) 1,633
10 years (75 h) 52 0.70 (0.48, 1.01) 25 0.66 (0.41, 1.07) 111
10 years (>75 h) 81 1.13 (0.82, 1.57) 32 0.93 (0.59, 1.46) 105
1The numbers do not match exactly to the total numbers of cases (1,521) and controls (3,301) since there were strata without cases and strata
without controls in the data. We report here the numbers of cases and controls that are actually included in the analyses and for whom the values
of the explored exposure variables were known.–2Lower limit 1.5 years since phone use was deﬁned as regular when phone was used at least 6
months at least 1-year before reference date.–3Estimates adjusted for use of hands-free devices.
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Years since ﬁrst use and lifetime years of mobile phone use both
gave an OR of 0.99 (0.97, 1.01) per year (p for trend 0.28 for years
since ﬁrst use and 0.67 for lifetime years of use). When we restricted
the analysis to regular mobile phone users, the results remained
largely similar (trend test p-values 0.29 and 0.27 for years since ﬁrst
use and lifetime years of mobile phone use, respectively). There was
no increased risk for greater cumulative number of calls (OR5 1.00
per 10,000 calls, 95% CI: 0.97, 1.04, adjusted for hands-free devi-
ces). For cumulative hours of mobile phone use, the OR was 1.006
per 100 hr (1.002, 1.010, adjusted for hands-free devices) when such
use was analyzed as a continuous variable, but there was no trend of
risk with cumulative hours of use when the data were examined in
categories (Table III). The subgroup with the highest cumulative call
hours (>1475 hr, the cut-point deﬁned as the highest 10% of con-
trols with regular mobile phone use), had a slightly increased but
non-signiﬁcant OR (1.13, 95% CI: 0.86, 1.48) whereas that with the
highest cumulative number of calls (>21,740 calls) showed no
increased risk (OR 5 0.95, 95% CI 0.72, 1.26). The cumulative
number of calls 10 years or more before the reference date was not
associated with a signiﬁcantly increased risk of glioma (OR 5 1.09
per 10,000 calls, 95% CI: 0.89, 1.35; p for linear trend 0.14). Fur-
ther, for cumulative hours of mobile phone use more than 10 years
before the reference date, the OR was 1.03 per 100 hr (1.00, 1.05; p
for trend 0.16).
When we performed the analyses separately for glioblastoma,
we found no statistically signiﬁcantly increased risk in relation to
mobile phone use in any analysis. The results for glioblastoma did
not differ substantially from the results for all gliomas (Table III).
There was no evidence of increased risk of glioma related to
regular use of analogue or digital telephones (OR for analogue
telephones 5 0.85, 95% CI: 0.68, 1.06, for digital telephones 0.75,
95% CI: 0.65, 0.87, Table IV). From the analyses of continuous
variables, the OR for years since ﬁrst use for analogue telephones
(mean 9.2 years among regular users) was 0.99 (0.97, 1.01) per
year, whereas for digital telephones (mean 4.6 years among regu-
lar users), the OR was 0.97 (0.95, 1.00) per year.
Similar results were obtained for men and women: the OR for
regular use was 0.79 (0.65, 0.96) for men and 0.78 (0.63, 0.96) for
women (p for heterogeneity between sexes 0.94). In the analysis
of regular use by 5-year age group, no systematic differences were
found by age at reference date; the OR was smallest for the second
youngest age group (25–29 years) (0.33, 95% CI: 0.16, 0.69; p for
heterogeneity between age groups 0.39). No signiﬁcant heteroge-
neity between age groups or sexes was found for any other expo-
sure characteristic (i.e. ever use, cumulative number of calls, cu-
mulative hours of use and regular ipsilateral use) either. No differ-
ences in results were found related to a histopathological conﬁrm-
ation of diagnosis (available versus not) and interview type
(hospital/home/telephone).
The OR for regular ipsilateral use of mobile phones (phone use
reported to be on the same side of the head as the tumor was
located), based on assigning an index hemisphere randomly to
controls,10 was 1.13 (0.97, 1.31), whereas the OR for regular con-
tralateral use (phone use on the opposite side of the head to the tu-
mor) was 0.75 (0.64, 0.88) (Table V). The ORs for ﬁrst ipsilateral
and contralateral use 10 or more years ago were 1.39 (1.01, 1.92,
p trend for duration of ipsilateral use 0.04) and 0.98 (0.71, 1.37, p
trend for duration of contralateral use 0.11), respectively, based on
the same method (Table V). Excluding the subjects who had used
mobile phone on both sides of the head from the analyses did not
TABLE IV – ODDS RATIOS FOR GLIOMA IN RELATION TO ANALOGUE AND DIGITAL MOBILE PHONE USE
Analogue Digital
Cases1 Controls1 OR (95% CI) Cases1 Controls1 OR (95% CI)
Frequency of use
Never/nonregular use2 629 1,281 1.0 629 1,281 1.0
Regular use 232 471 0.85 (0.68, 1.06) 788 1,750 0.75 (0.65, 0.87)
Years since ﬁrst use
Never/nonregular use2 629 1,281 1.0 629 1,281 1.0
1.5–43 26 55 1.22 (0.72, 2.08) 458 1,091 0.72 (0.61, 0.85)
5–9 99 233 0.70 (0.52, 0.95) 326 648 0.80 (0.66, 0.96)
10 108 187 0.93 (0.69, 1.25) 4 12 0.53 (0.16, 1.72)
p for trend 5 0.26 p for trend5 0.04
p trend, for users only5 0.71 p trend, for users only 5 0.37
Lifetime years of use
Never/nonregular use2 629 1,281 1.0 629 1,281 1.0
0.5–4 156 313 0.90 (0.69, 1.16) 587 1,372 0.72 (0.62, 0.85)
5–9 59 125 0.75 (0.51, 1.08) 198 374 0.83 (0.67, 1.04)
10 16 31 0.92 (0.48, 1.77) 0 0 Not available
p for trend 5 0.27 p for trend5 0.64
p trend, for users only5 0.67 p trend, for users only 5 0.20
Cumulative number of calls4
Never/nonregular use2 629 1,281 1.0 626 1,278 1.0
<Median 111 231 0.88 (0.67, 1.17) 337 846 0.73 (0.61, 0.87)
Median-3rd quartile 47 117 0.61 (0.41, 0.90) 178 418 0.68 (0.54, 0.85)
>3rd quartile 64 112 1.01 (0.69, 1.46) 237 425 0.86 (0.70, 1.07)
p for trend 5 0.68 p for trend5 0.52
p trend, for users only5 0.43 p trend, for users only 5 0.18
Cumulative hours of use4
Never/nonregular use2 629 1,281 1.0 704 1,377 1.0
<Median 114 232 0.92 (0.70, 1.22) 335 843 0.72 (0.60, 0.86)
Median-3rd quartile 45 116 0.51 (0.34, 0.77) 173 419 0.68 (0.54, 0.84)
>3rd quartile 64 114 1.04 (0.71, 1.52) 243 427 0.87 (0.71, 1.08)
p for trend 5 0.82 p for trend5 0.75
p trend, for users only5 0.72 p trend, for users only 5 0.08
1The numbers do not match exactly to the total numbers of cases and controls since there were strata without cases and strata without controls
in the data. We report here the numbers of cases and controls that are actually included in the analyses and for whom the values of the explored
exposure variables were known.–2The reference category consists of subjects with never/nonregular use of any type of phone.–3Lower limit 1.5
years since phone use was deﬁned as regular when the phone was used at least 6 months during the period at least 1-year before the reference
date.–4Estimates adjusted for use of hands-free devices. For cumulative number of calls the data are divided, based on the distribution in con-
trols, into <2,920, 2,920–8,583 and >8,583 for analogue phones, and <1,829, 1,829–6,019 and >6,019 for digital phones. For cumulative hours
of mobile phone use the data are divided into <147, 147–492 and > 492 for analogue phones, and <102, 102–394 and >394 for digital phones.
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substantially affect the results (not shown). When restricting the
analysis to subjects with the quality of interview related to mobile
phone use rated as good or very good by the interviewers, the OR
for ﬁrst ipsilateral use 10 or more years ago was 1.21 (0.74, 1.96).
As the laterality analysis method is sensitive to random allocation
of the controls, its reliability was investigated. Based on 500 simu-
lations the method seemed rather stable, as the mean of the OR for
regular ipsilateral use was 1.12 (range 1.00–1.24) and for regular
contralateral use it was 0.76 (range 0.68–0.86).
A case-only analysis gave an overall relative risk (RR) for ipsi-
lateral mobile phone use of 1.24 (Fisher’s exact test: p < 0.001,
two-sided), based on 674 (44%) cases for whom both the side of
the tumor and the side of phone use were deﬁned. For the subjects
(n 5 60) with 10 or more years of exposure history (lifetime years
of mobile phone use), the ipsilateral RR was 1.01 (p 5 1.00)
whereas for subjects (n 5 106) for whom the ﬁrst use of a mobile
phone was more than 10 years ago (years since ﬁrst use), the RR
was 1.09 (p 5 0.53).
Discussion
The results of our analyses do not provide consistent evidence
for increased risk of glioma related to use of mobile phones. We
did not ﬁnd indications of increased risk related to regular mobile
phone use overall, or in the majority of the subanalyses based on
various exposure characteristics. The most exposed group (the
highest 10% based on the exposure distribution among controls)
did not show an elevated risk of glioma. Neither did the dose-
response analyses reveal a clear trend in relation to the overall du-
ration of mobile phone use, number of calls or hours of use. No
differences were found between analogue and digital phones and
the results for glioblastoma were similar to those including all
gliomas. Data from different countries also gave consistent results.
One subset of analyses did, however, indicate a possible associa-
tion with mobile phone use: reported ipsilateral use 10 or more
years ago was associated with signiﬁcantly increased risk of gli-
oma and there was also an increasing trend with years since ﬁrst
use on the ipsilateral side. Analyses of risk in relation to cumula-
tive hours of mobile phone use yielded mixed results and are of
very uncertain interpretation because they depend on the analyti-
cal method used and they may be driven by a small number of
extreme values that may be biased or erroneous. We also note that
the results reported here are to a certain degree sensitive to choice
of analytical method, and hence are not always identical with
those reported in national publications.11,12,14
In previous studies, largely negative results have been pub-
lished.23 In the German INTERPHONE study, mobile phone use
for at least 10 years was associated with an increased glioma risk
of borderline signiﬁcance.15 In the UK study, with material partly
overlapping that in the present analyses, increased risk of ipsilat-
eral use was found, but with a corresponding decrease on the con-
tralateral side.14 The Danish and Swedish data were published pre-
viously and the results did not indicate signiﬁcantly increased risk
of glioma related to mobile phone use.11,12 Another Swedish
group has found increased risks related to several aspects of
mobile phone use,16–19 but the reason for ﬁndings inconsistent
with most other reports remains unclear. A meta-analysis also
failed to reveal any signiﬁcant association between long-term mo-
bile phone use and intracranial tumors.24 Most earlier studies3–8
did not have sufﬁcient numbers of long-term mobile phone users
for meaningful risk assessment, if there is a latency of at least 5–
10 years.
Our study covers a large number of cases and controls com-
pared with previously published reports: the largest earlier study
included less than 1,000 gliomas.14 Additionally, the countries
included in these analyses are pioneers in mobile phone use and
therefore the number of mobile phone users with more than 10
years of exposure (88 cases) is larger than in previous analyses,
which allows more reliable estimation of the risk related to such
long-term mobile phone use. We adjusted exposure history to
TABLE V – ODDS RATIOS FOR GLIOMA RELATED TO LATERALITY OF THE TUMOR AND REPORTED SIDE OF MOBILE PHONE USE
Ipsilateral exposure1 Contralateral exposure1
Cases Controls OR (95% CI) Cases Controls OR (95% CI)
Frequency of use
Reference category2 803 2,127 1.0 920 2,143 1.0
Regular 471 1,002 1.13 (0.97, 1.31) 354 986 0.75 (0.64, 0.88)
Years since ﬁrst use
Reference category2 803 2,127 1.0 920 2,143 1.0
1.5–43 205 485 1.08 (0.88, 1.31) 150 474 0.70 (0.57, 0.87)
5–9 189 400 1.10 (0.89, 1.35) 137 391 0.74 (0.59, 0.92)
10 77 117 1.39 (1.01, 1.92) 67 121 0.98 (0.71, 1.37)
p for trend 5 0.04 p for trend5 0.11
p trend, for users only5 0.18 p trend, for users only 5 0.20
Lifetime years of use
Reference category2 803 2,127 1.0 920 2,143 1.0
0.5–4 275 639 1.07 (0.90, 1.28) 199 625 0.70 (0.58, 0.85)
5–9 144 282 1.18 (0.93, 1.49) 109 280 0.79 (0.61, 1.01)
10 43 74 1.14 (0.76, 1.72) 41 71 1.01 (0.67, 1.53)
p for trend 5 0.21 p for trend5 0.45
p trend, for users only5 0.40 p trend, for users only 5 0.21
Cumulative hours of use4
Reference category2 803 2,127 1.0 920 2,143 1.0
<Median 202 492 1.05 (0.86, 1.28) 140 485 0.67 (0.54, 0.83)
Median-3rd quartile 114 251 1.03 (0.80, 1.33) 97 249 0.78 (0.60, 1.02)
>3rd quartile 136 247 1.24 (0.97, 1.59) 106 240 0.85 (0.65, 1.10)
p for trend 5 0.69 p for trend5 0.01
p trend, for users only5 0.36 p trend, for users only 5 0.07
1Ipsilateral exposure 5 mobile phone use on the same side of the head as the tumor. Contralateral exposure 5 mobile phone use on the oppo-
site side of the head to the tumor. The numbers do not match exactly to the total numbers of cases and controls since there were strata without
cases and strata without controls in the data. We report here the numbers of cases and controls that are actually included in the analyses and for
whom the values of the explored exposure variables were known.–2Reference category is never/nonregular use of mobile phones, and for ipsila-
terality, phone use only on the opposite side of the head, and for contralaterality, phone use only on the same side of the head.–3Lower limit 1.5
years since phone use was deﬁned as regular when phone was used for at least 6 months during the period at least 1-year before reference
date.–4Estimates adjusted for use of hands-free devices. Data are divided, based on the distribution in controls, into <136, 136–567 and >567
for ipsilaterality, and <132, 132–553 and >553 for contralaterality.
1773MOBILE PHONE USE AND GLIOMA
match the reference period between cases and controls to account
for later interviewing of the controls, which is crucial to ensure
comparability of information for a rapidly changing exposure such
as mobile phone use. Few risk factors requiring control of poten-
tial confounding are known for glioma. We collected information
on high-dose radiation, hereditary risk factors and family history.
They were, however reported by only few subjects and exclusion
of exposed persons did not affect our results. Therefore, the role
of confounding appears minimal.
When a frequently fatal condition, such as glioma, is studied,
rapid loss of study subjects is inevitable. In the light of this, the
participation in our study is fairly high for cases in general. Yet,
participation among potential controls was quite low, which can
potentially induce selection bias. Previously, mobile phone users
have been found more likely to participate than non-users among
both cases and controls in Finland and Sweden.11,25 This may be
related to more common use of mobile phone use among people
with high level of education and socio-economic status, who are
also more willing to participate in research. However, this ﬁnding
is based on a relatively small number of non-participants who
were willing to report their mobile phone use, and may not there-
fore be directly applicable to the present results. In the current
report, the signiﬁcantly reduced OR for ever vs. never use of mo-
bile phones might be explained by this bias, in which case other
ORs in the study might have been similarly affected. On the other
hand, arguing against this, the country-speciﬁc ORs were not asso-
ciated with the participation rates.
Overestimation of exposure among controls due to selective
participation may underestimate true effects, i.e. bias results
towards the null. In the present study, we performed the trend
analyses for years since ﬁrst use and lifetime years of use also
based only on the regular mobile phone users, as such an analysis
would be less prone to selection bias if there is more selection
between users and non-users than between subjects with different
amount of mobile phone use. In both cases, the trend remained
fairly unchanged although the point estimate was increased
slightly towards unity. This ﬁnding is also consistent with the pos-
sibility that selection bias may have produced an apparent protec-
tive effect of mobile phone use in this study, reﬂected in the odds
ratio below 1 for regular use.
Mobile phone use is nowadays an unremarkable part of everyday
activities. Therefore, accurate recall of past patterns may be problem-
atic. Also, the amount of use has tended to increase which may result
in reporting exposures reﬂecting more closely current than past behav-
ior. Reports of past mobile phone use are subject to random error, as
recall even in the short term has been shown to be inaccurate.26–29
Over-reporting of the amount of mobile phone use by 50–100% has
been common. This is likely to attenuate any true relationship
between exposure and outcome, and it might distort dose-response.
However, information on whether the subject used the phone regularly
and on year of ﬁrst use is likely to be more reliable.
Bias due to differential recall of exposure by cases and controls
usually tends to overestimate the true effects. Overall, reported regu-
lar use of a mobile phone on the same side as that on which the brain
tumor was diagnosed (ipsilateral use) was not associated with a sig-
niﬁcantly increased risk of glioma, when analyzed with the method
used by L€onn and coworkers.10 The risk estimate for ipsilateral use
was slightly above unity, while that for contralateral use was below
one. This ﬁnding could be attributable to recall bias. Yet, the risk
seemed to increase with duration of ipsilateral phone use. The
method of Inskip also showed a slight increase for tumors located on
the same side as the mobile phone was used, although not signiﬁ-
cantly so for long-term use, based however only on a ﬁfth of the
total number of study subjects. The advantage of the case–case analy-
sis is the avoidance of recall bias. These ﬁndings leave open the pos-
sibility that long-term mobile phone use may increase the risk of
gliomas in the more exposed hemisphere.
However, ﬁndings related to reported ipsilateral use of mobile
phone are difﬁcult to interpret and lend themselves to both causal
and non-causal (artefactual) explanations. On one hand, the radio-
frequency ﬁeld is highly local and any possible effect may be lim-
ited to a small segment of the brain. On the other hand, there is
considerable potential for uncertainty in reporting the side where
the mobile phone is held, particularly for exposures a long time
ago. This may induce both random error and bias. Recall bias may
affect the reported side of mobile phone use if cases overreport
use on the side where the tumor was diagnosed, leading to spuri-
ously elevated risks. This would be most likely to occur if mobile
phone use was perceived as a potential cause of cancer. Our stud-
ies were not introduced to the participants as focusing on mobile
phone use (except in Sweden), but nevertheless, most subjects
were likely to be aware of this hypothesis due to media coverage
of the issue.
Our ﬁnding of decreased risk related to regular use on the con-
tralateral side is consistent with recall bias. The interviewers
regarded the quality of information slightly better for controls than
cases in our study. Restriction of analysis to subjects with the esti-
mated best quality of information related to mobile phone use
gave slightly lower, non-signiﬁcant risk estimates for ipsilateral
use, which may indicate information bias. It appears therefore that
exposure assessment based on interview may induce errors in both
directions, overestimation and underestimation of effects. The
only way to avoid these shortcomings is to use more objective
sources of information, such as operator records. They were, how-
ever, not available for the purposes of this study.
In conclusion, our results do not support mobile phone use for
less than 10 years as a cause of glioma. However, we found an in-
dication of increased risk in relation to reported ipsilateral phone
use of more than 10 years duration. This may be due to either
chance or causal effect or information bias, i.e. overreporting of
mobile phone use on the affected side by the cases with brain
tumors.
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Background Use of mobile telephones has been suggested as a possible risk
factor for intracranial tumours. To evaluate the effect of mobile
phones on risk of meningioma, we carried out an international,
collaborative case-control study of 1209 meningioma cases and
3299 population-based controls.
Methods Population-based cases were identified, mostly from hospitals, and
controls from national population registers and general practitioners’
patient lists. Detailed history of mobile phone use was obtained by
personal interview. Regular mobile phone use (at least once a week
for at least 6 months), duration of use, cumulative number and hours
of use, and several other indicators of mobile phone use were assessed
in relation to meningioma risk using conditional logistic regression
with strata defined by age, sex, country and region.
Results Risk of meningioma among regular users of mobile phones was
apparently lower than among never or non-regular users (odds
ratio, OR¼ 0.76, 95% confidence interval, CI 0.65, 0.89). The risk
was not increased in relation to years since first use, lifetime years
of use, cumulative hours of use or cumulative number of calls. The
findings were similar regardless of telephone network type
(analogue/digital), age or sex.
Conclusions Our results do not provide support for an association between
mobile phone use and risk of meningioma.
Keywords cellular phones, brain neoplasms, case-control studies
Meningiomas are neoplasms originating from the
meningeal tissue covering the brain and spinal cord.
They are usually benign, with 1–3% exhibiting
malignant growth.1 The incidence of meningiomas
varies between populations, being higher among
women than men.2 The aetiology of meningiomas has
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remained elusive, with some hereditary syndromes
(mainly neurofibromatosis type 2 and tuberous sclero-
sis) and high doses of ionizing radiation among the few
established risk factors.3 Radiofrequency electromag-
netic fields emitted by mobile telephones has been
suggested as a possible risk factor for meningiomas,
mainly based on the analogy with ionizing radiation
and the proximity of the meningeal tissue to the
handset, i.e. the source of the radiofrequency field.
Previous studies of meningioma risk in relation to
mobile phone use have included a relatively small
number of study subjects with long-term exposure.
Although some positive findings have been reported,
so far the totality of epidemiological evidence does
not demonstrate an increase in risk of meningiomas
related to mobile phone use.4–9 We conducted a large
international study to assess the possible association
between use of mobile phones and risk of intra-
cranial meningioma, using a shared protocol of the
INTERPHONE study coordinated by the International
Agency for Research on Cancer.10 The data for this
study were collected from five Northern European
countries, Denmark, Finland, Norway, Sweden and
Southeast England, where mobile phone use has been
common for at least a decade.11 Results from the
Danish, Swedish and Norwegian studies have been
published earlier.12–14 Collaborative analyses of acous-
tic neuroma15 and glioma16 risks based on these
studies have also been reported previously.
Materials and methods
Selection of study subjects
The study was carried out in Denmark (nationwide),
Finland (98% of the national population, excluding
Northern Lapland and A˚land), Norway (the Southern
and Middle parts, representing 90% of population),
Sweden (Umea˚, Stockholm, Gothenburg and Lund
regions, 65% of population) and the United Kingdom
(Thames region of Southeast England, 23% of
population).
Eligibility criteria for cases included age 20–69 years
in the Nordic countries and 18–59 years in Southeast
England, residence in the study area and diagnosis of
intracranial meningioma (International Classifica-
tion of Diseases for Oncology, Third Edition, codes
9530–9539) between 2000 and 2004 (the exact study
periods were slightly different between countries).
Cases were identified through neurosurgery, oncology
and neurology departments of several hospitals in the
study areas. In addition, the national or regional
cancer registries were used to evaluate and enhance
completeness of coverage. The inclusion criteria were
similar to earlier publications12–14 and the slightly
smaller numbers of cases than in national reports are
due to revised diagnosis, date of diagnosis or history
of previous brain tumour. The diagnosis was micro-
scopically confirmed in 93% of the cases (Table 1).
Controls were selected through the national popula-
tion registers in the Nordic countries. As there is no
such register in the UK, the matched controls were
randomly selected from general practitioners’ patient
lists. In all countries, the controls were frequency-
matched to the cases by sex, 5-year age group (at
ascertainment date) and region of residence. Eligible
cases were approached either by mail, or personally at
the clinics, while the controls were first approached
by mail. If the subjects contacted by mail did not
respond, another letter was sent or the subject was
approached by telephone. Before asking for participa-
tion, study subjects received both an invitation letter
and written information about the study. Informed
consent was obtained from all study participants. The
ethical review of the study protocol was carried out by
local committees in each country.
Data collection
Exposure assessment was based on personal interview
that was typically performed at a hospital or at the
subject’s home and conducted by trained interviewers.
Proxy interviews were used for 1.6% of cases and 0.1%
of controls. Telephone interviews were common in
Norway, where 48% of cases and 45% of controls were
Table 1 Country specific details of the cases and controls
Denmark Finland Norway Sweden
UK-Southeast
England Total
Cases
Included (N) 173 334 206 271 225 1209
Participation rate (%) 73 90 71 84 55 74
Microscopically confirmed (%) 173 325 179 236 216 1129
Telephone interviewed (N) 0 3 99 12 0 114
Controls
Included (N) 819 870 353 627 630 3299
Participation rate (%) 52 42 69 66 43 50
Telephone interviewed (N) 0 7 159 40 2 208
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interviewed over the telephone, but infrequent in the
other countries (0–4% among cases and 0–6% con-
trols). The interview covered use of hand-held mobile
phones, medical history, education and family history
of brain tumours. Regular use of mobile phones was
defined as making or receiving calls at least once a
week for at least 6 months. For regular mobile phone
users, a detailed history of use was obtained, including
start and end dates as well as the frequency and
laterality of use, type of phone, use of hands-free
devices and other factors, such as type of telephone
network. Show cards were used to facilitate recall of
the phone models used. Information on the model of
phones, calendar period of use, operator and network
code of the phone number was used to classify phones
as analogue or digital. In some of the countries, some
information was also collected about Digital Enhanced
Cordless Technology (DECT) and other cordless phones
but this information was not used in the analyses,
because the average power that they transmit is only
0.01W versus 0.25/0.125W with GSM 900/1800 phones
and 1W with NMT 900 phones.
Data handling and statistical analysis
Frequency-matching employed throughout the
INTERPHONE study allowed us to utilize the entire
control group recruited for all intracranial tumours
(glioma, meningioma and acoustic neuroma) in the
matched strata of the meningioma cases, to increase
statistical power. The analysis covered several features
of reported mobile phone use that are potentially
relevant for exposure to radiofrequency electromag-
netic fields. Cumulative hours of use was calculated
from average number and duration of calls. The anal-
yses were performed using both continuous and cate-
gorical exposure variables. In analyses of categorical
exposure variables, the cut-points were chosen based
on the distribution among controls. The reference
category consisted of the never and non-regular users,
with the other cut-points defined by the 50 and 75th
percentiles of the exposure distribution among regular
mobile phone users. In the analyses of cumulative
number of calls and cumulative hours of mobile phone
use, the exposure was adjusted for the reported use of
hands-free devices. The exposure was reduced by 100%
if the subject reported use of hands-free devices all
the time, by 75% if most of the time, 50% if half of the
time and 25% if sometimes but less than half of the
time. An additional analysis of the subgroup with
the highest cumulative number of calls and cumulative
hours of use was performed with the cut-point defined
as the value among the 10% of controls with the
heaviest mobile phone use (among regular users).
For calculation of exposure indices, a reference date
was determined for each subject. For cases, the refer-
ence date was the date of diagnosis. As the controls
were interviewed on average later than the cases and as
the prevalence of mobile phone use increased rapidly
over time, the reference date for controls was corrected
for this delay. Thus, the reference date for controls was
defined as the interview date adjusted for the
mean interval between the diagnostic and interview
date of cases, and the difference between the mean
interview date of cases and controls (in days)
i.e. refdatecontrol¼ intdatecontrol (mean intdatecases
mean diagdatecases) (mean intdatecasesmean
intdatecontrols). All mobile phone use within 1 year
prior to the reference date was excluded from analysis,
except when calculating the years since first use, which
was evaluated up to the reference date.
The odds ratios (OR) for meningioma associated
with mobile phone use were estimated with condi-
tional logistic regression, with strata defined by sex,
5-year age group, region and country. Based on previ-
ous literature on aetiology of meningioma, highest
educational level attained, family history of menin-
gioma, radiotherapy to the head and neck region (at
least 10 years before the reference date), and past
diagnosis of neurofibromatosis or tuberous sclerosis of
the subject were regarded as potential confounders.
All the analyses were conducted both with and with-
out considering the effects of the potential con-
founding factors. Adjustment for family history and
socio-economic status in the analyses did not affect
the results, nor did exclusion of subjects with neuro-
fibromatosis, tuberous sclerosis or a history of radio-
therapy to the head and neck region. Therefore, all
the results reported are from analyses taking into
account only the stratification variables (sex, 5-year
age group, region and country).
Analyses were conducted separately by type of
phone (analogue and digital). Furthermore, analyses
were performed both based on the whole dataset
and individually by country, and also by sex and
by 10-year age group. Heterogeneity in the results
between countries, 10-year age groups and sexes was
assessed with the likelihood ratio test by comparing
nested models, with one including both main effects
and an interaction between the stratification factor
and the exposure indicator, and the other including
only the main effects.
The tumour location was assessed in relation to
the reported predominant side of mobile phone use,
using previously described methods.5,13 The Inskip
method5 is based on case-only design, while the Lo¨nn
approach13 includes also the controls in the analysis.
For cases, ipsilateral location was defined as tumour
on the same side where the mobile phone was mainly
held, whereas contralateral location was defined as
tumour on the opposite side of where the phone was
primarily held. For subjects reporting bilateral use
(similar amount of use on both sides), both hemi-
spheres were regarded as exposed. As controls have
no tumour, an index laterality was randomly allocated
to each of them in the analyses with the Lo¨nn
method. In this study, the method used by Lo¨nn
et al.13 was modified so that the reference group com-
prised only never and non-regular users but not those
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using the phone on the other side that were included
in the reference group in the original analysis. All the
analyses were conducted with the statistical software
STATA (version 9).17
Results
A total of 1629 eligible cases and 6581 controls were
identified. Of the potential cases, 74% participated
(1209 subjects, range 55–90% between countries,
Table 1) and of the controls, 50% (3299 subjects,
range 42–69%). The most frequent reasons for non-
participation were refusal (9% of cases and 33% of
controls), inability to contact the subject (8% of cases
and 15% of controls) and illness or death (3% of cases
and 0.5% of controls). Since there were strata with
either no cases or no controls, several study subjects
were excluded, leaving finally 1204 cases (of the 1209
who participated) and 2945 controls (of the 3299 who
participated) in the analysis. The recall of mobile
phone use in the interview was judged to be ‘good’ or
‘very good’ by the interviewers for 82% of the cases
and 85% of the controls. The demographic character-
istics of the study subjects are shown in Table 2.
Regular mobile phone use was associated with an
apparently reduced risk of meningioma, (OR 0.76, 95%
confidence interval, CI: 0.65, 0.89), based on 48%
regular users among cases and 58% among controls
(Table 3). Years since first use or lifetime years of
use were not associated with an increased risk of
meningioma, as the OR for both variables was 0.99
(0.96, 1.01) per year. Cumulative number of calls was
not associated with the risk of meningioma (OR¼ 1.00
per 10 000 calls, 95% CI: 0.96, 1.05, adjusted for
hands-free devices). Those with the highest number of
calls or hours of use (421 753 calls and 41476 h, as
among the highest 10% of controls) did not have an
increased risk of meningioma (OR¼ 0.86, 95% CI:
0.60, 1.24 and 1.13, 95% CI 0.82–1.57, respectively).
When only mobile phone use at least 10 years prior to
the index date was considered, the results were not
materially changed. The OR for cumulative number of
calls 10 or more years ago was 1.07 (0.80, 1.41) per
10 000 calls, whereas for cumulative hours of use it
was 1.02 (0.99, 1.05) per 100 h.
Even though the distribution of cumulative call
hours was skewed among both cases and controls, we
also explored the linear relation of the call hours as a
continuous variable to meningioma risk. It revealed
an apparently positive association (OR 1.005 per
100 h, 95% CI: 1.001, 1.010), but this was driven by
a small number of very high values which in turn
reflected subjects with implausibly high reported
mean daily hours of use. The result for cumulative
hours of use was mostly based on subjects with more
than 3h of daily use (the 99th percentile for daily
hours of use was 2.4 for controls and 3.5 for cases).
When we excluded the subjects with more than 2h of
daily use (44 cases and 27 controls, corresponding to
1.7% of observations), no relation was detected. In the
analysis of log-transformed number of call hours, no
obvious association was observed (results not shown).
When analogue and digital networks were investi-
gated, the results did not differ substantially from
each other, or from the results based on all mobile
phones. For analogue telephones, the OR for years
since first use was 0.99 per year (0.96, 1.01), whereas
for digital telephones, it was 0.97 per year (0.64,
1.00). When cumulative hours of use was analysed as
a continuous variable, the OR for analogue phones
was 1.003 (0.992, 1.014) and for digital phones 1.008
(1.002, 1.014) per 100 h. In the analyses of categorical
variables, only minor differences between the two
telephone types emerged, possibly due to relatively
small numbers of cases within exposure categories
(Table 4).
The country-specific meningioma ORs for regular use
were 0.87 (0.60, 1.27) for Denmark, 0.75 (0.56, 1.01)
for Finland, 0.85 (0.57, 1.29) for Norway, 0.68 (0.49,
0.94) for Sweden and 0.72 (0.51, 1.01) for Southeast
England. No indication of heterogeneity between
countries was detected in results for regular use
(P¼ 0.84) or any other indicator of mobile phone use
(all P-values40.2). Sex did not modify the relationship
between mobile phone use and meningioma risk, as
the OR for regular use compared with never or non-
regular use was 0.79 (0.59, 1.06) for men and 0.75
(0.62, 0.89) for women. There was no heterogeneity by
sex or age in the results for regular use (P¼ 0.74 and
0.70, respectively) or in any other indicator of mobile
phone use (results not shown). The possible effect of
the interview type (hospital/home/telephone) was also
investigated and found out to have only marginal
Table 2 Demographic characteristics of the study
population
Cases Controls
N % N %
Sex
Male 301 24.9 1530 46.4
Female 908 75.1 1769 53.6
Age at reference date (years)
18–29 22 1.8 244 7.4
30–39 129 10.7 490 14.9
40–49 293 24.2 751 22.8
50–59 481 39.8 1103 33.4
60–69 284 23.5 711 21.6
Highest educational level
Compulsory school 399 33.0 933 28.3
Secondary/vocational school 285 23.6 789 23.9
Higher secondary school 236 19.5 832 25.2
University 284 23.5 738 22.4
Not known 5 0.4 7 0.2
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impact on the results (not shown). Additional analyses
were also performed excluding cases without micro-
scopically confirmed diagnosis (n¼ 80), but this did
not affect the results (not shown). We also conducted
analyses including only those subjects whose recall of
mobile phone use was reported by the interviewers to
be good or very good but the results were not altered
substantially (not shown).
Table 3 Odds ratios of meningioma related to mobile phone use, with number of cases and controls
included in the analyses
Casesa Controlsa OR (95% CI)
Frequency of use
Never/non-regular use 631 1249 1.0
Regular use 573 1696 0.76 (0.65, 0.89)
Years since first use
Never/non-regular use 631 1249 1.0
1.5–4b 286 808 0.72 (0.60, 0.86)
5–9 214 676 0.78 (0.64, 0.96)
510 73 212 0.91 (0.67, 1.25)
Lifetime years of use
Never/non-regular use 631 1249 1.0
0.5–4 363 1063 0.72 (0.61, 0.86)
5–9 163 488 0.83 (0.66, 1.05)
510 42 130 0.85 (0.57, 1.26)
Cumulative number of callsc
Never/non-regular use 631 1249 1.0
<2195 285 844 0.68 (0.57, 0.82)
2195–7790 130 375 0.86 (0.67, 1.10)
47790 128 423 0.83 (0.64, 1.07)
Cumulative hours of usec
Never/non-regular use 631 1249 1.0
<125 278 850 0.68 (0.57, 0.82)
125–514 125 376 0.79 (0.62, 1.02)
4514 140 411 0.88 (0.68, 1.13)
Cumulative number of calls by time since first use
Never/non-regular use 631 1249 1.0
<10 years 500 1484 0.74 (0.63, 0.87)
510 years (41537 calls) 38 105 0.88 (0.58, 1.33)
510 years (41537 calls) 31 104 0.83 (0.53, 1.29)
Cumulative hours of use by time since first use
Never/non-regular use 631 1249 1.0
<10 years 500 1484 0.74 (0.63, 0.87)
510 years (470 h) 33 104 0.77 (0.50, 1.19)
510 years (470 h) 35 104 0.94 (0.61, 1.44)
All odds ratios obtained from analysis that was stratified by sex, five-year age group, region and country.
aThe numbers do not match exactly to the total numbers of cases (1209) and controls (3299) since there were
strata without cases and strata without controls in the data. We report here the numbers of cases and controls
that are actually included in the analyses and for whom the values of the explored exposure variables were
known.
bLower limit 1.5 years since phone use was defined as regular when phone was used at least six months at least
one year prior to reference date.
cEstimates adjusted for use of hands-free devices. The cut-points are defined by 50th and 75th percentiles of the
exposure distribution among controls that were regular mobile phone users.
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In the laterality analyses, both regular ipsilateral use
(OR¼ 0.81, 95% CI: 0.66, 0.99), and regular contral-
ateral use (OR¼ 0.67, 0.54, 0.83) were associated with
apparently lower meningioma risk than never or non-
regular mobile phone use. Years since first or lifetime
years of ipsilateral use were not clearly related to
meningioma, as the ORs were 1.05 (0.67, 1.65) and
0.99 (0.57, 1.73), respectively, for the subjects with
the longest (410 years) exposure history (Table 5).
The laterality analyses were also conducted excluding
subjects who had used a mobile phone on both sides
of the head, but this had little effect on the results
(not shown). When the laterality analyses were con-
ducted using only cases (by the method similar to
Inskip et al.5), an overall relative risk (RR) of 1.09
(Fisher’s exact test, P¼ 0.10, two sided) was obtained
for meningioma in relation to ipsilateral phone use,
based on 212 exposed and 184 unexposed cases. For
subjects with exposure duration 410 years (n¼ 30),
the RR was 1.61 (P¼ 0.11), and for subjects whose
first use was 10 or more years ago (n¼ 52), the RR
was 1.26 (P¼ 0.17).
Discussion
We did not find evidence of increased risk of menin-
gioma in relation to mobile phone use, as regular use,
years since first use, lifetime years of use or cumu-
lative number of calls, were not associated with an
increased risk. Our results are consistent with most
previous studies and reviews on the issue.4–6,8,9,18,19
Table 4 Odds ratios for meningioma in relation to analogue and digital mobile phone use
Analogue Digital
Casesa Controlsa OR (95% CI) Casesa Controlsa OR (95% CI)
Frequency of use
Never/non-regular useb 631 1249 1.0 631 1249 1.0
Regular use 125 437 0.76 (0.58, 0.98) 533 1598 0.74 (0.63, 0.87)
Years since first use
Never/non-regular useb 631 1249 1.0 631 1249 1.0
1.5–4c 9 49 0.40 (0.18, 0.86) 342 993 0.72 (0.61, 0.86)
5–9 62 215 0.75 (0.53, 1.06) 183 593 0.77 (0.62, 0.95)
510 54 178 0.87 (0.61, 1.26) 8 13 1.87 (0.71, 4.93)
Lifetime years of use
Never/non-regular useb 631 1249 1.0 631 1249 1.0
0.5–4 83 284 0.78 (0.57, 1.06) 421 1249 0.73 (0.62, 0.86)
5–9 37 122 0.81 (0.53, 1.25) 107 344 0.78 (0.60, 1.02)
510 5 29 0.43 (0.15, 1.20) 3 0 Not available
Cumulative number of callsd
Never/non-regular useb 631 1249 1.0 631 1249 1.0
<median 68 204 0.81 (0.59, 1.12) 265 795 0.68 (0.56, 0.81)
median-3rd quartile 17 108 0.43 (0.24, 0.76) 125 359 0.86 (0.67, 1.10)
43rd quartile 35 114 0.89 (0.57, 1.40) 118 390 0.77 (0.59, 1.00)
Cumulative hours of used
Never/non-regular useb 631 1249 1.0 631 1249 1.0
<median 66 207 0.79 (0.57, 1.10) 252 800 0.66 (0.55, 0.80)
median-3rd quartile 19 111 0.43 (0.25, 0.75) 119 367 0.78 (0.61, 1.01)
43rd quartile 34 110 0.94 (0.60, 1.48) 138 372 0.90 (0.70, 1.16)
All odds ratios obtained from analysis that was stratified by sex, five-year age group, region and country.
aThe numbers do not match exactly to the total numbers of cases and controls since there were strata without cases and strata
without controls in the data. We report here the numbers of cases and controls that are actually included in the analyses and for
whom the values of the explored exposure variables were known.
bThe reference category consists of subjects with never/non-regular use of any type of phone.
cLower limit 1.5 years since phone use was defined as regular when the phone was used at least six months during the period at
least one year prior to the reference date.
dEstimates adjusted for use of hands-free devices. For cumulative number of calls the data are divided, based on the distribution in
controls, into <2907, 2907–8530 and 48530 for analogue phones, and <1857, 1857–6048 and 46048 for digital phones. For
cumulative hours of mobile phone use the data are divided into <146, 146–490 and4490 for analogue phones, and <101, 101–398
and4398 for digital phones.
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Cumulative number of hours (and to some extent
also cumulative number of calls) and lifetime years of
use represent cumulative exposure, ipsilateral use and
possibly analogue phones represent higher intensity
(magnetic field strength) and years since first use
represent induction period. No increased risk was
found in relation to duration of use, ipsilateral use or
use of analogue phones. In the analysis of cumulative
hours of use based on a categorical exposure indi-
cator, there was no increased risk for meningioma,
not even in the highest (10%) exposure category.
When the continuous variable was used, some indica-
tion of an association was found, that was, however,
based on small number of extreme and possibly
erroneous values. The cumulative hours of use may
contain uncertainties as an exposure indicator, as it
is derived from the number and the duration of
calls multiplied by the duration of mobile phone
use. Additionally, both parameters were frequently
reported also as ranges from which an average
was used for estimating calling time. This may
easily result in overestimation of exposure unless
number and duration of calls are independent. If daily
call-time of 30min is composed of one 30-min call
or thirty 1-min calls, it could be misinterpreted as
on average 15 calls of 15-min duration, i.e. 225min
(nearly 4 h) constituting substantial overestimation.
It is also possible that cases over-report their mobile
phone use (recall bias). Some evidence of this was
observed, as in the distribution of cumulative hours of
use the highest values among cases clearly exceeded
those among controls and were generally based on
implausibly high reported hours of mean daily use
over long periods. When we performed an additional
analysis of cumulative hours of use and excluded the
subjects with more than 2h of daily use correspond-
ing to only 1.7% of observations, the OR was no
longer increased.
The strengths of the study include a larger number
of meningioma cases than in any previous report.
This allowed us to obtain precise risk estimates and
conduct detailed analyses of various aspects of mobile
Table 5 Odds ratios for meningioma related to laterality of the tumour and reported side of mobile phone use
Ipsilateral phone usea Contralateral phone usea
Cases Controls OR (95% CI) Cases Controls OR (95% CI)
Frequency of use
Never/non-regular use 486 1249 1.0 486 1249 1.0
Regular 250 918 0.81 (0.66, 0.99) 224 905 0.67 (0.54, 0.83)
Years since first use
Never/non-regular use 486 1249 1.0 486 1249 1.0
1.5–4b 128 442 0.77 (0.60, 0.99) 105 424 0.62 (0.47, 0.80)
5–9 89 363 0.78 (0.56, 1.04) 95 364 0.78 (0.58, 1.05)
510 33 113 1.05 (0.67, 1.65) 24 117 0.62 (0.38, 1.03)
Lifetime years of use
Never/non-regular use 486 1249 1.0 486 1249 1.0
0.5–4 157 580 0.73 (0.58, 0.92) 142 563 0.65 (0.52, 0.83)
5–9 72 258 0.99 (0.72, 1.36) 65 263 0.71 (0.51, 1.01)
510 21 73 0.99 (0.57, 1.73) 13 68 0.64 (0.33, 1.23)
Cumulative hours of usec
Never/non-regular use 486 1249 1.0 486 1249 1.0
<median 127 469 0.75 (0.59, 0.97) 111 456 0.62 (0.48, 0.80)
median-3rd quartile 59 208 0.82 (0.57, 1.15) 50 220 0.65 (0.45, 0.94)
43rd quartile 58 225 0.89 (0.62, 1.27) 58 216 0.81 (0.56, 1.17)
All odds ratios obtained from analysis that was stratified by sex, five-year age group, region and country.
aIpsilateral phone use¼mobile phone use on the same side of the head as the tumour. Contralateral phone use¼mobile phone use
on the opposite side of the head to the tumour. The numbers do not match exactly to the total numbers of cases and controls since
there were strata without cases and strata without controls in the data. We report here the numbers of cases and controls that are
actually included in the analyses and for whom the values of the explored exposure variables were known. Also, in this analysis
only subjects with both the side of tumour and use are included. The number of cases in the reference group is different to the
main analysis (631) since there were 145 cases to whom the side of the tumour was not defined (115 with a central tumour and 30
with a missing value).
bLower limit 1.5 years since phone use was defined as regular when phone was used for at least six months during the period at
least one year prior to reference date.
cEstimates adjusted for use of hands-free devices. Data are divided, based on the distribution in controls, into <136, 136–573 and
4573 for ipsilateral phone use, and <133, 133–566 and4566 for contralateral phone use.
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phone use. Furthermore, the number of subjects with
long-term exposure is higher than in the earlier
studies, due to the recent study period and study
populations where large-scale mobile phone use was
adopted early. This is essential, as the induction
period may be long for a slowly developing benign
tumour such as meningioma. A related aspect is
larger cumulative exposure, providing a better oppor-
tunity to identify possible effects in a highly exposed
group. On the other hand, the weaknesses of our
study are the low participation rate among controls
and the fact that mobile phone use and other expo-
sures are based on self-reports. These limitations are
shared by most other studies on the subject.
An apparently reduced risk was found related to
regular use of mobile phones. A likely explanation for
at least some of the risk reduction is selection bias.
There is some empirical evidence for higher participa-
tion among mobile phone users than non-users
for both cases and controls in the study.13,20 When
mobile phone users are more willing to participate in
epidemiological studies than non-users, exposure in
the source population is overestimated, which may
result in underestimation of the risk in relation
to mobile phone use and may partly explain the
decreased risk estimates detected in this study, if the
selection was differential between cases and controls.
Participation varying with level of use may distort the
dose–response relation and lead to a J-shaped pattern,
consistent with some of our results. The slightly lower
proportion of controls with basic education only may
be a related finding, as participation in research is
commonly associated with a high educational level.21
Latent disease bias, where early symptoms of the
disease may make cases less likely to become mobile
phone users in the period preceding the diagnosis,
may also explain the reduced risk estimate. However,
the most common symptoms of meningioma are sei-
zures and headache,22,23 which are unlikely to affect
mobile phone use. Furthermore, we found little indi-
cation of such bias since the proportion of cases was
similar to that of controls across the start of use
categories, and also among those that started mobile
phone use within a year before the reference date
(20% vs 21%).
There was no evidence for confounding, as the crude
results were very similar to those of the analyses
accounting for highest educational level, family
history of meningiomas, tuberous sclerosis, neurofi-
bromatosis or previous radiotherapy to the head and
neck region. Also, when calculating the exposure
histories, the fact that controls were interviewed on
average later than the cases was taken into account
by adjustment, which is crucial when investigating an
exposure such as mobile phone use that increases
rapidly over time.
Considerable random error has been demonstrated
in self-reported amount of mobile phone use.24–26
That is understandable, as mobile phone use is
nowadays an unremarkable aspect of everyday life.
As mobile phone use has increased during the years
of use, the retrospectively reported amount of use
may be influenced by not only past, but also current
mobile phone use. In the INTERPHONE study, over-
reporting of duration of calls by up to 50–100% was
common.27 Non-differential misclassification of expo-
sure is likely to bias the results towards the null,
should there be an effect, particularly when a dichot-
omous or continuous measure of exposure is used.28
This is not equally obvious when categorical (multi-
nomial) exposure indicators are used, as in our study.
Information about regular vs non-regular use reported
by the study subjects is likely to be more reproducible
and crude measures might therefore be more robust
than detailed, quantitative indices. Yet, the afore-
mentioned selection bias may distort those analyses.
Obviously, an objective source of exposure informa-
tion, independent of the study subject, would provide
highly valuable information. Yet, only one small
cohort study has been able to use quantitative expo-
sure information from operators, but it had a very
short follow-up and inadequate number of events.29
Another cohort has also obtained information from
subscriber lists, but only about ownership of a sub-
scription, without any traffic data.8
In conclusion, our study does not provide evidence
for an increased risk of meningioma in relation to
mobile phone use. An apparent association was
detected for cumulative hours of use as a continuous
exposure indicator but this was based on a small
number of extreme and possibly erroneous values.
No such association was detected in the categorical
analyses. Thus, the present findings do not suggest
mobile phone use is associated with an increased risk
of meningioma.
Acknowledgements
All countries: the Quality of Life and Management
of Living Resources program of European Union and
the International Union against Cancer (UICC) (RCA/
01/08). The UICC received funds for this study from
the Mobile Manufacturers’ forum and the GSM Asso-
ciation. Provision of funds to the INTERPHONE study
investigators via UICC was governed by agreements
that guaranteed INTERPHONE’s complete scientific
independence.
The Finnish study: Academy of Finland (grant
no. 80921), Emil Aaltonen Foundation and Doctoral
Programs for Public Health.
The UK study: the Mobile Telecommunications,
Health and Research (MTHR) programme.
The Swedish Study: the Swedish Research Council.
The Nordic–UK collaboration thanks the interviewers
for their contribution for data collection and
Dr Elisabeth Cardis and the rest of the IARC team
for their input to this study. We are also grateful to
MOBILE PHONE USE AND MENINGIOMA 1311
James Doughty and Jan Ivar Martinsen for program-
ming work.
The Finnish centre thanks Dr J Ja¨a¨skela¨inen (Helsinki
University Hospital), Dr S Valtonen (Turku University
Hospital), Prof. J Koivukangas (Oulu University Hos-
pital), Prof. M Vapalahti (Kuopio University Hospital),
Dr T Kuurne and Dr H Haapasalo (Tampere University
Hospital) and Prof. R Sankila (Finnish Cancer
Registry) for their contributions to collection of the
material.
The Norwegian centre thanks Jan Ivar Martinsen
for data management and Karl G Blaasaas for his
contribution with data collection, data management
and analyses.
The Swedish centre thanks the Swedish Regional
Cancer Registries and the hospital staff; especially the
following key persons at the hospitals: Dr J Boethius,
Dr O Flodmark, Prof. I Langmoen, Dr A Lilja, Dr T
Mathiesen, Dr I Olsson Lindblom and Dr H Stibler
(Karolinska University Hospital), Dr J Lycke, Dr A
Michanek and Prof. L Pellettieri (Sahlgrenska Uni-
versity Hospital), Prof. T Mo¨ller and Prof. L Salford
(Lund University Hospital), Dr T Bergenheim,
Dr L Damber, Prof. R Henriksson and Dr B Malmer
(Umea˚ University Hospital).
The Southeast England centre would like to thank
all participants for their contribution to the study.
They also thank Prof. H Møller, Mr B Plewa and
Mr S Richards from the Thames Cancer Registry
and the following neuropathologists, neurosurgeons,
neuro-oncologists, clinical oncologists, neurologists,
administrators and secretaries for the help they
provided: Mr DG Hardy, Mr PJ Kilpatrick,
Mr R Macfarlane (Addenbrooke’s Hospital); Ms
M Cronin, Ms T Foster, Ms S Furey, Dr M G Glaser,
Ms F Jones, Mr NDMendoza, Prof. ES Newlands,Mr KS
O’Neill, Mr D Peterson, Ms F Taylor, Prof. J van Dellon
(Charing Cross Hospital); Dr JJ Bending (Eastbourne
District Hospital); Mr PR Bullock, Mr C Chandler, Mr
B Chitnavis, Mr L Doey, Mr RWGullan, Prof. CE Polkey,
Mr R Selway, Mr MM Sharr, Ms L Smith, Prof.
AJ Strong, Mr N Thomas (King’s College Hospital);
Dr GM Sadler (Maidstone Hospital); Dr S Short (Mount
Vernon Hospital); Prof. S Brandner, Mr AD Cheesman,
Miss JP Grieve, Mr WJ Harkness, Dr R Kapoor, Mr
ND Kitchen, Mrs T Pearce, Mr MP Powell, Dr J Rees,
Prof. F Scaravilli, Prof. DT Thomas, Mr LD Watkins
(National Hospital for Neurology and Neurosurgery);
Mr AR Aspoas, Mr S Bavetta, Mr J C Benjamin, Mr KM
David, Mr JR Pollock, Dr E Sims (Oldchurch Hospital);
Mrs J Armstrong, Mr J Akinwunmi, Mr G Critchley,
Mr L Gunasekera, Mr C Hardwidge, Mr JS Norris, Dr
PE Rose, Mr PH Walter, Mr PJ Ward, Dr M Wilkins
(Princess Royal Hospital); Prof. TZ Aziz, Prof. D Kerr,
Mr PJ Teddy (Radcliffe Infirmary); Ms M Allen,
Ms T Dale, Mr R Bradford, Prof. AP Dhillon, Mr NL
Dorward, Ms D Farraday-Browne, Dr DJ McLaughlin,
Mr RS Maurice-Williams, Dr K Pigott, Ms B Reynolds,
Ms C Shah, Mr C Shieff, Dr EM Wilson (Royal Free
Hospital); Mr F Afshar, Mr HE Ellamushi, Prof. PM
Richardson, Mr HI Sabin, Mr J Wadley (Royal London
Hospital); Prof. M Brada, Mr D Guerrero, Dr FH Saran,
Mrs D Traish (Royal Marsden Hospital); Dr S Whitaker
(Royal Surrey County Hospital); Dr PN Plowman
(St Bartholomew’s Hospital); Mrs Carole Bramwell,
Prof. A Bell, Mr F Johnston, Mr H Marsh, Mr A Martin,
Mr PS Minhas, Miss A Moore, Mr S Stapleton,
Dr S Wilson (St George’s Hospital); Dr RP Beaney
(St Thomas’ Hospital).
References
1 . In: Kleihues P, Cavenee WK (eds). Pathology and genetics
of tumours of nervous system. Lyon: IARC Press, 2000.
2 Klaeboe L, Lo¨nn S, Scheie D et al. Incidence of
intracranial meningiomas in Denmark, Finland, Norway
and Sweden, 1968–1997. Int J Cancer 2005;117:996–1001.
3 Inskip PD, Linet MS, Heineman EF. Etiology of brain
tumors in adults. Epidemiol Rev 1995;17:382–414.
4 Hardell L, Na¨sman A˚, Pa˚hlson A, Hallquist A, Hansson
Mild K. Use of cellular telephones and the risk for brain
tumours: a case-control study. Int J Oncol 1999;15:113–16.
5 Inskip PD, Tarone RE, Hatch EE et al. Cellular-telephone
use and brain tumors. N Engl J Med 2001;344:79–86.
6 Auvinen A, Hietanen M, Luukkonen R, Koskela R-S.
Brain tumors and salivary gland cancers among cellular
telephone users. Epidemiology 2002;13:356–59.
7 Hardell L, Carlberg M, Hansson Mild K. Pooled analysis
of two case-control studies on the use of cellular and
cordless telephones and the risk of benign brain tumours
diagnosed during 1997–2003. Int J Oncol 2006;28:509–18.
8 Schu¨z J, Jakobsen R, Olsen JH, Boice JD Jr,
McLaughlin JK, Johansen C. Cellular telephone use and
cancer risk: update of a nationwide Danish Cohort.
J Natl Cancer Inst 2006;98:1707–13.
9 Schu¨z J, Bohler E, Berg G et al. Cellular phones, cordless
phones, and the risks of glioma and meningioma
(Interphone Study Group, Germany). Am J Epidemiol
2006;163:512–20.
10 Cardis E, Richardson L, Deltour I et al. The INTERPHONE
study: design, epidemiological methods, and description
of the study population. Eur J Epidemiol 2007;22:647–64.
11 Gibney O. Global mobile subscriber database. London,
England: Informa Telecoms & Media, 2005.
12 Christensen HC, Schutz J, Kosteljanetz M et al. Cellular
telephones and risk for brain tumors: a population-
based, incident case-control study. Neurology 2005;64:
1189–95.
13 Lo¨nn S, Ahlbom A, Hall P, Feychting M; Swedish
Interphone Study Group. Long-term mobile phone use
and brain tumor risk. Am J Epidemiol 2005;161:526–35.
14 Klaeboe L, Blaasaas KG, Tynes T. Use of mobile phones in
Norway and risk of intracranial tumours. Eur J Cancer Prev
2007;16:158–64.
15 Schoemaker MJ, Swerdlow AJ, Ahlbom A et al. Mobile
phone use and risk of acoustic neuroma: results of the
Interphone case-control study in five North European
countries. Br J Cancer 2005;93:842–48.
1312 INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
16 Lahkola A, Auvinen A, Raitanen J et al. Mobile phone use
and risk of glioma in five North European countries.
Int J Cancer 2007;120:1769–75.
17 StataCorp. Stata Statistical Software: Release 9.0. Texas,
Stata Corporation: College Station, 2005.
18 Ahlbom A, Green A, Kheifets L, Savitz D, Swerdlow A;
ICNIRP (International Committee for Non-Ionizing
Radiation Protection) Standing Committee on Epidemiol-
ogy. Epidemiology of health effects of radiofrequency
exposure. Environ Health Perspect 2004;112:1741–54.
19 Lahkola A, Tokola K, Auvinen A. Meta-analysis of mobile
phone use and intracranial tumors. Scand J Work Environ
Health 2006;32:171–77.
20 Lahkola A, Salminen T, Auvinen A. Selection bias due to
differential participation in a case-control study of mobile
phone use and brain tumors. Ann Epidemiol 2005;15:
321–25.
21 Inskip PD, Tarone RE, Hatch EE et al. Sociodemographic
indicators and risk of brain tumors. Int J Epidemiol
2003;32:225–33.
22 Rohringer M, Sutherland GR, Louw DF, Sima AA.
Incidence and clinicopathological features of menin-
gioma. J Neurosurg 1989;71:665–72.
23 DeMonte F, Marmor E, Al-Mefty O. Meningiomas. In:
Kaye A, Laws ER, Jr (eds). Brain Tumors: An Encyclopedic
Approach. New York: Churchill Livingstone, 2001.
24 Parslow RC, Hepworth SJ, McKinney PA. Recall of past
use of mobile phone handsets. Radiat Prot Dosimetry
2003;106:233–40.
25 Samkange-Zeeb F, Berg G, Blettner M. Validation of self-
reported cellular phone use. J Expo Anal Environ Epidemiol
2004;14:245–48.
26 Berg G, Schutz J, Zamkange-Zeeb F, Blettner M.
Assessment of radiofrequency exposure from cellular
telephone daily use in an epidemiological study:
German validation study of the international case-control
study of cancers of the brain – INTERPHONE study.
J Expo Anal Environ Epidemiol 2005;15:217–24.
27 Vrijheid M, Cardis E, Armstrong BK et al. Validation of
short term recall of mobile phone use for the Interphone
study. Occup Environ Med 2006;63:237–43.
28 Armstrong BG. Effect of measurement error on epide-
miological studies of environmental and occupational
exposures. Occup Environ Med 1998;55:651–56.
29 Dreyer NA, Loughlin JE, Rothman KJ. Cause-specific mor-
tality in cellular telephone users. JAMA 1999;282:1814–16.
Published by Oxford University Press on behalf of the International Epidemiological Association
 The Author 2008; all rights reserved. Advance Access publication 19 October 2008
International Journal of Epidemiology 2008;37:1313–1315
doi:10.1093/ije/dyn200
Commentary: Observational studies may
conceal a weakly elevated risk under the
appearance of consistently reduced risks
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The paper by Lahkola et al.1 is interesting in two
respects. First, the issue of possible health effects, in
particular cancers, of mobile phones is of obvious
public health importance given the wide extent of the
exposure. Second, the paper raises several noteworthy
methodological issues of general import.
The study of meningiomas in five countries reported
in the paper adds two countries to previous articles
covering three countries2–4 and is an integral part of a
larger multinational study on meningiomas, gliomas,
acoustic neurinoma and parotid gland tumours in 13
countries (‘Interphone’)5 whose findings are as yet
unpublished. Multi-centric international studies ori-
ginate and develop within a variety of contexts and
constraints, ranging from the degree of urgency of the
question under study to the investigators’ research
and career interests to conditions posed by funding
bodies. Given this spectrum of circumstances, each
study will necessarily have its own criteria for the
publication of results, and a variety of criteria are
justifiable provided they are explicitly agreed upon
beforehand by the participating investigators.
From a research viewpoint, however, the rationale
for multi-centric studies largely rests on the potential
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Objectives   A summary of epidemiologic evidence regarding the effect of mobile phone use on intracranial
tumor risk was obtained by means of a meta-analysis.
Methods   Reports of published studies on mobile phone use and intracranial tumors were sought. Altogether 12
relevant publications were identified from the PubMed database and reference lists of articles. Fixed or random
effects analysis was carried out depending on the presence of heterogeneity between studies. Risk estimates
were obtained for people who had used mobile phones for the longest periods of time (>5 years in most reports).
A pooled estimate was calculated for all intracranial tumors combined and also separately for different
histological tumor types. Separate analyses were conducted also based on the tumor location and type of mobile
telephone network (NMT or GSM).
Results  Twelve studies with 2780 cases gave a pooled odds ratio (OR) of 0.98 [95% confidence interval (95%
CI) 0.83–1.16] for all intracranial tumors related to mobile phone use. For gliomas, the pooled OR was 0.96
(95% CI 0.78–1.18), for meningiomas it was 0.87 (95% CI 0.72–1.05), and for acoustic neuromas it was 1.07
(95% CI 0.89–1.30). Little indication was found for increased risks of analogue or digital phone use or temporal
or occipital tumors.
Conclusions   The totality of evidence does not indicate a substantially increased risk of intracranial tumors
from mobile phone use for a period of at least 5 years.
Key terms    brain neoplasm; cellular phone; pooled analysis.
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The use of mobile phones (also called cellular phones)
has increased rapidly worldwide since the early 1990s.
This increase has generated concern about the possible
adverse health effects of mobile phone use, particularly
the risk of intracranial tumors.
The first study concerning the association between
intracranial tumors and mobile phone use was published
in 1999 (1). After this case-control study, which did not
report any significantly increased risks of intracranial
tumors among mobile phone users, several studies have
appeared in the literature. However, the published re-
sults are somewhat inconsistent, and single studies ap-
pear inconclusive. Several reviews summarizing the re-
sults have been published and most conclude that mo-
bile phones are not likely to cause intracranial tumors
(2–6). To complement the qualitative summaries pro-
vided by the reviews, a meta-analysis provides a tool
for the quantitative synthesis of individual studies. A
meta-analysis was used to estimate the overall magni-
tude of the risk for intracranial tumors, comprised of
brain tumors such as gliomas and meningiomas, as well
as acoustic neuromas, in relation to mobile phone use.
Material and methods
We searched for the epidemiologic evidence on mobile
phone use and intracranial tumors in the PubMed data-
base (www.ncbi.nlm.nih.gov) using the following
searching terms (used in the title or abstract): (1) mo-
bile/cellular phone/telephone and (2) brain tumor/can-
cer/neoplasm or glioma or meningioma or neuroma/
schwannoma. In addition, we browsed the reference lists
of the retrieved articles. We obtained a numerical sum-
mary of the published results without a detailed quali-
tative review of individual studies. Such reviews have
been published previously (2–6).
Altogether 19 articles (1, 7–24), published by 1 De-
cember 2005, were identified that meet the following
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inclusion criteria: (i) being original publications, (ii)
using individual exposure data, (iii) based on a  case–
control or cohort format, (iv) reporting quantitative
measures of association [point estimates expressed ei-
ther as odds ratios (OR) or as standardized incidence
ratios (SIR)], and (v) reporting information needed for
the estimation of confidence intervals (the standard er-
ror or confidence interval of the effect measure or the
number of persons by exposure and outcome status). A
meta-analysis requires that the studies to be pooled have
similar aims and end points. One study was excluded
because the end point was brain tumor mortality rather
than incidence, and another was excluded that addressed
only facial nerve tumors (7–8). No studies were exclud-
ed due to language other than English, and no unpub-
lished reports were identified. No studies were exclud-
ed because of dissimilar procedures, as both the inclu-
sion criteria and exposure assessment methods were
similar enough to allow pooling. As the approaches were
relatively uniform, no grading by quality was regarded
as necessary.
We were able to retrieve all of the 17 identified stud-
ies fulfilling the criteria. On the basis of the considera-
tions, five articles (9–11, 18–19) were excluded from
the analysis because they used overlapping study par-
ticipants of other articles that were already included in
the material. Altogether 12 studies (1, 12–17, 20–24)
were finally included in the analysis (table 1). Of these
studies, nine were population-based (1, 14–16, 20–24),
and three were hospital-based (12–13, 17). All of the
hospital-based studies were carried out in the United
States, while the population-based studies were Euro-
pean. Eleven were case–control studies (1, 12–13, 15–
17, 20–24), and one was a cohort study (14). All of the
studies included in the meta-analysis used incident in-
tracranial tumor cases. Exposure assessment was based
on interviews or questionnaires in all but two studies
that used telephone company records (14–15). Six of the
Table 1. Key features of the studies included in the meta-analysis. (OR = odds ratio, 95% CI = 95% confidence interval, US = United
States)
Study Country End points Number a Exposure assessment Telephone Longest OR b 95% CI b
types duration
of mobile
phone use
Hardell et al, Sweden Intracranial tumors (astrocytic, oligo 34 cases, Postal questionnaire + Analogue, >5 years 0.83 0.49–1.42
1999 (1) dendroglial and ependymal tumors, 69 controls telephone interview digital
mixed glioma, meningioma)
Muscat et al, US Malign intracranial tumors (astrocytic, 17 cases, Interview Not >4 years 0.7 0.4–1.4
2000 (12) oligodendroglial and ependymal 22 controls specified
tumors, mixed glioma)
Inskip et al, US Intracranial tumors (glioma, menin- 22 cases, Interview Not >5 years 0.9 c 0.5–1.6
2001 (13) gioma, acoustic neuroma) 31 controls specified
Johansen et al, Denmark Cancer (brain and nervous system, 66 gliomas, Company records, Not Mean 0.92 e, f 0.74–1.16
2001 (14) gliomas, meningiomas) 16 menin- 420 095 mobile phone specified follow-up
giomas d subscribers time
3.1 years
Auvinen et al, Finland Intracranial tumors (glioma, 18 cases, Company records Analogue, >2 years 1.5 0.9–2.5
2002 (15) meningioma) 64 controls digital
Hardell et al, Sweden Intracranial tumors (astrocytic, oligo- 153 cases, Postal questionnaire + Analogue, >5 years 0.9 g 0.6–1.5
2002 (16) dendroglial and ependymal tumors, 124 controls telephone interview digital
mixed glioma, meningioma, pituitary
tumors, acoustic neuroma)
Muscat et al, US Acoustic neuroma 11 cases, Interview Not 3–6 years 1.7 0.5–5.1
2002 (17) 6 controls specified
Lönn et al, Sweden Glioma, meningioma 136 cases, Interview Analogue, >5 years h 0.73 f 0.55–0.96
2005 (20) 171 controls digital
Christensen et Denmark Glioma, meningioma 83 cases, Interview Not >5 years h 0.66 f 0.46–0.95
al, 2005 (21) 193 controls specified
Schoemaker et Nordic Acoustic neuroma 127 cases, Interview Analogue, >5 years h 0.95 f 0.75–1.18
al, 2005 (22) countries 646 controls digital
Hardell et al, Sweden Acoustic neuroma, meningioma 87 cases, Postal questionnaire + Analogue, >5 years h 1.4 f 1.02–1.93
2005 (23) 129 controls telephone interview digital
Hardell et al, Sweden Malign intracranial tumors 98 cases, Postal questionnaire + Analogue, >5 years  h 1.49 f 1.10–2.02
(in press) (24) 129 controls telephone interview digital
a The number of cases and controls in the subcategories of the original studies that are included in the meta-analysis. The subcategories were selected to
achieve the maximum length of mobile phone use.
b The overall estimate for the use of mobile phones that was used in the meta-analysis.
c Relative risk.
d Among mobile phone users (a cohort study with 135 cancer cases of the brain and nervous system).
e Standardized incidence ratio.
f Calculated by the authors of the meta-analysis through the pooling of different exposure or tumor categories reported in the original studies.
g Digital phones.
h Calculated by pooling the original categories in the articles, 5–9 years (or 5–10) and >10 years, to one category of >5 years.
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studies (1, 16, 20, 22, 23–24) reported excluding the
exposure within ≤1 year from the index date (diagnosis
of cases and corresponding date among the controls) in
the analysis, while such restriction of exposure was not
reported in the rest of the studies. The participation rates
among the cases varied between 73% and 92%, and
among controls it ranged from 51% and 91%.
The articles to be included in the analyses were re-
viewed independently by two authors (AL & KT), and
all of the relevant data (odds ratios, relative risks, and
standardized incidence ratios with 95% confidence in-
tervals) were retrieved and entered into evidence tables.
In the absence of heterogeneity, we carried out the
meta-analysis using the inverse variance-weighted
method for combining the odds ratios (25). This ap-
proach is equivalent to a fixed-effects analysis, on the
assumption that the effect is constant across studies and
all differences between the studies are attributable to
random variation (25). Most of the studies used identi-
cal factors, such as age and gender, for matching or ad-
justment. The weights were calculated on the basis of
the width (subtraction of the lower and upper limit) of
the confidence interval (CI), due to problems with the
rounding of the original confidence intervals in some
of the studies. When evidence for heterogeneity between
studies was found, a random effects analysis was used,
which allowed the true risks to vary between studies and
assumed a random distribution for these estimates
around a common central value.
To improve the accuracy, we recalculated the over-
all odds ratio for intracranial tumors for one study (16)
because the original confidence intervals in the article
were reported only with one decimal. For four studies
(20, 22–24), we pooled two exposure categories, 5–9
years (or 5–10 years) and >10 years into >5 years, to
achieve similar exposure classification as in the other
reports. Furthermore, different tumor categories were
also pooled prior to the meta-analysis of the total odds
ratio (all tumors combined) for the articles that report-
ed them only separately (14, 21). When the estimates
were reported only separately for analogue and digital
phones (but not for all mobile phones combined), we
used the odds ratio for digital phones for the calcula-
tions of the total odds ratio since it is possible that the
same persons had been using both analogue and digital
telephones and thus were included in both categories in
the original reports (16, 23–24). In addition, digital
phone use was more common in most studies.
Our analysis concentrated on the persons most like-
ly to demonstrate an effect, if such exists (ie, the ex-
posed group was defined as those who had used a mo-
bile phone for the longest time, rather than ever users).
In most studies, these persons were those with at least 5
years of use, but, in four studies, the longest period was
shorter (4 years, from 3 to 6 years, 2 years and the
cohort study with the mean follow-up time of 3.1 years,
table 1). A pooled odds ratio was calculated for all in-
tracranial tumors combined, based on both duration
(years) and cumulative hours of mobile phone use. The
odds ratio was also calculated separately for the follow-
ing three histological groups of tumors: gliomas (com-
prising astrocytic, oligodendroglial, and ependymal tu-
mors, as well as mixed gliomas—nine studies), menin-
giomas (eight studies), and acoustic neuromas (six stud-
ies). Furthermore, a pooled estimate was calculated sep-
arately for telephone types (analogue and digital, seven
studies), laterality (reported phone use on the same and
opposite side of the head where the tumor occurred, sev-
en and five studies, respectively), study base (hospital-
based versus population-based, 12 studies), as well as
tumors of the temporal (excluding acoustic neuromas,
eight studies), and occipital lobes (five studies). Final-
ly, we also conducted analyses of ipsilaterality (phone
use on the same side that the tumor occurred) by tumor
type.
Study heterogeneity was assessed using the Q sta-
tistic to determine whether the results of various stud-
ies were consistent enough to be combined. Further-
more, we assessed sensitivity (influence of single stud-
ies) by calculating pooled estimates while excluding
each study at a time. The effect of possible publication
bias was investigated by means of a funnel plot. Final-
ly, we performed a regression analysis to assess wheth-
er the intracranial tumor risk was related to the dura-
tion of mobile phone use. The regression analysis was
based on all but the one study that used a cohort design
(14). In the analysis, we used the geometric mean of the
duration of mobile phone use and weighted odds ratios
from each study as in the meta-analysis. From the stud-
ies, we included the maximum number of exposure cat-
egories available in the published reports. For each ex-
posure category, the duration of use was assigned as the
geometric mean of the lower and upper limit of that cat-
egory. If the authors had not reported an upper limit for
the duration of mobile phone use, we estimated the max-
imal duration by assuming that the use of mobile phones
had started in 1987 when the first handheld mobile tel-
ephones were introduced. The regression analysis was
carried out only for all tumor types combined.
Results
The total number of cases in the published studies was
5799, of which 2424 were among mobile phone users.
Our analyses included a total of 2870 cases, including
748 cases with at least 2–5 years of mobile phone use.
The largest subgroup was gliomas (total 1352 cases, 339
classified as exposed in this analysis), followed by
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meningiomas (527 and 149), and acoustic neuromas
(605 and 167). These figures have some uncertainties
since the number of persons in different exposure or tu-
mor categories were not reported in some reports (1, 16,
23–24). The proportion of microscopically confirmed
cases ranged between 25% and 100% (the lower per-
centage is related to acoustic neuromas that are usually
detected in computer scans).
As there was evidence for heterogeneity between the
studies for all tumor types combined on the basis of the
duration of mobile phone use, a random effects model
was used. The pooled estimate based on the 11 studies
was very close to unity, and the upper limit of the con-
fidence interval was below 1.2 (figure 1). The sensitiv-
ity analysis showed that the odds ratio was not strongly
influenced by any single study (figure 2).
The pooled odds ratio for all tumors combined, on
the basis of the cumulative hours of mobile phone use,
was very close to unity and was obtained from a ran-
dom effects model (table 2). The type of study base had
little influence on the results, as the pooled odds ratio
for the population-based studies (from the random ef-
fects model) was only slightly higher than that of the
hospital-based studies, obtained from the fixed effects
model (table 2).
The analyses by histological type gave similar re-
sults. The pooled odds ratios for gliomas (from the ran-
dom effects model) and meningiomas (from the fixed
effects model) were slightly below one, whereas, for
acoustic neuromas (from the fixed effects model), the
estimate was slightly above one (table 2). The exclu-
sion of the four studies with a maximal exposure dura-
tion shorter than 5 years did not materially affect the
results for any tumor type.
The pooled estimates for the use of analogue and
digital telephones were obtained with a random effects
analysis and were both slightly above one and nonsig-
nificant. The pooled odds ratio for analogue telephones
was somewhat higher than for digital telephones. No ev-
idence of increased risks was found for temporal or oc-
cipital tumors, on the basis of the random and fixed ef-
fects model, respectively. However, for the ipsilateral
tumors (ie, those occurring on the same side on which
the phone was predominantly used) the odds ratio was
above one, with borderline nonsignificance. When the
tumor types were analyzed separately by laterality in
relation to phone use, a nonsignificantly elevated odds
ratio was found for the ipsilateral gliomas, whereas the
odds ratios were closer to unity for meningiomas and
acoustic neuromas. The odds ratio for the contralateral
tumors was very close to one (table 2).
In the regression analysis, we found little evidence
of an increasing risk of intracranial tumors with dura-
tion of mobile phone use (regression coefficient 0.0072,
P=0.41). Finally, a funnel plot was used to assess pos-
sible publication bias, but it revealed no indication of
such selection (figure 3).
Discussion
Our objective was to pool published risk estimates and
thereby assess the influence of random variation and
heterogeneity between the study results. This meta-anal-
ysis showed little evidence of an association between
mobile phone use and the risk of all intracranial tumors
combined. Our findings are in line with the previously
narrative summaries in which the quality of the studies
also included in this meta-analysis has been assessed (5,
26). In the subgroup analyses, no strong or consistent
association was found with different subgroups of tu-
mors defined by morphologic type (glioma, meningioma,
Figure 1. Results of the original studies and meta-analysis (random
effects model) of mobile phone use and intracranial tumors. The odds
ratios are on a log scale. Pooled odds ratio = 0.98 (95% confidence
interval 0.83–1.16). It is indicated which studies included gliomas,1
meningiomas,2 and acoustic neuromas.3
Figure 2. Results of the sensitivity analysis for all types of intracranial
tumors combined based on the duration of mobile phone use (years).
Each study was excluded at a time from the analysis to assess its
influence. The study removed from the analysis is indicated next to the
error bar. It is indicated which studies included gliomas,1 meningi-
omas,2 and acoustic neuromas.3
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Table 2. Pooled estimates of intracranial tumor risk among mobile phone users and measures of heterogeneity between the studies
included in the analyses.
Model 95% CI Heterogeneity
Fixed effect Random
analysis effect analysis
All intracranial Hardell et al 1999 (1), Muscat et al 2000 (12), Inskip et al Random effects 0.98 0.83–1.16 χ2 = 26.67, χ2 = 10.88,
tumors, duration 2001 (13), Johansen et al 2001 (14), Auvinen et al 2002 (15), P=0.01 P=0.45
of mobile phone Hardell et al 2002 (16), Muscat et al 2002 (17), Lönn et al
use (years) a 2005 (20), Christensen et al 2005 (21), Schoemaker et al
2005 (22), Hardell et al 2005 (23), Hardell et al 2005 (24)
All intracranial Hardell et al 1999 (1), Muscat et al 2000 (12), Inskip et al 2001 Random effects 0.98 0.73–1.30 χ2 = 38.05, χ2 = 9.27,
tumors, cumulative (13), Hardell et al 2002 (16), Muscat et al 2002 (17), Lönn et al P<0.01 P=0.41
hours of mobile 2005 (20), Christensen et al 2005 (21), Schoemaker et al 2005
phone use b (22), Hardell et al 2005a (23), Hardell et al 2005 (24)
All intracranial Hardell et al 1999 (1), Johansen et al 2001 (14), Auvinen et Random effects 0.99 0.82–1.21 χ2 = 24.59, χ2 = 8.48,
tumors, population al 2002 (15), Hardell et al 2002 (16), Lönn et al 2005 (20), P=0.01 P=0.39
based studies a Christensen et al 2005 (21), Schoemaker et al 2005 (22),
Hardell et al 2005a (23), Hardell et al 2005b (24)
All intracranial Muscat et al 2000 (12), Inskip et al 2001 (13), Muscat et al Fixed effects 0.87 0.59–1.30 χ2 = 1.78, .
tumors, hospital 2002 (17) P=0.41
based studies a
Gliomas c, d Hardell et al 1999 (1), Muscat et al 2000 (12), Inskip et al Random effects 0.96 0.78–1.18 χ2 = 20.01, χ2 = 8.64,
2001 (13), Johansen et al 2001 (14), Auvinen et al 2002 P=0.01 P=0.37
(15), Hardell et al 2002 (16), Lönn et al 2005 (20),
Christensen et al 2005 (21), Hardell et al 2005 (24)
Meningiomas d Hardell et al 1999 (1), Inskip et al 2001 (13), Johansen et al Fixed effects 0.87 0.72–1.05 χ2 = 7.28, .
2001 (14), Auvinen et al 2002 (15), Hardell et al 2002 (16), Lönn P=0.40
et al 2005 (20), Christensen et al 2005 (21), Hardell et al (23)
Acoustic Hardell et al 1999 (1), Inskip et al 2001 (13), Hardell et al Fixed effects 1.07 0.89–1.30 χ2 = 5.69, .
neuromas d 2002 (16), Muscat et al 2002 (17), Shoemaker et al 2005 P=0.34
(22), Hardell et al 2005 (23)
Analogue phone e Hardell et al 1999 (1), Auvinen et al 2002 (15), Hardell et al Random effects 1.17 0.91–1.49 χ2 = 16.28, χ2 = 6.11,
2002 (16), Lönn et al 2005 (20), Schoemaker et al 2005 P=0.01 P=0.41
(22), Hardell et al 2005 (23), Hardell et al 2005 (24)
Digital phone e Hardell et al 1999 (1), Auvinen et al 2002 (15), Hardell et al Random effects 1.04 0.80–1.35 χ2 = 14.65, χ2 = 5.57,
2002 (16), Lönn et al 2005 (20), Hardell et al 2005 (23), P=0.02 P=0.47
Hardell et al 2005 (24), Shoemaker et al 2005 (22)
Temporal tumors f Hardell et al 1999 (1), Muscat et al 2000 (12), Inskip et al 2001 Random effects 1.02 0.68–1.52 χ2 = 32.69, χ2 = 6.81,
(13), Johansen et al 2001 (14), Hardell et al 2002 (16), Lönn et P< 0.01 P=0.45
al 2005 (20), Hardell et al 2005 (23), Hardell et al 2005 (24)
Occipital tumors g Muscat et al 2000 (12), Inskip et al 2001 (13), Johansen et Fixed effects 0.82 0.54–1.25 χ2 = 3.29, .
al 2001 (14), Hardell et al 2002 (16), Lönn et al 2005 (20)  P=0.52
Contralateral Hardell et al 2002 (16), Lönn et al 2005 (20), Schoemaker et al Random effects 1.02 0.78–1.35 χ2 = 11.56, χ2 = 4.30,
tumors h, i 2005 (22), Hardell et al 2005 (23), Hardell et al 2005 (24) P=0.02 P=0.37
Ipsilateral Hardell et al 1999 (1), Inskip et al 2001 (13), Hardell et al 2002 Random effects 1.36 0.99–1.87 χ2 = 24.51, χ2 = 10.70,
tumors h, j (16), Muscat et al 2002 (17), Lönn et al 2005 (20), Schoemaker P=0.01 P=0.15
et al 2005 (22), Hardell et al 2005 (23), Hardell et al 2005 (24)
Ipsilateral gliomas j Hardell et al 1999 (1), Inskip et al 2001 (13), Lönn et al Random effects 1.33 0.78–2.28 χ2 = 10.34, χ2 = 2.67,
2005 (20), Hardell et al 2005 (24) P=0.02 P=0.45
Ipsilateral Hardell et al 1999 (1), Inskip et al 2001 (13), Lönn et al Fixed effects 1.16 0.82–1.63 χ2 = 1.96, .
meningiomas j 2005 (20), Hardell et al 2005 (24) P=0.58
Ipsilateral acoustic Inskip et al 2001 (13), Muscat et al 2002 (17), Schoemaker Random effects 1.05 0.41–2.67 χ2 = 10.91, χ2 = 4.62,
neuromas j et al 2005 (22), Hardell et al 2005 (23) P=0.01 P=0.20
a The longest duration of exposure was >5 years in all other reports, except in that of Muscat et al (12), in which >4 years was used, that of Johansen et al
(14) with a mean follow-up time of 3.1 years, that of Auvinen et al (15), in which >2 years was used, and that of Muscat et al (17), which used 3–6 years.
b The exposure was defined as ≥424 hours in all other reports, except in that of Hardell et al (16), in which >55 hours was used, in that of Muscat et al (17),
in which >60 hours was used, and in those of Hardell et al (23, 24), in which >64 hours was used.
c The glioma group consisted of astrocytic, oligodendroglial, and ependymal tumors and mixed gliomas.
d The exposure was defined as >5 years in all other reports, except in those of Hardell et al (1, 16), in which >1 years was used, in that of Muscat et al (12),
in which >4 years was used, in that of Johansen et al (14), which reported “ever use”, in that of Auvinen et al (15), in which >2 years was used, and in that
of Muscat et al (17) in which 3–6 years was used.
e The exposure was defined as >5 years in all other reports except in that of Auvinen et al (15), in which >2 years was used.
f The exposure was defined as >5 years in all other reports, except in that of Hardell et al (1), in which >1 years was used, in that of Muscat et al (12), which
reported “ever use”, in that of Inskip et al (13), which reported “used more than five times”, and in that of Johansen et al (14), in which the exposure
duration was undefined.
g The exposure was defined as “ever use” in that of Muscat et al 12, “used more than five times” in that of Inskip et al (13), >1 years in that of Hardell et
al (16), and >5 years in that of Lönn et al (20), whereas in that of Johansen et al (14) the exposure duration was undefined.
h Contralateral = tumor located on the side opposite of that generally used for the mobile phone, ipsilateral = tumor located on the same side generally
used for the mobile phone.
i The exposure was defined as >1 years in all other reports except in those of Lönn et al (20) and Hardell et al (24), in which >5 years was used.
j The exposure was defined as >1 years in all other reports, except in that of Inskip et al (13) in which >0.5 years was used and in those of  Lönn et al (20)
and Hardell et al (24) in which >5 years was used.
Tumor type(s), Included studies l Pooled
or other OR
restrictions
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acoustic neuroma) or anatomic location (temporal or
occipital lobe) of intracranial tumors. The regression
analysis showed no clear association between the dura-
tion of mobile phone use and the risk of intracranial tu-
mors.
A somewhat increased odds ratio for ipsilateral tu-
mors was found, but the finding was nonsignificant. On
the contrary, the pooled odds ratio for contralateral tu-
mors was very close to unity. It is evident that the re-
ported use of a mobile phone is subject to uncertainty
due to both random error and information bias (recall
bias). Several studies have shown substantial random
error already for the short-term recall of mobile phone
use (27–29). No studies have been reported with respect
to comparing the accuracy of reported mobile phone use
between cases and controls to evaluate possible infor-
mation bias. However, the fact that some studies have
shown decreased risks on the contralateral side suggests
information bias (16, 20).
Our analysis was based on users with the longest
possible duration of mobile phones. In most studies,
these were people with at least 5 years of mobile phone
use. This approach was chosen a priori, as mobile
phones have been introduced relatively recently and
therefore a sufficient duration of exposure and latency
to allow detection of possible effect was considered a
key limitation of the published studies. We felt that the
gains of having a well-defined exposed group with the
highest achievable duration of exposure outweighed the
disadvantage of excluding 50% of the persons in the in-
termediate exposure category. Five years is still, how-
ever, a relatively short time for the induction of intrac-
ranial tumors, even if the postulated mechanism, if any,
has been thought to be based on promotion rather than
on initiation because radiofrequency fields do not have
the energy to break the chemical bonds (cause ioniza-
tion) required for inducing mutations. Hence a limita-
tion of the studies conducted so far is the relatively small
number of persons with long-term (eg, more than
10 years) mobile phone use.
Meta-analyses of nonrandomized studies are more
prone to bias than those combining experimental stud-
ies. One source of uncertainty is different adjustment
for confounding between studies. All of the studies in
the current meta-analysis used adjustment for age and
gender. Other established risk factors for intracranial
tumors include hereditary factors and high doses of ion-
izing radiation. These are, however, relatively rare. In
several studies, the influence of these factors was as-
sessed by conducting separate analyses excluding per-
sons with such exposures. As none of the studies report-
ed a substantial effect in such analyses, confounding by
these factors appears unlikely. We did not use quality
assessment and scoring because the methodology in all
of the studies was similar.
We found statistically significant heterogeneity be-
tween the results from different studies in the main anal-
ysis of all intracranial tumors and additionally in 11 of
16 subgroup analyses. This finding could be due to dif-
ferences between the studies in procedures or definitions
related to end points or exposure assessment. An alter-
native explanation for inconsistent results is the varia-
bility of the true effect between study populations [eg,
due to exposure patterns such as the intensity of mobile
phone use, field strength (specific absorption rate) or
other features].
Furthermore, pooling studies requires that they have
been conducted in a comparable fashion, and the pub-
lished reports contain the essential information to be
extracted. We found some inconsistencies in the expo-
sure classification between the studies. Most important-
ly, the cut-point for the longest exposure duration var-
ied between studies. Furthermore, five studies did not
report analogue and digital phones separately, four did
not specify the laterality of mobile phone use, and three
studies of astrocytomas did not specify tumor lobe.
Figure 3. Funnel plot of the studies includ-
ed in the meta-analysis, showing no evi-
dence of publication bias concerning in-
tracranial tumors and mobile phone use.
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Due to the incomplete reporting of data in published
studies, we were not able to evaluate several factors si-
multaneously (eg, ipsilateral acoustic neuromas) in re-
lation to use of analogue phones. We chose to exclude
a cohort study with brain tumor mortality as the end
point because, in such analyses, determinants of survival
(case fatality) may also affect the results if correlated
with the exposure of interest (7). In this case, the study
was so small (2 exposed cases) that its inclusion would
not have affected our results.
The number of intracranial tumors among long-term
mobile phone users in the current meta-analysis was still
only approximately 750. However, results from this
meta-analysis indicate that the use of mobile phones for
up to 5 years does not increase intracranial tumor risk.
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Selection Bias Due to Differential Participation in a Case–Control
Study of Mobile Phone Use and Brain Tumors
ANNA LAHKOLA, MSC, TIINA SALMINEN, PHD, AND ANSSI AUVINEN, MD, PHD
PURPOSE: To evaluate the possible selection bias related to the differential participation ofmobile phone
users and non-users in a Finnish case–control study on mobile phone use and brain tumors.
METHODS: Mobile phone use was investigated among 777 controls and 726 cases participating in the full
personal interview (full participants), and 321 controls and 103 cases giving only a brief phone interview
(incomplete participants). To assess selection bias, the Mantel-Haenszel estimate of odds ratio was
calculated for three different groups: full study participants, incomplete participants, and a combined group
consisting of both full and incomplete participants.
RESULTS: Among controls, 83% of the full participants and 73% of the incomplete participants had
regularly used amobile phone. Among cases, the ﬁgures were 76% and 64%, respectively. The odds ratio for
brain tumor based on the combined group of full and incomplete participants was slightly closer to unity
than that based only on the full participants.
CONCLUSIONS: Selection bias tends to distort the effect estimates below unity, while analyses based on
more comprehensive material gave results close to unity.
Ann Epidemiol 2005;15:321–325.  2005 Elsevier Inc. All rights reserved.
KEY WORDS: Brain Neoplasms, Case–Control Studies, Cellular Phones, Selection Bias.
INTRODUCTION
The use of mobile phones has increased rapidly in many
countries since the early 1990s. This has generated concern
about possible adverse health effects of mobile phone use,
particularly risk of brain tumors. Few studies have been
published on the issue and the results have been largely
negative (1–8).
The largest study so far is an ongoing international
collaborative case–control study (INTERPHONE) coordi-
nated by the International Agency for Research on Cancer.
In Finland, which is one of the participating countries,
participation proportion among controls has been lower
than in some earlier Finnish case–control studies. The aim
of this study was to evaluate the possible selection bias in
mobile phone use in the Finnish part of the INTERPHONE
study.
MATERIALS AND METHODS
The National Advisory Board on Health Care and Ethics
approved the study protocol. The source population of the
Finnish INTERPHONE study consisted of subjects aged
20 to 69 years, resident in Finland (excluding Northern
Lapland and A˚land with 1.5% of the Finnish population).
The cases were recruited prospectively in the ﬁve Finnish
University hospitals, excluding cases with a previous brain
tumor diagnosis. In Finland, practically all neurosurgical
treatment is provided by these ﬁve hospitals, and the
catchment area of these hospitals covers the entire country.
The controls were identiﬁed from the Population Register
Centre with frequency matching on the expected age, sex,
and hospital district distribution of the cases. The controls
were approached by mail and asked to participate in the
study.
Before asking for consent, the subjects were informed of
the aims and procedures of the study, with mobile phone use
as one of the several exposures of interest. All consenting
cases and controls were interviewed by the study personnel.
In the interview, information was obtained onmobile phone
use, X-ray examinations, medical history, working history,
and family history of brain tumors. Regular use of mobile
phones (at least once a week for at least six months) was
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assessed. The interview covered a detailed history of mobile
phone use including start of use, types of phones, laterality,
hands-free equipment, and other circumstances of use.
Those who did not want to participate in the full interview
(approximately 1 hour) were asked to give a brief telephone
interview (roughly 5 minutes) focusing only on mobile
phone use and educational attainment. As detailed in-
formation on mobile phone use is not available, the primary
analysis of brain tumor risk related to mobile phone use will
be based on full participants only.
The study period in the Finnish INTERPHONE study
was from November 2000 to September 2002. The overall
participation proportion in the Finnish part of the
INTERPHONE study was 46% among primary controls
and 84% among cases and the most common reasons given
by the subjects for refusal were lack of time, inconvenience,
and illness in the family. To evaluate the possible bias from
differential participation, data collection on mobile phone
use and education among subjects unwilling to participate in
the full study commenced in April 2001 (ﬁve months after
start of recruitment).
We evaluated possible selection bias by comparing
mobile phone use between full study participants and those
refused subjects who gave the brief telephone interview
(incomplete participants). The effect of education on study
participation and onmobile phone use was also investigated.
For the analyses, education was divided into three classes:
low (elementary or comprehensive school), intermediate
(high school, vocational school or college), and high
(vocational high school, university). Study participation
was evaluated using logistic regression, with explanatory
factors including sex, education, ﬁve-year age group and
mobile phone use. All the analyses were made separately
for cases and controls. A total of 1098 controls (532
women and 566 men) and 829 cases (337 women and 492
men) were included in the analyses. Of the controls, 777
subjects were full participants and 321 incomplete
participants, whereas among cases the numbers of full
and incomplete participants were 726 and 103, respectively.
The number of total refusers was 519 among controls and 65
among cases.
The effect measure used was the Mantel-Haenszel
estimate of odds ratio (OR) obtained from analysis adjusted
for education, region, sex, and ﬁve-year age group. The
effect of selection bias was assessed by comparing the OR
calculated based on the subjects participating in the full
interview (full participants) with the OR calculated using
combined information provided by the full participants and
the subjects accepting only the brief telephone interview
(incomplete participants).
To evaluate mobile phone use among subjects who
declined even the telephone interview, we searched a public
telephone number database for the possible mobile phone
numbers of two sub-groups of controls: randomly selected 50
full participants as well as 50 total refusers. The number
search from the database was performed based on the name
and home address of the subject and those, for whom
a matching entry (in terms of both criteria) was found, were
classiﬁed as mobile phone users.
RESULTS
Regular use of a mobile phone was reported more frequently
by fully participating than incompletely participating
controls; 83% (95% conﬁdence interval [CI], 81, 86) versus
73% (95% CI, 68, 76), respectively. The difference in
reported mobile phone use between full and incomplete
participants was obvious among the female controls; 88%
(95%CI, 85, 92) versus 67% (95%CI, 60, 73). Amongmen,
mobile phone use was comparable among the incomplete
and full participants; the reported prevalence being 80%
(95% CI, 76, 83) and 83% (95% CI, 77, 90), respectively
(Table 1).
Among cases, the reported prevalence of mobile phone
use was 76% (95% CI, 73, 80) among full participants and
64% (95% CI, 55, 74) among incomplete participants.
Again, fully participating female cases reported regular use of
mobile phone more frequently (85%, 95% CI, 80, 89) than
incompletely participating female cases (57%, 95% CI, 42,
71), whereas for men the ﬁgures were similar; 71% (95% CI,
67, 75) and 71% (95% CI, 59, 83), respectively (Table 1).
Controls who participated in the full personal interview
were more highly educated than those who gave consent
only for the brief telephone interview. Of the full
participants, 16% had high, 54% intermediate, and 29%
low level of education, whereas those ﬁgures for the
incomplete participants were 9%, 44%, and 48%, respec-
tively (p ! 0.001). A similar phenomenon was observed
among cases; the proportion of highly educated people was
higher among the fully participating than among the in-
completely participating cases (22% and 6%, respectively).
Education was also related to mobile phone use; among both
cases and controls the subjects with the lowest level of
education were least likely to have used a mobile phone
(Table 2).
In the multivariate logistic regression, mobile phone use
was associated with full participation among both cases and
controls even after controlling for age, sex, and education.
Among controls, the crude OR for participation was 1.9
(95% CI, 1.4, 2.5), whereas the adjusted OR was 1.9 (95%
Selected Abbreviations and Acronyms
CI Z conﬁdence interval
OR Z odds ratio
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CI, 1.4, 2.8). Among cases the corresponding ORs were 1.8
(95% CI, 1.1, 2.8) and 1.5 (95% CI, 0.9, 1.4), respectively.
The odds ratio for brain tumor associated with regular use
of a mobile phone based on full study participants was 0.55
(95% CI, 0.39, 0.77) whereas the OR based on the
incomplete participants (those not willing to give a full
personal interview) was 0.62 (95% CI, 0.26, 1.51). The OR
based on the full set of subjects (including both the full and
incomplete participants) was 0.73 (95% CI, 0.56, 0.96). For
female full participants and combined group of full and
incomplete participants the ORs were 0.52 (95% CI, 0.28,
0.97) and 0.94 (95% CI, 0.62, 1.42), respectively. For males
the ﬁgures were 0.56 (95%CI, 0.38, 0.84) and 0.61 (95%CI,
0.43, 0.88), respectively.
Of the 50 randomly selected controls who gave a full
interview, 64% had a listed mobile phone number, whereas
among the 50 totally refused controls mobile phone number
was available only for 42% (pZ 0.03).
DISCUSSION
Our results demonstrate that mobile phone users are
somewhat more likely to participate in a study on brain
TABLE 1. Mobile phone use among study subjects by sex and study participation, Finnish case–control study of brain tumors
Regular use of mobile phone
Yes No Total
Controls Women Full participants* 287 (88%) 39 (12%) 326 (100%)
Incomplete participantsy 135 (67%) 68 (34%) 203 (100%)
Total 422 (80%) 107 (20%) 529 (100%)
Men Full participants 359 (80%) 92 (20%) 451 (100%)
Incomplete participants 95 (83%) 19 (17%) 114 (100%)
Total 454 (80%) 111 (20%) 565 (100%)
All Full participants 646 (83%) 131 (17%) 777 (100%)
Incomplete participants 230 (73%) 87 (87%) 317 (100%)
Total 876 (80%) 218 (20%) 1094 (100%)
Cases Women Full participants 245 (85%) 45 (16%) 290 (100%)
Incomplete participants 26 (57%) 20 (44%) 46 (100%)
Total 271 (81%) 65 (19%) 336 (100%)
Men Full participants 309 (71%) 127 (29%) 436 (100%)
Incomplete participants 39 (71%) 16 (29%) 55 (100%)
Total 348 (71%) 143 (29%) 491 (100%)
All Full participants 554 (76%) 172 (24%) 726 (100%)
Incomplete participants 65 (64%) 36 (36%) 101 (100%)
Total 619 (75%) 208 (25%) 827 (100%)
*Full personal interview.
yBrief telephone interview only.
TABLE 2. Educational level among study subjects by study participation and mobile phone use, Finnish case–control study of brain
tumors
Educational level
Low Intermediate High Total
Controls Full participants* 228 (29%) 422 (54%) 127 (16%) 777 (100%)
Incomplete participantsy 150 (48%) 138 (44%) 28 (9%) 316 (100%)
Total 378 (35%) 560 (51%) 155 (14%) 1093 (100%)
Cases Full participants 257 (35%) 313 (43%) 156 (22%) 726 (100%)
Incomplete participants 51 (50%) 46 (45%) 6 (6%) 103 (100%)
Total 308 (37%) 359 (43%) 162 (20%) 829 (100%)
Controls Phone usersz 260 (30%) 485 (56%) 129 (15%) 874 (100%)
Non-users 115 (54%) 74 (34%) 26 (12%) 215 (100%)
Total 375 (34%) 559 (51%) 155 (14%) 1089 (100%)
Cases Phone users 190 (31%) 288 (47%) 141 (23%) 619 (100%)
Non-users 117 (56%) 70 (34%) 21 (10%) 208 (100%)
Total 307 (37%) 358 (43%) 162 (20%) 827 (100%)
*Full personal interview.
yBrief telephone interview only.
zMobile phone use at least once a week for at least 6 months.
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tumor etiology than non-users. A higher proportion of
subjects, who gave a full personal interview, had used
a mobile phone regularly than those consenting only to
a brief telephone interview, both among cases and controls.
This difference wasmore pronounced amongwomen in both
cases and controls.
Differences in participation by exposure status can
induce selection bias. Results based only on the full
participants showed an apparent protective effect of mobile
phone use. However, this effect was substantially reduced
when also subjects agreeing only to a brief telephone
interview were included in the analysis. If information of
total refusers had been available, we assume that the
estimate would have been even closer to 1.0 and non-
signiﬁcant. Even minor distortion of results may be of
consequence; the results of the earlier studies suggest that
the effect of mobile phone use on brain tumor risk is likely to
be small, if any.
To evaluate selection bias, i.e., differences between the
target population and actual study subjects (full partici-
pants), we compared those who fully complied (gave
personal interview) with partial compliers (only a short
telephone interview). The majority of the subjects refusing
the full interview did provide information on education and
regular use of mobile phones but we still lacked information
from those subjects who declined completely or could not be
contacted. However, we obviously had a little information
on those people, when we conducted the mobile phone
number search and found out that listed mobile phone
numbers could be found for fewer total refusers than full
participants (42% versus 64%). This difference was even
greater than that between incomplete and full participants
in reported prevalence of mobile phone use (73% vs. 83%).
Yet, this does not include unlisted phone numbers
(approximately 6% of all mobile phone numbers) that
were not available from the public telephone number
database. However, this would affect the comparison only if
the proportion of unlisted numbers differed between total
refusers and complete participants.
It is likely that a proportion of those who could not be
contacted would have agreed to participate in the study.
Therefore, this group probably represents both full and
incomplete participants and would not differ as much from
the full participants as those who refused to take part in the
study. Overall, the difference between full participants and
other eligible study subjects is probably greater than that
observed between full and incomplete participants but less
than that between refusers and full participants.
The relationship between willingness to participate and
use of mobile phones was partly related to the level of
education. However, the differences between full and
incomplete participants remained in our study even after
adjustment for education.
Selection bias due to non-response is a potential
problem in all case–control studies with incomplete
enrolment, and evaluation of differential recruitment in
terms of exposure of interest is essential (9). However,
magnitude of selection bias depends not only on the
completeness of response, but also the distribution of
exposure between participants and non-participants (10).
In our study, there was evidence for higher participation
among mobile phone users than non-users, among both
cases and controls. This resulted in only slight distortion
of the outcome measure away from the null. As selection
bias is a particularistic phenomenon, our results pertain to
the Finnish study alone and generalization to other
studies, even those following the same study protocol, is
problematic. Though encouraging, our results give only
limited information on the overall validity of the
INTERPHONE study, as other biases may also distort
the results, including recall bias. Considering the risk
estimates corrected for selection bias, it also should be
kept in mind that they are based on only a subset of the
Finnish INTERPHONE study, combining different types
of brain tumors and furthermore, unadjusted for potential
confounders. Therefore, the results are not applicable for
risk assessment concerning mobile phone use and brain
tumors.
In conclusion, substantial distortion of results due to
selection bias related to differences in mobile phone use
among full study participants and incomplete participants
appears unlikely in our study.
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